0001493152-21-031557.txt : 20211215 0001493152-21-031557.hdr.sgml : 20211215 20211215151026 ACCESSION NUMBER: 0001493152-21-031557 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20211031 FILED AS OF DATE: 20211215 DATE AS OF CHANGE: 20211215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hartford Great Health Corp. CENTRAL INDEX KEY: 0001482554 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 205422795 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54439 FILM NUMBER: 211494011 BUSINESS ADDRESS: STREET 1: 8832 GLENDON WAY CITY: ROSEMEAD STATE: CA ZIP: 91770 BUSINESS PHONE: 626-656-6192 MAIL ADDRESS: STREET 1: 8832 GLENDON WAY CITY: ROSEMEAD STATE: CA ZIP: 91770 FORMER COMPANY: FORMER CONFORMED NAME: Photoamigo, Inc. DATE OF NAME CHANGE: 20100128 10-Q 1 form10-q.htm
0001482554 false 7/31 Q1 P5Y P5Y P2Y P2Y 0001482554 2021-08-01 2021-10-31 0001482554 2021-12-15 0001482554 2021-10-31 0001482554 2021-07-31 0001482554 HFUS:TuitionMember 2021-08-01 2021-10-31 0001482554 HFUS:TuitionMember 2020-08-01 2020-10-31 0001482554 us-gaap:ServiceMember 2021-08-01 2021-10-31 0001482554 us-gaap:ServiceMember 2020-08-01 2020-10-31 0001482554 2020-08-01 2020-10-31 0001482554 us-gaap:CommonStockMember 2021-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001482554 us-gaap:RetainedEarningsMember 2021-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2021-07-31 0001482554 us-gaap:CommonStockMember 2021-08-01 2021-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-31 0001482554 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-08-01 2021-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2021-08-01 2021-10-31 0001482554 us-gaap:CommonStockMember 2021-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001482554 us-gaap:RetainedEarningsMember 2021-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2021-10-31 0001482554 us-gaap:CommonStockMember 2020-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0001482554 us-gaap:RetainedEarningsMember 2020-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2020-07-31 0001482554 2020-07-31 0001482554 us-gaap:CommonStockMember 2020-08-01 2020-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2020-08-01 2020-10-31 0001482554 us-gaap:RetainedEarningsMember 2020-08-01 2020-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-01 2020-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2020-08-01 2020-10-31 0001482554 us-gaap:CommonStockMember 2020-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2020-10-31 0001482554 us-gaap:RetainedEarningsMember 2020-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2020-10-31 0001482554 2020-10-31 0001482554 HFUS:HangzhouLongjingQiaoFuVacationHotelCoLtdMember 2020-12-31 0001482554 HFUS:ShanghaiHartfordComprehensiveHealthManagementLtdMember 2020-12-31 0001482554 HFUS:ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember 2020-03-23 0001482554 HFUS:PudongHaojinChildhoodEducationLtdMember 2019-07-24 0001482554 HFUS:EarlyChildhoodEducationServicesMember 2021-08-01 2021-10-31 0001482554 HFUS:EarlyChildhoodEducationServicesMember 2020-08-01 2020-10-31 0001482554 HFUS:JointVentureAgreementMember 2019-03-22 0001482554 HFUS:ShareholdersMember HFUS:HartfordGreatHealthManagementShanghaiLtdMember 2020-07-31 0001482554 HFUS:JointVentureAgreementMember srt:MaximumMember 2020-06-19 0001482554 HFUS:JointVentureAgreementMember srt:MinimumMember 2020-06-19 0001482554 HFUS:HFIntlEducationMember 2021-08-01 2021-10-31 0001482554 HFUS:HFIntlEducationMember 2021-05-30 2021-06-01 0001482554 HFUS:JointVentureAgreementMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember HFUS:SevenEducationTextbooksMember 2019-03-22 0001482554 HFUS:JointVentureAgreementMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember HFUS:TenHaiDeFuDeMember 2019-03-22 0001482554 HFUS:JointVentureAgreementMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember srt:ChiefExecutiveOfficerMember 2021-03-31 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember 2020-07-20 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember 2020-07-19 2020-07-20 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember 2021-07-31 0001482554 HFUS:ShanghaiSeniorHealthConsultingLtdMember 2019-02-28 0001482554 HFUS:ShanghaiSeniorHealthConsultingLtdMember 2019-01-31 0001482554 HFUS:ShanghaiPasadenaLtdMember 2019-02-28 0001482554 HFUS:ShanghaiPasadenaLtdMember 2019-01-31 0001482554 HFUS:ShanghaiLuoShengInternationalTradeLtdMember 2019-01-31 0001482554 HFUS:HartfordGreatHealthManagementShanghaiLtdMember HFUS:QiaoGardenInternationalTravelAgencyMember 2020-12-31 0001482554 HFUS:HartfordGreatHealthManagementShanghaiLtdMember HFUS:QiaoGardenInternationalTravelAgencyMember 2020-12-30 2020-12-31 0001482554 HFUS:QiaoGardenIntelTravelMember 2020-12-31 0001482554 HFUS:QiaoGardenIntelTravelMember 2020-12-29 2020-12-31 0001482554 us-gaap:LeaseholdImprovementsMember 2021-10-31 0001482554 us-gaap:LeaseholdImprovementsMember 2021-07-31 0001482554 HFUS:FinanceLeaseAssetsMember 2021-10-31 0001482554 HFUS:FinanceLeaseAssetsMember 2021-07-31 0001482554 us-gaap:FurnitureAndFixturesMember 2021-10-31 0001482554 us-gaap:FurnitureAndFixturesMember 2021-07-31 0001482554 HFUS:OfficeEquipmentVehiclesMember 2021-10-31 0001482554 HFUS:OfficeEquipmentVehiclesMember 2021-07-31 0001482554 us-gaap:ConstructionInProgressMember 2021-10-31 0001482554 us-gaap:ConstructionInProgressMember 2021-07-31 0001482554 srt:MinimumMember 2021-07-31 0001482554 srt:MaximumMember 2021-07-31 0001482554 HFUS:TwoSubleaseAgreementsMember 2020-05-31 0001482554 HFUS:TwoSubleaseAgreementsMember 2020-05-29 2020-05-31 0001482554 HFUS:NewleaseAgreementMember 2020-06-01 0001482554 HFUS:SubleaseAgreementsMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2021-08-01 2021-10-31 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember HFUS:FiveYearNewleaseAgreementMember 2020-09-02 0001482554 HFUS:EarlyTerminationAgreementMember 2021-07-31 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember HFUS:EarlyTerminationAgreementMember 2021-07-01 2021-07-31 0001482554 HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember 2021-01-06 0001482554 HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember 2021-01-09 0001482554 HFUS:HangzhouLongjingQiaoFuVacationHotelCoLtdMember 2010-10-01 0001482554 HFUS:ShanghaiQiaohongRealEstateCoLtdMember 2021-10-31 0001482554 HFUS:ShanghaiQiaohongRealEstateCoLtdMember 2021-08-01 2021-10-31 0001482554 HFUS:ShanghaiQiaohongRealEstateCoLtdMember 2020-08-01 2020-10-31 0001482554 HFUS:HFHMMember us-gaap:LicenseMember 2021-10-31 0001482554 HFUS:AffiliatesMember 2021-10-31 0001482554 HFUS:AffiliatesMember 2021-07-31 0001482554 HFUS:ShanghaiQiaoGardenPropertyManagementGroupMember 2021-10-31 0001482554 HFUS:ShanghaiQiaoGardenPropertyManagementGroupMember 2021-07-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2021-10-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2021-07-31 0001482554 HFUS:HartfordHotelInvestmentIncMember HFUS:RelatedPartyMember 2021-10-31 0001482554 HFUS:HartfordHotelInvestmentIncMember HFUS:RelatedPartyMember 2021-08-01 2021-10-31 0001482554 HFUS:HartfordHotelInvestmentIncMember HFUS:RelatedPartyMember 2020-08-01 2020-10-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2021-10-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2021-07-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2019-04-29 2019-04-30 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember HFUS:SecondLongTermAgreementMember 2021-04-29 2021-04-30 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2021-08-01 2021-10-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2020-08-01 2020-10-31 0001482554 HFUS:HartfordGreatHealthManagementShanghaiLtdMember 2020-12-31 0001482554 HFUS:HartfordGreatHealthManagementShanghaiLtdMember HFUS:QiaoGardenInternationalTravelAgencyMember 2020-12-29 2020-12-31 0001482554 2020-12-29 2020-12-31 0001482554 HFUS:HFIntlEducationMember HFUS:TwoDebtAgreementsMember 2019-09-30 0001482554 HFUS:HFIntlEducationMember HFUS:TwoDebtAgreementsMember 2019-09-29 2019-09-30 0001482554 HFUS:HZLJMember 2021-10-31 0001482554 HFUS:HZLJMember 2021-07-31 0001482554 HFUS:HZLJMember 2021-08-01 2021-10-31 0001482554 HFUS:HFIntlEducationMember 2021-10-31 0001482554 HFUS:HFIntlEducationMember 2021-07-31 0001482554 HFUS:HFIntlEducationMember 2021-08-01 2021-10-31 0001482554 HFUS:HZLJMember 2020-07-31 0001482554 HFUS:HZLJMember 2020-08-01 2021-07-31 0001482554 HFUS:HFIntlEducationMember 2020-07-31 0001482554 HFUS:HFIntlEducationMember 2020-08-01 2021-07-31 0001482554 HFUS:QiaoGardenIntTravelMember 2020-07-31 0001482554 HFUS:QiaoGardenIntTravelMember 2020-08-01 2021-07-31 0001482554 HFUS:QiaoGardenIntTravelMember 2021-07-31 0001482554 2020-08-01 2021-07-31 0001482554 HFUS:SHHZJMember 2021-07-31 0001482554 HFUS:TwoLeaseAgreementsMember 2020-04-12 2020-04-13 0001482554 HFUS:TwoLeaseAgreementsMember 2021-08-01 2021-10-31 0001482554 HFUS:HFSHMember HFUS:SublessorMember 2021-07-06 2021-07-07 0001482554 HFUS:HartfordInternationalEducationTechnologyCoLtdMember HFUS:SublessorMember 2021-07-06 2021-07-07 0001482554 HFUS:TwoLeaseAgreementsMember HFUS:NonrefundableRentalDepoitMember 2021-07-06 2021-07-07 0001482554 HFUS:IntellectualPropertiesMember HFUS:HFHMMember 2021-08-01 2021-10-31 0001482554 HFUS:HFHMMember us-gaap:LicenseMember 2021-08-01 2021-10-31 0001482554 HFUS:HFHMMember us-gaap:LicenseMember 2020-08-01 2021-07-31 0001482554 HFUS:HospitalityMember 2021-08-01 2021-10-31 0001482554 HFUS:EducationMember 2021-08-01 2021-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2021-08-01 2021-10-31 0001482554 HFUS:HospitalityMember 2021-10-31 0001482554 HFUS:EducationMember 2021-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2021-10-31 0001482554 HFUS:HospitalityMember 2020-08-01 2020-10-31 0001482554 HFUS:EducationMember 2020-08-01 2020-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2020-08-01 2020-10-31 0001482554 HFUS:HospitalityMember 2020-10-31 0001482554 HFUS:EducationMember 2020-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2020-10-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:CNY xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: October 31, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

For the transition period from ________ to ________

 

Commission File Number: 000-54439

 

HARTFORD GREAT HEALTH CORP.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada

(State or other jurisdiction of incorporation or organization)

 

51-0675116

(I.R.S. Employer Identification Number)

 

8832 Glendon Way, Rosemead, California 91770

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number including area code: (626)321-1915

 

 

Former name, former address, and former fiscal year, if changed since last report

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by checkmark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.001 par value   HFUS   OTC Markets Group

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 100,108,000 shares of common stock outstanding as of December 15, 2021.

 

 

 

 

 

 

Index

 

      Page
Part I - FINANCIAL INFORMATION    
       
Item 1. Unaudited Consolidated Financial Statements    
  Condensed Consolidated Balance Sheets as of October 31, 2021 (unaudited) and July 31, 2021   3
  Condensed Consolidated Statements of Operations (unaudited) for the three months ended October 31, 2021 and 2020   4
  Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) for the three months ended October 31, 2021 and 2020   5
  Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)   6
  Condensed Consolidated Statements of Cash Flows (unaudited) for the three months ended October 31, 2021 and 2020   7
  Notes to Condensed Consolidated Financial Statements (unaudited)   8
       
Item 2. Management’s Discussion and Analysis or Plan of Operation   17
       
Item 3. Quantitative and Qualitative Disclosures About Market Risk   20
       
Item 4. Controls and Procedures   20
       
Part II - OTHER INFORMATION    
       
Item 1. Legal Proceedings   21
       
Item 1A. Risk Factors   21
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   21
       
Item 3. Defaults Upon Senior Securities   21
       
Item 4. Mine Safety Disclosures   21
       
Item 5. Other Information   21
       
Item 6. Exhibits   21
       
SIGNATURES   22

 

2

 

 

HARTFORD GREAT HEALTH CORP.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   October 31, 2021   July 31, 2021 
   (Unaudited)     
ASSETS          
Current Assets          
Cash and cash equivalents  $44,284   $27,612 
Restricted cash   -    26,566 
Prepaid and Other current receivables   173,825    286,232 
Related party receivable   431,356    325,864 
Inventory   324,120    323,814 
Total Current Assets   973,585    990,088 
Non-current Assets          
Property and equipment, net   744,392    593,517 
ROU assets-operating lease   3,642,091    3,837,186 
Other assets   246,785    321,807 
Total Non-current Assets   4,633,268    4,752,510 
TOTAL ASSETS  $5,606,853   $5,742,598 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities          
Related party loan and payables  $4,933,706   $4,391,325 
Contract liabilities   606,383    545,346 
Current operating Lease liabilities   2,460,483    2,508,959 
Other current payable   556,298    471,603 
Total Current Liabilities   8,556,870    7,917,233 
           
Long-term loan from related party   670,007    657,572 
Lease liabilities, noncurrent   2,061,154    2,154,243 
TOTAL LIABILITIES   11,288,031    10,729,048 
           
Commitments and contingencies (Note 13)   -    - 
           
Stockholders’ Equity (Deficit)          
Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding   -    - 
Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of October 31 and July 31, 2021   100,108    100,108 
Additional paid-in capital   2,173,521    2,173,521 
Accumulated deficit   (6,403,051)   (5,821,519)
Accumulated other comprehensive loss   (270,962)   (233,487)
Noncontrolling interest   (1,280,794)   (1,205,073)
Total Stockholders’ Deficit   (5,681,178)   (4,986,450)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $5,606,853   $5,742,598 

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

3

 

 

HARTFORD GREAT HEALTH CORP.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

       
   Three months ended 
   October 31, 
   2021   2020 
Tuition revenue  $155,364   $46,593 
Service revenue   14,448    32,794 
Total revenue   169,812    79,387 
           
Operating cost and expenses          
Cost of revenue   335,004    133,948 
Depreciation and amortization   28,219    19,141 
Selling, general and administrative   479,540    584,504 
Total Operating Cost and Expenses   842,763    737,593 
Operating Loss   (672,951)   (658,206)
           
Other Income (Expense)          
Interest (expense), net   (16,166)   (822)
Other income, net   40,957    678 
Other income (expense), net   24,791    (144)
           
Loss before income taxes   (648,160)   (658,350)
Income Tax Expense   -    800 
Net Loss   (648,160)   (659,150)
Less: net loss attributable to noncontrolling Interest   (66,628)   (134,393)
           
Net Loss Attributable to Hartford Great Health Corp  $(581,532)  $(524,757)
           
Net loss per common share:          
Basic and Diluted  $(0.01)  $(0.01)
Weighted average shares outstanding:          
Basic and diluted   100,108,000    99,108,000 

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

4

 

 

HARTFORD GREAT HEALTH CORP.

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

 

       
   Three months ended 
   October 31, 
   2021   2020 
Net Loss  $(581,532)  $(524,757)
Other Comprehensive income (loss), net of income tax          
Foreign currency translation adjustments   (46,568)   (108,456)
Total other comprehensive loss   (46,568)   (108,456)
Less: total other comprehensive loss attributable to noncontrolling interest    (9,093)   (28,212)
Total Other Comprehensive Loss Attributable to Hartford Great Health Corp   (37,475)   (80,244)
Total Comprehensive Loss  $(619,007)  $(605,001)

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

5

 

 

HARTFORD GREAT HEALTH CORP.

 

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

 

                   Accumulated       Total 
           Additional       Other       Stockholders’ 
   Common Stock   Paid - in   Accumulated   Comprehensive   Noncontrolling   Equity 
   Shares   Amount   Capital   (Deficit)   loss   Interest   (Deficit) 
Balance, July 31, 2021   100,108,000    100,108    2,173,521    (5,821,519)   (233,487)   (1,205,073)   (4,986,450)
Net (loss)   -    -    -    (581,532)   -    (66,628)   (648,160)
Foreign currency translation adjustment   -    -    -    -    (37,475)   (9,093)   (46,568)
Balance, October 31, 2021 (unaudited)   100,108,000    100,108    2,173,521    (6,403,051)   (270,962)   (1,280,794)   (5,681,178)

 

                   Accumulated       Total 
           Additional       Other       Stockholders’ 
   Common Stock   Paid - in   Accumulated   Comprehensive   Noncontrolling   Equity 
   Shares   Amount   Capital   (Deficit)   loss   Interest   (Deficit) 
Balance, July 31, 2020   99,108,000    99,108    2,154,521    (3,568,185)   (55,146)   (917,489)   (2,287,191)
Net (loss)   -    -    -    (524,757)   -    (134,393)   (659,150)
Foreign currency translation adjustment   -    -    -    -    (80,244)   (28,212)   (108,456)
Balance, October 31, 2020 (unaudited)   99,108,000    99,108    2,154,521    (4,092,942)   (135,390)   (1,080,094)   (3,054,797)

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

6

 

 

HARTFORD GREAT HEALTH CORP.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

 

   2021   2020 
   Three months ended 
   October 31, 
   2021   2020 
Cash flows from operating activities:          
Net loss including noncontrolling interests  $(648,160)  $(659,150)
Adjustments to reconcile net loss including noncontrolling interests to net cash (used in) operating activities:          
Depreciation and amortization   28,219    19,141 
Loss on disposal of property and equipment   -    733 
Changes in operating assets and liabilities:          
Prepaid and other current receivables   116,580    (21,729)
Inventory   2,497    (87,962)
Other assets   74,757    87,026 
Related party receivables and payables   (123,017)   12,607 
Contract liabilities   55,881    75,203 
Other current payable   35,152    (76)
Operating lease assets and liabilities   39,003    62,101 
Other liabilities   6,997    6,534 
Net cash (used in) operating activities   (412,091)   (505,572)
Cash flows from investing activities:          
Cash proceeds from Acquisitions   -    26,924 
Cash used in Acquisitions   -    (14,660)
Purchases of property and equipment   (127,928)   - 
Net cash (used in) provided by investing activities   (127,928)   12,264 
Cash flows from financing activities:          
Proceeds of related party notes payable   60,000    25,156 
Principal payments on finance lease   -    (21,257)
Advances from related parties   469,995    506,288 
Net cash provided by financing activities   529,995    510,187 
           
Effect of exchange rate changes on cash   130    2,540 
Net change in cash, cash equivalents and restricted cash   (9,894)   19,419 
Cash, cash equivalents and restricted cash at beginning of period   54,178    65,277 
Cash, cash equivalents and restricted cash at end of period  $44,284   $84,696 
           
Supplemental Cash Flow Information          
Interest paid  $-   $- 
Income taxes paid  $-   $800 
Non-cash investing and financing activities:          
Payable to acquiree  $-   $10,462 
Unpaid bills for leaseholder improvements  $44,946   $- 

 

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

 

7

 

 

HARTFORD GREAT HEALTH CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. The financial statements and notes are the responsibility of the Company’s management. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied in the preparation of the financial statements. This disclosure should be read in conjunction with our audited financial statements for the year ended July 31, 2021, including footnotes, contained in our Annual Report on Form 10-K,

 

Organization

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.

 

Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s 60 percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”) and its 90 percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020, see note 3 Acquisitions, Joint Ventures and Deconsolidation.

 

The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two 100% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”).

 

Basis of Presentation

 

The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation. The Company’s net income (loss) excludes income (loss) attributable to the noncontrolling interests.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Reclassifications

 

Certain amounts on the prior-year consolidated balance sheet, consolidated statement of operations and cash flows were reclassified to conform to current-year presentation, with no effect on ending stockholders’ equity.

 

8

 

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.

 

Revenue Recognition

 

The Company adopted ASC Topic 606 Revenue from Contracts with Customers (“Topic 606) on August 1, 2019, applying the modified retrospective method to all contracts that were not completed as of August 1, 2019. The Company is building up its core business upon the completion of multiple acquisitions in March 2019 and limited operations occurred during the years ended July 31, 2021 due to the impact of COVID-19 pandemic. The revenue for the three months period ended October 31, 2021 and 2020 were mainly generated from HZLJ, PDHJ and Gelinke.

 

Revenue is recognized when control of promised goods or services is transferred to our customers in an amount of consideration to which we expect to be entitled to in exchange for those goods or services. We follow the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. ASC 606 has no material impacts on the Company’s financial positions. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms. The Company recorded $606,383 and $545,346 unsatisfied performance obligations and contract liabilities as of October 31 and July 31, 2021, respectively.

 

a.Early childhood education services: HF Int’l Education generates revenue from childhood education classes provided to its customers. The educational services consist of parent-child and bilingual childcare classes. Each contract of educational classes is accounted for as a single performance obligation which is satisfied proportionately over the service period. Tuition fee is generally collected in advance and is initially recorded as deferred revenue and transferred to contract liabilities after trial period. Refunds are provided to parents if they decide within the trial period that they no longer want to take the class. After the trial period, if a parent withdraws from a class, usually only that unearned portion of the fee is available to be returned. For the three months ended October 31, 2021 and 2020, $155,364 and $46,593, respectively, of revenue were derived from early childhood education classes provided.

 

b.Hospitality services: HZLJ generates revenue primarily from the room rentals, sale of food and beverage and other miscellaneous hospitality services. The Company recognizes room rental and services daily as services are provided. Under ASC 606, the pattern and timing of recognition of income from hotel facility is consistent with the prior accounting model.

 

9

 

 

Recent Accounting Pronouncements.

 

Recently adopted accounting pronouncements

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes which is intended to simplify various aspects related to accounting for income taxes. The standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. The adoption of ASU No. 2019-12 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

Recently issued accounting pronouncements not yet adopted

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. The standard, including subsequently issued amendments (ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10 and ASU 2019-11), requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements.

 

NOTE 2. GOING CONCERN

 

The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp. has incurred losses since inception, resulting in an accumulated deficit of $6,403,051 as of October 31, 2021. These conditions raise substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern.

 

In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.’s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation.

 

The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern.

 

NOTE 3. ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION

 

Joint Venture – HF Int’l Education

 

On March 22, 2019, HFSH entered into a joint venture agreement (the “JV agreement”) with Shanghai Jingyu Education Tech Ltd. (“SH Jingyu”) and one individual investor, to form a new entity - HF Int’l Education to provide childcare education services. HFSH initially owned 65.0% ownership HF Int’l Education, and reduced to 61.0% during the year ended on July 31, 2020 because of equity transactions between noncontrolling shareholders. On June 19, 2020, the board of HF Int’l Education decided to increase registered capital to RMB10 million from RMB5 million, and three out of four noncontrolling shareholders gave up the subscription rights. As a result, HFSH held 75.5% of HF Int’l Education and a total of 24.5% equity was held by noncontrolling shareholders. Pursuant to the board meeting held on June 1, 2021, the noncontrolling shareholders sold a total 14.5% equity at zero consideration to HFSH. As a result, HFSH holds 90.0% of HF Int’l Education and $403,131 noncontrolling loss was absorbed by HFSH as a result of the ownership restructure at HF Int’l Education.

 

Continuous operation losses caused by the market uncertainties including pandemic and government regulations, HF Int’l Education entered agreements to sell the copyrights of seven education textbooks and ten “HaiDeFuDe” registered trademarks owned for RMB1.2 million and RMB1.0 million, respectively, to Hartford Health Management (Shanghai) Co., Ltd (“HFHM”) in March 2021 with approval of the board of directors. The CEO of HFHM is a shareholder of the Company who owns more than 5% of the Company’s common stocks.

 

Operation result of HF Int’l Education are included in the Company’s consolidated financial statements commencing on the formation date. The Company classifies the ownership interest held by other four parties as “Noncontrolling interest” on the consolidated balance sheet.

 

10

 

 

Acquisition of Gelinke

 

On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Gelinke, who engages at early childhood education services in Changning District, Shanghai. The results of operations of the acquired entities are included in the Company’s consolidated financial statements commencing on the acquisition date. The Company has recorded an allocation of purchase price to Gelinke’s tangible and identifiable intangible assets acquired and liabilities assumed based on their fair value at the acquisition date. The Company accounted the acquisition transaction in accordance with FASB ASC 805, Business Combinations, under acquisition accounting method. The related transaction costs were immaterial and included in General and administrative expenses in the accompanying consolidated statements of operations. The acquisition was completed on August 31, 2021. The calculation of purchase price and purchase price allocation is as follows:

 

   Assets Acquired and 
   Liabilities Assumed 
Cash and cash equivalents   1,809 
Restricted Cash   25,009 
Prepaid and Other current receivables   4,696 
Property and Equipment, net   4,294 
Unearned revenue   (78,696)
Goodwill   67,712 
Total consideration*   24,824 

 

*$10,462 (RMB70,000) payable to the acquiree plus $14,362 (RMB100,000) cash payment totaled $24,824 consideration for the acquisition.

 

Goodwill is mainly attributable to synergies expected from the acquisition of license, list of customers and teacher workforce. Due to unfavorable operation result of Gelinke during the year ended July 31, 2021, management determined that $67,712 goodwill generated from Gelinke Acquisition was fully impaired and temporally ease the operation of Gelinke by the end of August, 2021.

 

Other Acquisitions

 

In January and February 2019, HFSH entered agreements to acquire 85 percent ownership of Shanghai Senior Health Consulting Ltd. (“SH Senior”) and 55 percent ownership of Shanghai Pasadena Ltd. (“SH Pasadena”). On December 31, 2020, HFSH withdrew from the two acquisition agreements. No penalty results from the withdrawn.

 

In January 2019, HFSH entered agreements to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”), As of October 31, 2021, the agreement has not yet taken effect as no consideration has been paid toward this acquisition. The agreement will be executed when the Company is financially ready to move forward, and the purchase price will be calculated based on the net assets of each entity on executing dates. There was no penalty levied or to be levied due to delayed execution or inexecution.

 

Disposal of subsidiary

 

On December 31, 2020, HFSH disposed its 90 percent owned subsidiary - Qiao Garden Int’l Travel to an individual (the “Disposal”). The individual is a relative of the CEO, Qiao Garden Int’l Travel became a related party after deconsolidation. The operation results, assets and liabilities, and cash flows of Qiao Garden Int’l Travel were deconsolidated from the Company’s consolidated financial statements effective on December 31, 2020. The Disposal of Qiao Garden was consummated through a three-party settlement among HFSH, SH Qiaohong and Qiao Garden Int’l Travel (the “Three-Party Settlement”): the original investment RMB 4.5 million plus RMB 0.5 million investment income were agreed to returned from Qiao Garden Int’l Travel as a result of the Disposal and settled with a payable due to SH Qiaohong at SHHF, who was a debtor of Qiao Garden Int’l Travel, see Note 14, Related Party Transactions.

 

Net assets (liabilities) disposed of: 

Net assets (liabilities) disposed of:    
Cash and cash equivalents   172 
Restricted cash   29,944 
Related party receivable   782,224 
Related party payable   (98,615)
Other current payable   (3,876)
Noncontrolling interest   (60,812)
Net assets of the subsidiary, excluding noncontrolling interest   649,037 
Consideration   753,354 
Gain on disposal of the subsidiary   (104,317)
Gain on disposal of noncontrolling interest   (60,812)
Gain on disposal of the subsidiary, excluding noncontrolling interest   (43,505)

 

Net inflow / (outflow) of cash and cash equivalents in respect of the disposal subsidiary: 

     
Cash and cash equivalents   (172)
Restricted cash   (29,944)
Cash and cash equivalents deconsolidated   (30,116)

 

11

 

 

NOTE 4. RESTRICTED CASH

 

The Company early adopted ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, and includes restricted cash with cash and cash equivalents when reconciling the beginning of year and end of year total amounts shown on the statements of cash flows. The restricted cash are collaterals required by the local government in China for the early education license Gelinke held as of July 31, 2021, subsequently on August 26, the restricted cash had been withdrawal and transferred to other bank accounts as a result of operation halt at Gelinke.

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows. 

   October 31, 2021
(unaudited)
   July 31, 2021 
Cash and cash equivalents  $44,284   $27,612 
Restricted cash   -    26,566 
Total cash, cash equivalents and restricted cash shown in the statement of cash flows  $44,284   $54,178 

 

NOTE 5. PREPAID AND OTHER CURRENT RECEIVABLES

 

Prepaid and other current receivable amounts of $173,825 and $286,232 as of October 31 and July 31, 2021, respectively, mainly consist of advances for purchase and renovation project, employee operating advances and others.

 

NOTE 6. INVENTORY

 

Inventory mainly consists of books, the early childhood education materials. Inventory is stated at the lower of cost or net realizable value. As of October 31 and July 31, 2021, inventory balance was $324,120 and $323,814, respectively.

 

NOTE 7. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consists of the following at October 31 and July 31, 2021: 

   October 31,   July 31, 
   2021 (unaudited)   2021 
Leasehold improvements  $419,181   $214,184 
Finance lease assets   293,247    290,714 
Furniture and fixtures   311,064    289,000 
Office equipment and vehicles   163,312    161,529 
Construction in progress   18,702    67,044 
 Property and equipment, gross   1,205,506    1,022,471 
Less: accumulated depreciation and amortization   (461,114)   (428,954)
 Property and equipment, net  $744,392   $593,517 

 

Depreciation expense for the three months ended October 31, 2021 and 2020, was $28,219 and $19,141, respectively.

 

NOTE 8. OTHER ASSETS

 

Other assets consist of the following at October 31 and July 31, 2021: 

   October 31, 2021 (unaudited)   July 31, 2021 
Other miscellaneous assets  $30,205   $32,308 
Rental deposits   216,580    289,499 
 Other assets  $246,785   $321,807 

 

NOTE 9. OTHER CURRENT PAYABLES

 

The following is a breakdown of the accounts and other payables as of October 31 and July 31, 2021: 

   October 31, 2021 (unaudited)   July 31, 2021 
Payable to acquirees  $152,636   $151,317 
Accrued payroll   9,553    11,064 
Payable to publisher   140,500    139,287 
Other payables   253,609    169,935 
 Other Current Payables  $556,298   $471,603 

 

Payable to acquiree is the unpaid consideration for the acquisitions described in Note 3 Acquisitions and Joint Venture.

 

12

 

 

NOTE 10. LEASES

 

At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. Leases are classified as either finance leases or operating leases based on criteria in Accounting Standards Codification (“ASC”) 842. Operating leases are included in ROU assets-Operating lease, Current Operating Lease liabilities and Operating lease liabilities, finance leases are included in Property and Equipment and Other Liabilities in the condensed Consolidated Balance Sheet.

 

Right-of-use (“ROU”) assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the lease did not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in China market. ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases, consisting of lease payments, is recognized on a straight-line basis over the lease term. Lease expense for finance leases consists of the amortization of the ROU asset on a straight-line basis over the asset’s estimated useful life and interest expense is calculated using the amortized cost basis.

 

As of July 31, 2021, the Company has multiple operating leases for office spaces and a finance lease of land and hotel building. Our operating leases have remaining lease terms ranging from one year to five years, with various term extensions available. Our finance lease has remaining lease term of thirty years. The Company has elected not to recognize ROU assets and lease liabilities for short-term operating leases that have a term of twelve months or less.

 

In June 2018 and January 2019, HFSH and HF Int’l Education entered two lease agreements with Shanghai Longjin Corporate Management Co., Ltd (the “Sublessor”) to lease office spaces (the “Subleases”). HFSH and HF Int’l Education received Notices of Lease Termination from the Sublessor for late payments on April 13, 2020 and filed a civil lawsuit against the Sublessor on July 10, 2020 (see Note 16). And the original lease agreement entered between the Sublessor and the landlord of the office building (the “Landlord”) was terminated by the Landlord on June 1, 2020 due to payment default. The two sublease agreements entered with the Sublessor was terminated on June 1, 2020 and approximately $921,000 ROU and $891,000 lease liability associated with the two Subleases as of May 31, 2020 were eliminated and $29,000 other expenses was recognized as a result. HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces with a five-year term. On July 13, 2021, HF Int’l Education entered a sublease agreement with sub-lessee (a third party) for some office space with two-year term, amount of $34,711 was recognized as sublease income, included under other income, for the three months ended October 31, 2021.

 

On September 1, 2020, Gelinke entered a five-year new lease agreement at the original office location upon the completion of the acquisition. Approximately $1.2 million ROU and lease liability, respectively, were recognized with the new lease at lease commencement date. On August 15, 2021, an early termination agreement was entered to terminate this lease on August 30, 2021. As a result, approximately $1 million ROU and lease liability, respectively, associated with this lease as of July 31, 2021 were eliminated and $40,005 gain was recognized.

 

HZHF terminated its original office lease on January 6, 2021. Approximately $287,000 ROU and $258,000 lease liability associated with the original lease agreement were eliminated. On January 9, 2021, HFHZ entered into a two-year new lease with smaller space at the same location. Approximately $49,000 ROU and lease liability, respectively, were recognized with the new lease at lease commencement date.

 

The finance lease was obtained through HZLJ acquisition on March 22, 2019. On October 1, 2010, HZLJ took over the lease of the land and hotel building for 41 years. Finance lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease.

 

13

 

 

Lease-related assets and liabilities at October 31 and July 31, 2021 were as follows: 

   October 31,   July 31, 
   2021 (unaudited)   2021 
Assets          
Finance lease right-of-use assets, cost (Note 7)  $293,247   $290,714 
Less: accumulated amortization   (80,814)   (80,547)
Finance lease right-of-use assets, net   212,433    210,167 
ROU assets-Operating lease   3,642,091    3,837,186 
Total Lease ROU assets  $3,854,524   $4,047,353 
Liabilities          
Current Operating Lease liabilities  $2,460,483   $2,508,959 
Operating lease liabilities, noncurrent   1,682,178    1,785,528 
Finance lease liabilities, noncurrent   378,976    368,715 
Total Lease liabilities  $4,521,637   $4,663,202 

 

The components of lease cost for the three months ended October 31, 2021 and 2020: 

       
   Three months ended October 31, 
   2021 (unaudited)   2020 (unaudited) 
Operating lease cost  $306,544   $345,713 
Finance leases:          
Amortization of ROU assets   1,775    1,712 
Interest on finance lease liabilities   6,997    6,661 
Finance lease cost   8,772    8,373 
Total lease cost  $315,316   $354,086 

 

Supplemental cash flow information for leases for the three months ended October 31, 2021 and 2020: 

  Three months ended October 31, 
   2021   2020 
Operating cash flows paid for operating leases  $186,127   $54,230 
Financing cash flows paid for finance leases   -    21,257 

 

The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases at October 31, 2021 was as follows: 

   October 31, 2021 
  Operating Leases   Finance Leases 
Weighted-average remaining lease term (years)   3.8    29.8 
Weighted-average discount rate   8%   8%

 

The following table reconciles the undiscounted future minimum lease payments for operating and finance leases executed at October 31, 2021: 

   Operating Leases   Finance Leases 
2022  $1,211,921   $23,417 
2023   1,153,762    24,197 
2024   1,206,431    24,978 
2025   1,117,410    25,758 
2026   88,795    26,539 
2027 and thereafter   -    963,985 
Total lease payments  $4,778,319   $1,088,874 
Less interest   (635,658)   (709,898)
Present value of future lease payments  $4,142,661   $378,976 
Current Lease liabilities   2,460,483    - 
Noncurrent Lease liabilities   1,682,178    378,976 

 

14

 

 

NOTE 11. RELATED PARTY TRANSACTIONS

 

Related Party Receivables

 

The original loan balance of $721,000 due from Shanghai Qiaohong Real Estate Co., Ltd. (“SH Qiaohong”), the noncontrolling interest of HZLJ, was acquired through HFSH acquisition. HFSH lent the amount to SH Qiaohong for two years on June 21, 2018 bearing annual interest of six percent. On August 1, 2020, the loan has been extended to July 31, 2022. The balance was settled through a Three-way settlement agreement on December 31, 2020, see following “Three-Party Settlement Agreement” paragraph for detail. For the three months ended October 31, 2021 and 2020, $- and $9,778 of interest income were recognized, respectively.

 

$401,147 advances to HFHM were made pursuant to the license agreements entered by HF Int’l Education and its three subsidiaries in June 2021. See Note 14 for details. The remaining related party receivable of $30,209 and $29,948 as of October 31 and July 31, 2021, respectively, represents the operating advances made to the affiliates which are managed by the same management team. These advances do not bear interest and are considered due on demand.

 

Related Party Payables and loans

 

As of October 31 and July 31, 2021, amounts of $621,526 and $616,159, are payable to SH Qiaohong, respectively. The balances were mainly funding support from SH Qiaohong for operation. The funding support bears no interest and due on demand.

 

As of October 31 and July 31, 2021, amount of $624,445 and $619,051, respectively, is payable to Shanghai Qiao Garden Property Management Group (“Qiao Garden Group”), an entity managed by the same management team. The balance was assumed through HZLJ acquisition. This payable balance does not bear interest and is considered due on demand.

 

HFSH had payable balances to Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), an entity managed by the same management team, in the amounts of $3,425,682 and $2,926,782 as of October 31 and July 31, 2021, respectively. The payable is funding support from SH Oversea for operation, bears no interest and due on demand.

 

From September 2020 to October 2021, the Company borrowed several notes in a total principal amount of $205,000, in form of a short-term loan at 5% per annum from a related party, Hartford Hotel Investment Inc., an entity managed by the same management team. $2,461 and $nil of interest expense, respectively, were recorded during the three months ended October 31, 2021 and 2020. The unpaid principal and interest totaling $211,317 will be due on demand.

 

As of October 31 and July 31, 2021, the Company has $670,007 and $657,572, respectively, short-term payable to Shanghai DuBian Assets Management Ltd. (“Dubian”), which is owned by the Company’s ex-CEO’s relative. The payable balance was assumed from the acquisition transaction. On April 30, 2019, both parties entered a long-term agreement to convert the payable to a long-term debt, with expiration date on April 30, 2021, bearing approximately 2.5 percent of annual interest. On April 30, 2021, both parties entered a second long-term agreement to extend another two years, with expiration date on April 30, 2023, bearing approximately 4% of annual interest. $6,659 and $3,749 of interest expense were recognized during the three months ended October 31, 2021 and 2020, respectively. The unpaid principal and interest will be due on the maturity date. This loan payable is not exposed to market risk due to the stable and fixed interest rates in accordance with the loan agreements. As of October 31 and July 31, 2021, the estimated fair value of long term loan payable was approximately $668,228 and $655,940, respectively.

 

The remaining related party payable of $50,736 and $80,477 as of October 31 and July 31, 2021, respectively, represents the unpaid portion of operating advances made to the Company by affiliates which are managed by the same management team. These advances do not bear interest and are considered due on demand.

 

Three-Party Settlement Agreement

 

On December 31, 2020, a Three-Party Settlement agreement among HFSH, SH Qiaohong and Qiao Garden Int’l Travel was entered. Pursuant to the agreement, around $721,000 (RMB$5,031,699) payable due to SH Qiaohong under HFSH was settled with the receivable due from the same related party under Qiao Garden Int’l Travel through withdrawal of 90% ownership of Qiao Garden Int’l Travel HFSH owned. Total RMB5.0 million including the original investment RMB4.5 million was withdrawn from Qiao Garden Int’l Travel, and $104,317 (RMB697,000) gain on disposal was recognized at disposal date.

 

Other Related Party Transactions

 

Office space at Rosemead, CA is provided to Hartford Great Health Corp. at no cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material.

 

On September 30, 2019, HF Int’l Education entered two debt agreements with the related parties, SH Qiao Hong and SH Oversea. Each debt agreement provides a line of credit up to RMB9.0 million with two-year term, bearing 3.0% annum interest rate. The unpaid principal and interest will be due on the maturity dates. As of October 31, 2021, no balance was withdrawn from the two lines of credits by HF Int’l Education.

 

15

 

 

NOTE 12. NONCONTROLLING INTERESTS

 

Noncontrolling interests consisted of the following as of October 31, 2021 and July 31, 2021:

 

Name of Entity  % of Non-Controlling Interests   July 31, 2021   Net loss     Restructure of subsidiary       Disposal of subsidiary     Foreign currency translation adjustment   October 31, 2021
(unaudited)
 
HZLJ   40.0%  $(962,998)  $(12,858)        $(6,977)  $(982,833)
HF Int’l Education
   10.0%   (242,075)   (53,770)               (2,116)   (297,961)
Total       $(1,205,073)  $(66,628)              $(9,093)  $(1,280,794)

 

Name of Entity  % of Non-Controlling Interests   July 31, 2020   Net loss   Restructure of subsidiary   Disposal of subsidiary   Foreign currency translation adjustment   July 31, 2021 
HZLJ   40.0%  $(889,068)  $(42,285)  $-   $-   $(31,645)  $(962,998)
HF Int’l Education   *10.0%   (88,692)   (548,547)   403,131    -    (7,967)   (242,075)
Qiao Garden Intl Travel   -    60,271    1,827    -    (62,098)   -    - 
Total       $(917,489)  $(589,005)  $403,131   $(62,098)  $(39,612)  $(1,205,073)

 

*90% equity of SHHZJ, a limited partnership and 10% shareholder of HF Int’l Education, is held by Mr. Song, ex-CEO of the Company on behalf of an unrelated individual. However, HF Int’l Education does not have the obligation to absorb losses of SHHZJ or a right to receive benefits from SHHZJ that could potentially be significant to SHHZJ, thus, SHHZJ is not considered a VIE of HF Int’l Education. In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation.

 

NOTE 13. COMMITMENTS AND CONTINGENCIES

 

There has been below material contractual obligations and other commitments except the lease commitments disclosed in Note 10 Leases.

 

Lawsuits related to lease agreements

 

In June 2018 and January 2019, HFSH and HF Int’l Education entered two lease agreements with Shanghai Longjin Corporate Management Co., Ltd (the “Sublessor”) to lease some office spaces. On April 13, 2020, HFSH and HF Int’l Education received Notices of Lease Termination from the Tenant for late payments. HFSH and HF Int’l Education then filed a civil case against the Sublessor for over-charged rent fees because of fictitious office size and requested refund in the total amount approximately $481,000 (RMB3.3 million) till July 10, 2020. The Sublessor was further in default under the lease agreements due to its lease agreement with the landlord of the office properties (the “Landlord”) was terminated on June 1, 2020 by the Landlord. HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces in a five-year term.

 

On July 7, 2021, the district court verdict the final ruling and awarded HFSH and HF Int’l Education total amounts of RMB870,336 and RMB268,450 to be returned by the Sublessor. However, the rental deposits of RMB313,286 paid to the Sublessor are non-refundable. No further appeal on these rental dispute cases will be granted. These final ruling proceedings are pending execution by the district court, which has not yet executed as of October 31, 2021. Associated with this Sublessor under the two lease agreements, the Company previously accrued $165,698 rental payable net with deposit. As a result of the final ruling, the total $165,698 rental payable, net with deposit, accrued at HFSH and HF Int’l Education was written off and recognized as other income during the year ended July 31, 2021.

 

License agreements

 

In June 2021, HF Int’l Education and its three subsidiaries: PDHJ, HDFD and Gelinke entered license agreements with HFHM for the rights to use the intellectual Properties (the “IPs”) HFHM owns. The IPs cover in the license agreements are four set of curriculum structure designed and fifteen trademarks including “HaiDeFuDe” registered trademarks purchased from HF Int’l Education. As a return, on a monthly basis, HF Int’l Education and its subsidiaries pays 90% of its tuition revenue generated to HFHM as license usage fee. For the three months ended October 31, 2021, the Company incurred total $139,827 license fees pursuant to the license contracts. As of October 31 and July 31, 2021, the Company advanced $401,147 and $295,916, respectively, to HFHM for the future license fees.

 

NOTE 14. SEGMENT INFORMATION

 

The Company currently operates in following industry segments: hospitality (hotel and travel agency) and early childhood education industry in China.

 

Segment information on assets as of October 31, 2021 and revenue generated during the three months ended October 31, 2021, as follows:

 

   Hospitality   Education   Corporate and unallocated   Total 
Revenue  $14,448   $155,364   $-   $169,812 
Operating loss   (47,748)   (578,361)   (46,842)   (672,951)
Loss before tax   (61,150)   (537,707)   (49,303)   (648,160)
Net Loss Attributable to Hartford Great Health Corp   (48,292)   (483,936)   (49,304)   (581,532)
Total assets (excluding Intercompany balances)   351,627    5,286,171    (30,945)   5,606,853 

 

Segment information on assets as of October 31, 2020 and revenue generated during the three months ended October 31, 2020, as follows:

 

   Hospitality   Education  

Corporate

and unallocated

   Total 
Revenue  $32,794   $46,593   $-   $79,387 
Operating loss   (97,826)   (505,921)   (54,459)   (658,206)
Loss before tax   (97,814)   (505,921)   (54,615)   (658,350)
Net Loss Attributable to Hartford Great Health Corp   (87,372)   (381,970)   (55,415)   (524,757)
Total assets (excluding Intercompany balances)   1,426,445    6,403,378    49,296    7,879,119 

 

NOTE 15. SUBSEQUENT EVENTS

 

In accordance with ASC 855, “Subsequent Events”, the Company has evaluated subsequent events through the date of issuance of these unaudited financial statements and no subsequent events were noted.

 

16

 

 

Forward-Looking Statements

 

This Form 10-Q contains or incorporates by reference “forward-looking statements,” as that term is used in federal securities laws, about our financial condition, results of operations and business. These statements include, among others:

 

-statements concerning the benefits that we expect will result from our business activities and results of business development that we contemplate or have completed, such as increased revenues; and statements of our expectations, beliefs, future plans and strategies, anticipated developments and other matters that are not historical facts. These statements may be made expressly in this document or may be incorporated by reference to other documents that we will file with the SEC. You can find many of these statements by looking for words such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions used in this report or incorporated by reference in this report.

 

These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause our actual results to be materially different from any future results expressed or implied in those statements. Because the statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied. We caution you not to put undue reliance on these statements, which speak only as of the date of this report. Further, the information contained in this document or incorporated herein by reference is a statement of our present intention and is based on present facts and assumptions, and may change at any time and without notice, based on changes in such facts or assumptions.

 

Item 2. Management’s Discussion and Analysis or Plan of Operation Overview

 

This discussion updates our business plan for the three-month periods ending October 31, 2021. It also analyzes our financial condition at October 31, 2021 and compares it to our financial condition at July 31, 2021. This discussion and analysis should be read in conjunction with our audited financial statements for the year ended July 31, 2021, including footnotes, contained in our Annual Report on Form 10-K, and with the unaudited financial statements for the interim period ended October 31, 2021, including footnotes, which are included in this quarterly report.

 

Overview of the Business

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plan as set forth below.

 

Ability to continue as a “going concern”.

 

The independent registered public accounting firms’ reports on our financial statements as of July 31, 2021 and 2020, includes a “going concern” explanatory paragraph that describes substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to the factors prompting the explanatory paragraph are discussed in the financial statements, including footnotes thereto.

 

Plan of Operation

 

On December 28, 2018, the Company acquired Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF”). On March 22, 2019, the Company acquired 60 percent of Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”). On March 20, 2019, the Company acquired Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”) with 90 percent of Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), which was disposed on December 31, 2020, and formed a joint venture entity, Hartford International Education Technology Co., Ltd (“HF Int’l Education”).

 

The subsidiary of HFUS in Shanghai (HFSH) advances operating funds from two related party entities, SH Qiao Hong and SH Oversea Chinese Culture Media Ltd. The main purpose of the funding is to invest in Hartford International Education Technology (Shanghai) Co., Ltd. (HF Int’l Education). Upon signing of supplemental agreement, HFUS holds 75.5% ownership of HF Int’l Education and maintains control over HF Int’l Education. On July 24, 2019, HF Int’l Education established a 100% owned subsidiary, Pudong Haojin Childhood Education Ltd. (“PDHJ”). On October 28, 2019, PDHJ had its childhood education center opened. On March 23, 2020, HF Int’l Education established Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”) and was approved the business license to conduct childcare operations in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”). During the board meeting, SH Jingyu and another noncontrolling shareholders also sold a total of 14.5% equity at zero value to HFSH. As a result, HFSH currently holds 90% of HF Int’l Education and a total of 10% equity is held by two individual noncontrolling shareholders.

 

HF Int’l Education has developed an enhanced model of childcare franchise management program and registered a new brand name, “HaiDeFuDe”. HF Int’l Education has recruited a team of knowledgeable childcare teachers to develop series of independent textbooks designed to targeted age of young children and register for the copyrights for these textbooks in September of 2020. Since then, HF Int’l Education has begun marketing and promoting the enhanced model of franchise operation and management packaged program, under “HaiDeFuDe” brand, to an initial of 50 franchisees throughout different regions of China. To achieve that, HF Int’l Education has incorporated existing market resources throughout other major cities and provinces in China. The promotion of HF Int’l Education franchise operation and management model is expected to attract other childcare education centers to join the “HaiDeFuDe” brand, and HF Int’l Education expects to generate revenue from franchise and management fees.

 

Due to continued market uncertainties during the pandemic, the board of HFSH adopted a new management approach to ease cash flow and reduce operation loss. In March 2021, HF Int’l Education entered agreements with a third party, Hartford Health Management (Shanghai), Co. Ltd. (“HFHM”). HFHM purchased seven education & intellectual property copy rights and ten “HaiDeFuDe” registered trademarks from HF Int’l Education for a total amount of RMB1.2M and RMB1.0M, respectively. In June 2021, HF Int’l Education and its three subsidiaries entered license agreements with HFHM for the rights to use the intellectual Properties (the “IPs”) HFHM owns. The IPs cover in the license agreements are four sets of curriculum structure designed and fifteen trademarks including “HaiDeFuDe” registered trademarks purchased from HF Int’l Education. As a return, on a monthly basis, HF Int’l Education and its subsidiaries pays 90% of its tuition revenue generated to HFHM as license usage fee.

 

After further ease of restrictions from the pandemic, the Company will re-run special franchise promotion. There will be a great reduction in franchise fees for the first twenty childcare center that join “HaiDeFuDe” brand. In doing so, the Company expects to generate revenue of RMB16,000,000 from 50 franchisees by the end of 2022.

 

17

 

 

Results of Operations – Three Months Ended October 31, 2021 Compared to Three Months Ended October 31, 2020.

 

Revenue: We recognized $169,812 and $79,387 revenue in the three months ended October 31, 2021 and 2020, respectively. The revenue was mainly generated from two industry segments, the hospitality housing in HZLJ and childhood education care services in HF Int’l Education. The other business lines with limited operations have not generated revenue yet.

 

Operating Cost and Expenses: Cost of revenue increased to $335,004 for the three months ended October 31, 2021, compared to $133,948 during the comparable period of 2020. The increase of Cost of revenue was mainly due to the license fees paid to HFHM and rent cost of HDFD’s operating facility, see note 14. Operating expenses decreased to $507,759 for the three months ended October 31, 2021, compared to $603,645 during the comparable period of 2020. During the three months ended October 31, 2021, selling, general and administrative expenses decreased by $104,964, and depreciation and amortization expenses increased by $9,078.

 

Other Income (Expense): Other income, net increased to $24,791 for the three months ended October 31, 2021, compared to $144 of expenses for the corresponding period of 2020. Other income for the three months ended October 31, 2021 was mainly resulted from sublease income offset by interest expenses.

 

Net Loss Attributable to Noncontrolling Interest: For the three months ended October 31, 2021, we recorded a net loss attributable to noncontrolling interest of $66,628 compared to $134,393 for the corresponding period of 2020. The loss was allocated based on the ownership percentage of noncontrolling interest, which was mainly acquired through the acquisitions and Joint Ventures.

 

Net Loss Attributable to Hartford Great Health Corp: We recorded a net loss of $581,532 or $(0.01) per share for the three months ended October 31, 2021, compared to a net loss of $524,757 or $(0.01) per share for the three months ended October 31, 2020, an increase in loss of $56,775 due to the factors discussed above.

 

Liquidity and Capital Resources

 

As of October 31, 2021, we had a working capital deficit of $7,583,285 comprised of current assets of $973,585 and current liabilities of $8,556,870.

 

This represents an increase of $656,140 in the working capital deficit from the July 31, 2021 amount of $6,927,145.

 

During the three months ended October 31, 2021, our working capital deficit increased primarily because the additional advances from related parties for business operating.

 

We believe that our funding requirements for the next twelve months will be in excess of $1,900,000. We are currently seeking for further funding through related parties’ loan and finance.

 

As of October 31, 2021, the company has issued a total of 100,108,000 shares of common stock. On December 11, 2018, 96,090,000 shares of common stock were issued at the price of $0.02 per share to raise an additional $1,921,800 in capital. On November 24, 2020, the Company issued additional 1,000,000 shares of common stock to a significant shareholder of the Company at $0.02 per share.

 

We will seek additional financing in the form of debt or equity. There is no assurance that we will be able to obtain any needed financing on favorable terms, or at all, or that we will find qualified purchasers for the sale of our stock. Any sales of our securities would dilute the ownership of our existing investors.

 

18

 

 

Cash Flows – Three months ended October 31, 2021 Compared to Three months ended October 31, 2020

 

Operating Activities

 

During the three months ended October 31, 2021, $412,091 used in operating activities as compared to $505,572 used in the operations during the three months ended October 31, 2020. During the three months ended October 31, 2021, we recorded loss including noncontrolling interests of $648,160 , incurred non-cash depreciation of $28,219 , prepaid and other current receivables decreased by $116,580, other assets decreased by $74,757, other current payable increased by $35,152 , contract liabilities increased by $55,881, related party payables net with receivables decreased by $123,017, and operating lease liabilities net with operating lease assets increased by $39,003 as a result from the adoption of new lease guidance ASU No. 2016-02.

 

During the three months ended October 31, 2020, we recorded loss including noncontrolling interests of $659,150 , incurred non-cash depreciation of $19,141, prepaid and other current receivables increased by $21,729, inventory increased by $87,962, other assets decreased by $87,026, contract liabilities increased by $75,203, related party payables net with receivables increased by $12,607, and operating lease liabilities net with operating lease assets increased by $62,101 as a result from the adoption of new lease guidance ASU No. 2016-02.

 

Investing activities

 

Cash used in investing activities was $127,928 for the three months ended October 31, 2021 as compared to $12,264 cash provided by investing activities for the corresponding period in 2020. During the three months ended October 31, 2021, the cash used in investing activities was primarily due to the expenditure of leasehold improvements in HF Int’l Education.

 

During the three months ended October 31, 2020, HF Int’l Education acquired a new entity, Gelinke with cash net inflow of $12,264, see Note 4 Acquisitions and Joint Ventures.

 

Financing activities

 

Cash provided by financing activities was $529,995 for the three months ended October 31, 2021 as compared to $510,187 cash provided by financing activities for the three months ended October 31, 2020. The cash flows provided by financing activities for the three months ended October 31, 2021 was primarily attributable to $469,995 funding support from related parties, $60,000 proceeds of notes payable. The notes payable was borrowed from one related party with 5% annual interest rate. See Note 12 Related Party Transactions.

 

The cash flows provided by financing activities for the three months ended October 31, 2020 was primarily attributable to $506,288 funding support from related parties, $25,156 notes payable with interest offset by $21,257 finance lease principal payment. The notes payable was borrowed from one related party with 5% annual interest rate.

 

Future Capital Expenditures

 

In January 2019, HFSH entered agreements to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). As of October 31, 2021, the agreement has not yet taken effect as no consideration has been paid toward this acquisition. The agreement will be executed when the Company is financially ready to move forward, and the purchase price will be calculated based on the net assets of each entity on the execute date. There was no penalty levied or to be levied due to delayed execution or no-execution of those agreements.

 

19

 

 

Off-Balance Sheet Arrangements

 

As of and subsequent to October 31, 2021, we have no off-balance sheet arrangements.

 

Contractual Commitments

 

As of October 31, 2021, we have no other material contractual commitments except the office building and property leases which are included Note 10 Leases.

 

Critical Accounting Policies

 

Our significant accounting policies are disclosed in Note 1 of the footnotes to our unaudited financial statements above. There have been no other changes in our critical accounting policies since our most recent audit dated July 31, 2021.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

An evaluation was performed under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer (principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that, as of October 31, 2021, our disclosure controls and procedures were not effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms due to material weaknesses in our internal controls described below.

 

Management’s Report on Internal Control over Financial Reporting

 

Management’s assessment identified several material weaknesses in our internal control over financial reporting. These material weaknesses include the following:

 

The Company has yet established an internal control system over financial reporting, including sufficient and thorough financial reporting procedures, competence accounting personnel and a well written accounting policies manual under US GAAP in place.

 

Changes in Internal Control

 

During the three months period ended October 31, 2021, there has been no change in internal control within the Company.

 

20

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

On April 13, 2020, HFSH and HF Int’l Education received Notices of Lease Termination from the sub-lessor. HFSH and HF International Education then filed a civil case against the sub-lessor for return the over-charged rent expense because of fictitious office size, approximately $483,000 (RMB3.3 million). The sublease agreement was terminated on June 1, 2020. HF International Education entered a new lease agreement with the original landlord on June 1, 2020. On July 7, 2021, the district court announced the ruling and awarded HFSH a total amount of RMB870,336 to be returned by the sub-lessor, Shanghai Longjin Management and awarded HF International Education a total amount of RMB268,450 to be returned by the same sub-lessor. However, the rental deposits in the amount of RMB313,286 paid to the sub-lessor are non-refundable. No further appeal on these rental dispute cases will be granted. These final ruling proceedings are pending execution by the district court.

 

We were not subject to any other legal proceedings during the three months ended October 31, 2021, and are not currently subject to any legal proceedings, and to the best of our knowledge, no such proceeding is threatened, the results of which would have a material impact on our results of operation or financial condition. Nor, to the best of our knowledge, are any of our officers or directors involved in any legal proceedings in which we are an adverse party.

 

Item 1A. Risk Factors.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable to our Company.

 

Item 5. Other Information

 

Not applicable to our Company.

 

Item 6. Exhibits.

 

The following exhibits are filed with or incorporated by referenced in this report:

 

31.1* Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Rose Hong Wang.

 

31.2* Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Sheng-Yih Chang

 

32.1* Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Rose Hong Wang and Sheng-Yih Chang

 

101 Interactive Data Files

 

21

 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  HARTFORD GREAT HEALTH CORP.
   
Date: December 15, 2021 By: /s/ ROSE HONG WANG
    Rose Hong Wang
    Chief Executive Officer

 

22

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934

 

I, Rose Hong Wang, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Hartford Great Health Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 15, 2021

 

  /s/ ROSE HONG WANG
  Rose Hong Wang
  Chief Executive Officer

 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934

 

I, Sheng-Yih Chang, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Hartford Great Health Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 15, 2021

 

  /s/ Sheng-Yih Chang
  Sheng-Yih Chang
  Chief Financial Officer

 

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

Certification of Periodic Financial Report by the Chief Executive Officer and

Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Solely for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Hartford Great Health Corp. (the “Company”), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended October 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: December 15, 2021

/s/ ROSE HONG WANG
  Rose Hong Wang
  Chief Executive Officer

Date: December 15, 2021

/s/ SHENG-YIH CHANG
  Sheng-Yih Chang
  Chief Financial Officer

 

 

 

EX-101.SCH 5 hfus-20211031.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - RESTRICTED CASH link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - PREPAID AND OTHER CURRENT RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - OTHER ASSETS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - OTHER CURRENT PAYABLES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - NONCONTROLLING INTERESTS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - RESTRICTED CASH (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - OTHER ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - OTHER CURRENT PAYABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - NONCONTROLLING INTERESTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - PREPAID AND OTHER CURRENT RECEIVABLES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - INVENTORY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF OTHER ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE COST (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF NONCONTROLLING INTERESTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF NONCONTROLLING INTERESTS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF SEGMENT INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 hfus-20211031_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 hfus-20211031_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 hfus-20211031_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Product and Service [Axis] Tuition [Member] Service [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Noncontrolling Interest [Member] Business Acquisition [Axis] Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. [Member] Shanghai Hartford Comprehensive Health Management, Ltd. [Member] Series [Axis] Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd [Member] Pudong Haojin Childhood Education Ltd [Member] Early Childhood Education Services [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Joint Venture Agreement [Member] Title of Individual [Axis] Shareholders [Member] Ownership [Axis] Hartford Great Health Management (Shanghai) Ltd. [Member] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] HF Int'l Education [Member] Hartford International Education Technology Co., Ltd [Member] Indefinite-lived Intangible Assets [Axis] Seven Education Textbooks [Member] Ten “HaiDeFuDe” [Member] Chief Executive Officer [Member] Shanghai Gelinke Childcare Education Center [Member] Shanghai Senior Health Consulting Ltd. [Member] Shanghai Pasadena Ltd. [Member] Shanghai Luo Sheng International Trade Ltd. [Member] Qiao Garden International Travel Agency [Member] Consolidated Entities [Axis] Qiao Garden Intel Travel [Member] Long-Lived Tangible Asset [Axis] Leasehold Improvements [Member] Finance Lease Assets [Member] Furniture and Fixtures [Member] Office Equipment Vehicles [Member] Construction in Progress [Member] Two Sublease Agreements [Member] New Lease Agreement [Member] Sublease Agreements [Member] Five-Year New Lease Agreement [Member] Early Termination Agreement [Member] Hangzhou Hartford Comprehensive Health Management, Ltd [Member] Related Party [Axis] Shanghai Qiaohong Real Estate Co., Ltd. [Member] HFHM [Member] License [Member] Affiliates [Member] Shanghai Qiao Garden Property Management Group [Member] Shanghai Oversea Chinese Culture Media Ltd. [Member] Hartford Hotel Investment Inc [Member] Related Party [Member] Shanghai DuBian Assets Management Ltd. [Member] Second Long Term Agreement [Member] Two Debt Agreements [Member] HZLJ [Member] Qiao Garden Intl Travel [Member] SHHZJ [Member] Two Lease Agreements [Member] HFSH [Member] Sublessor [Member] Scenario [Axis] Nonrefundable Rental Depoit [Member] Finite-Lived Intangible Assets by Major Class [Axis] Intellectual Properties [Member] Segments [Axis] Hospitality [Member] Education [Member] Corporate and Unallocated [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Restricted cash Prepaid and Other current receivables Related party receivable Inventory Total Current Assets Non-current Assets Property and equipment, net ROU assets-operating lease Other assets Total Non-current Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities Related party loan and payables Contract liabilities Current operating Lease liabilities Other current payable Total Current Liabilities Long-term loan from related party Lease liabilities, noncurrent TOTAL LIABILITIES Commitments and contingencies (Note 13) Stockholders’ Equity (Deficit) Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of October 31 and July 31, 2021 Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss Noncontrolling interest Total Stockholders’ Deficit TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares outstanding Statement [Table] Statement [Line Items] Total revenue Operating cost and expenses Cost of revenue Depreciation and amortization Selling, general and administrative Total Operating Cost and Expenses Operating Loss Other Income (Expense) Interest (expense), net Other income, net Other income (expense), net Loss before income taxes Income Tax Expense Net Loss Less: net loss attributable to noncontrolling Interest Net Loss Attributable to Hartford Great Health Corp Basic and Diluted Basic and diluted Income Statement [Abstract] Net Loss Other Comprehensive income (loss), net of income tax Foreign currency translation adjustments Total other comprehensive loss Less: total other comprehensive loss attributable to noncontrolling interest Total Other Comprehensive Loss Attributable to Hartford Great Health Corp Total Comprehensive Loss Beginning balance, value Beginning balance, shares Net (loss) Foreign currency translation adjustment Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss including noncontrolling interests Adjustments to reconcile net loss including noncontrolling interests to net cash (used in) operating activities: Loss on disposal of property and equipment Changes in operating assets and liabilities: Prepaid and other current receivables Inventory Other assets Related party receivables and payables Contract liabilities Other current payable Operating lease assets and liabilities Other liabilities Net cash (used in) operating activities Cash flows from investing activities: Cash proceeds from Acquisitions Cash used in Acquisitions Purchases of property and equipment Net cash (used in) provided by investing activities Cash flows from financing activities: Proceeds of related party notes payable Principal payments on finance lease Advances from related parties Net cash provided by financing activities Effect of exchange rate changes on cash Net change in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Supplemental Cash Flow Information Interest paid Income taxes paid Non-cash investing and financing activities: Payable to acquiree Unpaid bills for leaseholder improvements Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] GOING CONCERN Business Combination and Asset Acquisition [Abstract] ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION Receivables [Abstract] RESTRICTED CASH Prepaid And Other Current Receivables PREPAID AND OTHER CURRENT RECEIVABLES Inventory Disclosure [Abstract] INVENTORY Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] OTHER ASSETS Payables and Accruals [Abstract] OTHER CURRENT PAYABLES Leases LEASES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Noncontrolling Interest [Abstract] NONCONTROLLING INTERESTS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Segment Reporting [Abstract] SEGMENT INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Organization Basis of Presentation Use of Estimates Reclassifications Income Taxes Revenue Recognition Recent Accounting Pronouncements. SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH SCHEDULE OF PROPERTY AND EQUIPMENT, NET SCHEDULE OF OTHER ASSETS SCHEDULE OF ACCOUNTS AND OTHER PAYABLES SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES SCHEDULE OF COMPONENTS OF LEASE COST SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES SCHEDULE OF NONCONTROLLING INTERESTS SCHEDULE OF SEGMENT INFORMATION Schedule of Product Information [Table] Product Information [Line Items] Business Acquisition, Percentage of Voting Interests Acquired Equity ownership percentage Income tax examination description Revenue Accumulated deficit Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Cash and cash equivalents Restricted Cash Prepaid and Other current receivables Property and Equipment, net Unearned revenue Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net, Total Purchase price Cash payments to acquire business Total consideration Cash and cash equivalents Restricted cash Related party receivable Related party payable Other current payable Noncontrolling interest Net assets of the subsidiary, excluding noncontrolling interest Consideration Gain on disposal of the subsidiary Gain on disposal of noncontrolling interest Gain on disposal of the subsidiary, excluding noncontrolling interest Cash and cash equivalents Restricted cash Cash and cash equivalents deconsolidated Joint venture acquired ownership interest Noncontrolling ownership interest Registered capital Noncontrolling shareholders, description Goodwill Business acquired ownership interest Investment from noncontrolling interest Investment income Restricted cash Total cash, cash equivalents and restricted cash shown in the statement of cash flows Prepaid and other current receivables Inventory's net Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items]  Property and equipment, gross Less: accumulated depreciation and amortization  Property and equipment, net Depreciation expense Other miscellaneous assets Rental deposits  Other assets Payable to acquirees Accrued payroll Payable to publisher Other payables  Other Current Payables Schedule Of Lease-related Assets And Liabilities Finance lease right-of-use assets, cost (Note 7) Less: accumulated amortization Finance lease right-of-use assets, net ROU assets-Operating lease Total Lease ROU assets Current Operating Lease liabilities Operating lease liabilities, noncurrent Finance lease liabilities, noncurrent Total Lease liabilities Schedule Of Components Of Lease Cost Operating lease cost Amortization of ROU assets Interest on finance lease liabilities Finance lease cost Total lease cost Operating cash flows paid for operating leases Financing cash flows paid for finance leases Weighted-average remaining lease term (years) Operating Leases Weighted-average remaining lease term (years) Finance Leases Weighted-average discount rate Operating Leases Weighted-average discount rate Finance Leases Operating Leases, 2022 Finance Leases, 2022 Operating Leases, 2023 Finance Leases, 2023 Operating Leases, 2024 Finance Leases, 2024 Operating Leases, 2025 Finance Leases, 2025 Operating Leases, 2026 Finance Leases, 2026 Operating Leases, 2027 and thereafter Finance Leases, 2027 and thereafter Operating Leases, Total lease payments Finance Leases, Total lease payments Less interest Less interest Present value of future lease payments Present value of future lease payments Including: current lease liabilities Including: current lease liabilities Including: noncurrent lease liabilities Including: noncurrent lease liabilities Operating leases remaining term Finance leases remaining term ROU of lease liability Lease liability Other expenses Lease term Sublease term description Gain on termination of lease Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Related party receivables Related party receivables, description Interest income Advance from related party Related Party Payables Short term borrowings Short term debt interest rate, percentage Interest expense Unpaid principal and interest Short-term and long-term payable Expiration date Interest rate Estimated fair value of long term loans payable Due to/from related party Acquired percentage Gain on disposal of subsidiary Line of credit facility, maximum borrowing capacity Debt instrument, term Line of credit facility, annum interest rate Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] % of Non-Controlling Interests Non-Controlling Interests beginning balance Net loss Restructure of subsidary Disposal of subsidiary Foreign currency translation adjustment Non-Controlling Interests ending balance Noncontrolling Interest [Table] Noncontrolling Interest [Line Items] Product Liability Contingency [Table] Product Liability Contingency [Line Items] Refund of fictitious office property requested Lease agreement, date Lease agreement, description Litigation Settlement, Amount Awarded from Other Party Payments for Rent Other Income [custom:LicenseDescription] Finite-Lived License Agreements, Gross [custom:PaymentToLicenseFee] Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Operating loss Loss before tax Net Loss Attributable to Hartford Great Health Corp Total assets (excluding Intercompany balances) Shanghai Qiaohong Real Estate Co., Ltd. [Member] HFHM [Member] Operating and finance lease liability noncurrent. Affiliates [Member] Shanghai Qiao Garden Property Management Group [Member] Shanghai Oversea Chinese Culture Media Ltd. [Member] Hartford Hotel Investment Inc [Member] Related Party [Member] Tuition [Member] Increase decrease in operating lease assets and liabilities. Advances from related parties. Unpaid bills for leaseholder improvements. Unpaid principal and interest. Short-term and long-term payable. Shanghai DuBian Assets Management Ltd. [Member] Second Long Term Agreement [Member] Hartford Great Health Management (Shanghai) Ltd. [Member] RMB [Member] Qiao Garden International Travel Agency [Member] Investment from Noncontrolling Interest. Gain on disposal of subsidiary. HF Int'l Education [Member] Two Debt Agreements [Member] Schedule of noncontrolling interests [Table Text Block] HZLJ [Member] Restructure of subsidary Disposal of subsidiary. Qiao Garden Intl Travel [Member] Prepaid and other current receivable [Text Block] Organization [Policy Text Block] Schedule of net assets liabilities disposed of subsidiary [Table Text Block] SHHZJ [Member] Noncontrolling shareholders, description. Refund of fictitious office property requested. Two Lease Agreements [Member] Lease agreement, description. HFSH [Member] Sublessor [Member] Hartford International Education Technology Co., Ltd [Member] Nonrefundable Rental Depoit [Member] Schedule of lease related assets and liabilities [Table Text Block] License Description Intellectual Properties [Member] Payment to license fee Schedule of future minimum lease payments for operating and finance leases [Table Text Block] Hospitality [Member] Education [Member] Corporate and Unallocated [Member] Restricted Cash. Business combination, recognized identifiable assets acquired and liabilities assumed, current assets, goodwill. Disposal group, including discontinued operation, restricted cash. Disposal group, including discontinued operation, related party receivable. Disposal Group, Including Discontinued Operation, Related party payable. Disposal group, including discontinued operation, noncontrolling interest. Disposal group, including discontinued operation, net assets of the subsidiary. Qiao Garden Intel Travel [Member] Shanghai Gelinke Childcare Education Center [Member] Disposal group, including discontinued operation, cash and cash equivalents and restricted cash. Office Equipment Vehicles [Member] Finance Lease Assets [Member] Rental deposits. Payable to publisher. Payable to Acquiree. Total Lease ROU assets. Total Lease liabilities. Finance lease cost. Early Termination Agreement [Member] Sublease Agreements [Member] Two Sublease Agreements [Member] New Lease Agreement [Member] Five-Year New Lease Agreement [Member] Hangzhou Hartford Comprehensive Health Management, Ltd [Member] Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd [Member] Joint venture acquired ownership interest. Joint Venture Agreement [Member] Shareholders [Member] Shanghai Senior Health Consulting Ltd [Member] Shanghai Pasadena Ltd. [Member] Shanghai Luo Sheng International Trade Ltd. [Member] Shanghai Hartford Comprehensive Health Management, Ltd. [Member] Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd [Member] Pudong Haojin Childhood Education Ltd [Member] Early Childhood Education Services [Member] Schedule of weighted average remaining lease term and weighted average discount rate for operating and finance leases [Table Text Block] Seven Education Textbooks [Member] Ten “HaiDeFuDe” [Member] Cost of revenue. Assets, Current Assets, Noncurrent Liabilities, Current Liabilities Liabilities and Equity Operating Costs and Expenses Other Operating Income (Expense), Net Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Other Accounts Payable Increase decrease in operating lease assets and liabilities Net Cash Provided by (Used in) Operating Activities Payments for Previous Acquisition Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents DisposalGroupIncludingDiscontinuedOperationRestrictedCash DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable Disposal Group, Including Discontinued Operation, Other Liabilities, Current DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest Goodwill [Default Label] Restricted Cash [Default Label] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Other Notes Payable, Current Finance Lease, Right-of-Use Asset, Accumulated Amortization Finance Lease, Right-of-Use Asset, after Accumulated Amortization TotalLeaseRightOfUseAssets LeaseLiabilities Lease, Cost Lessee, Operating Lease, Liability, Undiscounted Excess Amount Finance Lease, Liability, Undiscounted Excess Amount Finance Lease, Liability Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest EX-101.PRE 9 hfus-20211031_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001482554 2021-08-01 2021-10-31 0001482554 2021-12-15 0001482554 2021-10-31 0001482554 2021-07-31 0001482554 HFUS:TuitionMember 2021-08-01 2021-10-31 0001482554 HFUS:TuitionMember 2020-08-01 2020-10-31 0001482554 us-gaap:ServiceMember 2021-08-01 2021-10-31 0001482554 us-gaap:ServiceMember 2020-08-01 2020-10-31 0001482554 2020-08-01 2020-10-31 0001482554 us-gaap:CommonStockMember 2021-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001482554 us-gaap:RetainedEarningsMember 2021-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2021-07-31 0001482554 us-gaap:CommonStockMember 2021-08-01 2021-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-31 0001482554 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-08-01 2021-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2021-08-01 2021-10-31 0001482554 us-gaap:CommonStockMember 2021-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001482554 us-gaap:RetainedEarningsMember 2021-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2021-10-31 0001482554 us-gaap:CommonStockMember 2020-07-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0001482554 us-gaap:RetainedEarningsMember 2020-07-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-31 0001482554 us-gaap:NoncontrollingInterestMember 2020-07-31 0001482554 2020-07-31 0001482554 us-gaap:CommonStockMember 2020-08-01 2020-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2020-08-01 2020-10-31 0001482554 us-gaap:RetainedEarningsMember 2020-08-01 2020-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-01 2020-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2020-08-01 2020-10-31 0001482554 us-gaap:CommonStockMember 2020-10-31 0001482554 us-gaap:AdditionalPaidInCapitalMember 2020-10-31 0001482554 us-gaap:RetainedEarningsMember 2020-10-31 0001482554 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-31 0001482554 us-gaap:NoncontrollingInterestMember 2020-10-31 0001482554 2020-10-31 0001482554 HFUS:HangzhouLongjingQiaoFuVacationHotelCoLtdMember 2020-12-31 0001482554 HFUS:ShanghaiHartfordComprehensiveHealthManagementLtdMember 2020-12-31 0001482554 HFUS:ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember 2020-03-23 0001482554 HFUS:PudongHaojinChildhoodEducationLtdMember 2019-07-24 0001482554 HFUS:EarlyChildhoodEducationServicesMember 2021-08-01 2021-10-31 0001482554 HFUS:EarlyChildhoodEducationServicesMember 2020-08-01 2020-10-31 0001482554 HFUS:JointVentureAgreementMember 2019-03-22 0001482554 HFUS:HartfordGreatHealthManagementShanghaiLtdMember HFUS:ShareholdersMember 2020-07-31 0001482554 srt:MaximumMember HFUS:JointVentureAgreementMember 2020-06-19 0001482554 srt:MinimumMember HFUS:JointVentureAgreementMember 2020-06-19 0001482554 HFUS:HFIntlEducationMember 2021-08-01 2021-10-31 0001482554 HFUS:HFIntlEducationMember 2021-05-30 2021-06-01 0001482554 HFUS:SevenEducationTextbooksMember HFUS:JointVentureAgreementMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2019-03-22 0001482554 HFUS:TenHaiDeFuDeMember HFUS:JointVentureAgreementMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2019-03-22 0001482554 srt:ChiefExecutiveOfficerMember HFUS:JointVentureAgreementMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2021-03-31 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember 2020-07-20 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember 2020-07-19 2020-07-20 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember 2021-07-31 0001482554 HFUS:ShanghaiSeniorHealthConsultingLtdMember 2019-02-28 0001482554 HFUS:ShanghaiSeniorHealthConsultingLtdMember 2019-01-31 0001482554 HFUS:ShanghaiPasadenaLtdMember 2019-02-28 0001482554 HFUS:ShanghaiPasadenaLtdMember 2019-01-31 0001482554 HFUS:ShanghaiLuoShengInternationalTradeLtdMember 2019-01-31 0001482554 HFUS:QiaoGardenInternationalTravelAgencyMember HFUS:HartfordGreatHealthManagementShanghaiLtdMember 2020-12-31 0001482554 HFUS:QiaoGardenInternationalTravelAgencyMember HFUS:HartfordGreatHealthManagementShanghaiLtdMember 2020-12-30 2020-12-31 0001482554 HFUS:QiaoGardenIntelTravelMember 2020-12-31 0001482554 HFUS:QiaoGardenIntelTravelMember 2020-12-29 2020-12-31 0001482554 us-gaap:LeaseholdImprovementsMember 2021-10-31 0001482554 us-gaap:LeaseholdImprovementsMember 2021-07-31 0001482554 HFUS:FinanceLeaseAssetsMember 2021-10-31 0001482554 HFUS:FinanceLeaseAssetsMember 2021-07-31 0001482554 us-gaap:FurnitureAndFixturesMember 2021-10-31 0001482554 us-gaap:FurnitureAndFixturesMember 2021-07-31 0001482554 HFUS:OfficeEquipmentVehiclesMember 2021-10-31 0001482554 HFUS:OfficeEquipmentVehiclesMember 2021-07-31 0001482554 us-gaap:ConstructionInProgressMember 2021-10-31 0001482554 us-gaap:ConstructionInProgressMember 2021-07-31 0001482554 srt:MinimumMember 2021-07-31 0001482554 srt:MaximumMember 2021-07-31 0001482554 HFUS:TwoSubleaseAgreementsMember 2020-05-31 0001482554 HFUS:TwoSubleaseAgreementsMember 2020-05-29 2020-05-31 0001482554 HFUS:NewleaseAgreementMember 2020-06-01 0001482554 HFUS:SubleaseAgreementsMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2021-08-01 2021-10-31 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember HFUS:FiveYearNewleaseAgreementMember 2020-09-02 0001482554 HFUS:EarlyTerminationAgreementMember 2021-07-31 0001482554 HFUS:ShanghaiGelinkeChildcareEducationCenterMember HFUS:EarlyTerminationAgreementMember 2021-07-01 2021-07-31 0001482554 HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember 2021-01-06 0001482554 HFUS:HangzhouHartfordComprehensiveHealthManagementLtdMember 2021-01-09 0001482554 HFUS:HangzhouLongjingQiaoFuVacationHotelCoLtdMember 2010-10-01 0001482554 HFUS:ShanghaiQiaohongRealEstateCoLtdMember 2021-10-31 0001482554 HFUS:ShanghaiQiaohongRealEstateCoLtdMember 2021-08-01 2021-10-31 0001482554 HFUS:ShanghaiQiaohongRealEstateCoLtdMember 2020-08-01 2020-10-31 0001482554 us-gaap:LicenseMember HFUS:HFHMMember 2021-10-31 0001482554 HFUS:AffiliatesMember 2021-10-31 0001482554 HFUS:AffiliatesMember 2021-07-31 0001482554 HFUS:ShanghaiQiaoGardenPropertyManagementGroupMember 2021-10-31 0001482554 HFUS:ShanghaiQiaoGardenPropertyManagementGroupMember 2021-07-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2021-10-31 0001482554 HFUS:ShanghaiOverseaChineseCultureMediaLtdMember 2021-07-31 0001482554 HFUS:RelatedPartyMember HFUS:HartfordHotelInvestmentIncMember 2021-10-31 0001482554 HFUS:RelatedPartyMember HFUS:HartfordHotelInvestmentIncMember 2021-08-01 2021-10-31 0001482554 HFUS:RelatedPartyMember HFUS:HartfordHotelInvestmentIncMember 2020-08-01 2020-10-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2021-10-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2021-07-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2019-04-29 2019-04-30 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember HFUS:SecondLongTermAgreementMember 2021-04-29 2021-04-30 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2021-08-01 2021-10-31 0001482554 HFUS:ShanghaiDuBianAssetsManagementLtdMember 2020-08-01 2020-10-31 0001482554 HFUS:HartfordGreatHealthManagementShanghaiLtdMember 2020-12-31 0001482554 HFUS:QiaoGardenInternationalTravelAgencyMember HFUS:HartfordGreatHealthManagementShanghaiLtdMember 2020-12-29 2020-12-31 0001482554 2020-12-29 2020-12-31 0001482554 HFUS:HFIntlEducationMember HFUS:TwoDebtAgreementsMember 2019-09-30 0001482554 HFUS:HFIntlEducationMember HFUS:TwoDebtAgreementsMember 2019-09-29 2019-09-30 0001482554 HFUS:HZLJMember 2021-10-31 0001482554 HFUS:HZLJMember 2021-07-31 0001482554 HFUS:HZLJMember 2021-08-01 2021-10-31 0001482554 HFUS:HFIntlEducationMember 2021-10-31 0001482554 HFUS:HFIntlEducationMember 2021-07-31 0001482554 HFUS:HFIntlEducationMember 2021-08-01 2021-10-31 0001482554 HFUS:HZLJMember 2020-07-31 0001482554 HFUS:HZLJMember 2020-08-01 2021-07-31 0001482554 HFUS:HFIntlEducationMember 2020-07-31 0001482554 HFUS:HFIntlEducationMember 2020-08-01 2021-07-31 0001482554 HFUS:QiaoGardenIntTravelMember 2020-07-31 0001482554 HFUS:QiaoGardenIntTravelMember 2020-08-01 2021-07-31 0001482554 HFUS:QiaoGardenIntTravelMember 2021-07-31 0001482554 2020-08-01 2021-07-31 0001482554 HFUS:SHHZJMember 2021-07-31 0001482554 HFUS:TwoLeaseAgreementsMember 2020-04-12 2020-04-13 0001482554 HFUS:TwoLeaseAgreementsMember 2021-08-01 2021-10-31 0001482554 HFUS:SublessorMember HFUS:HFSHMember 2021-07-06 2021-07-07 0001482554 HFUS:SublessorMember HFUS:HartfordInternationalEducationTechnologyCoLtdMember 2021-07-06 2021-07-07 0001482554 HFUS:NonrefundableRentalDepoitMember HFUS:TwoLeaseAgreementsMember 2021-07-06 2021-07-07 0001482554 HFUS:IntellectualPropertiesMember HFUS:HFHMMember 2021-08-01 2021-10-31 0001482554 us-gaap:LicenseMember HFUS:HFHMMember 2021-08-01 2021-10-31 0001482554 us-gaap:LicenseMember HFUS:HFHMMember 2020-08-01 2021-07-31 0001482554 HFUS:HospitalityMember 2021-08-01 2021-10-31 0001482554 HFUS:EducationMember 2021-08-01 2021-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2021-08-01 2021-10-31 0001482554 HFUS:HospitalityMember 2021-10-31 0001482554 HFUS:EducationMember 2021-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2021-10-31 0001482554 HFUS:HospitalityMember 2020-08-01 2020-10-31 0001482554 HFUS:EducationMember 2020-08-01 2020-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2020-08-01 2020-10-31 0001482554 HFUS:HospitalityMember 2020-10-31 0001482554 HFUS:EducationMember 2020-10-31 0001482554 HFUS:CorporateAndUnallocatedMember 2020-10-31 iso4217:USD shares iso4217:USD shares iso4217:CNY pure 0001482554 false --07-31 Q1 P5Y P5Y P2Y P2Y 10-Q true 2021-10-31 2021 false 000-54439 HARTFORD GREAT HEALTH CORP. NV 51-0675116 8832 Glendon Way Rosemead CA 91770 (626) 321-1915 Yes Yes Non-accelerated Filer true true false false Common stock, par value $0.001 par value HFUS 100108000 44284 27612 26566 173825 286232 431356 325864 324120 323814 973585 990088 744392 593517 3642091 3837186 246785 321807 4633268 4752510 5606853 5742598 4933706 4391325 606383 545346 2460483 2508959 556298 471603 8556870 7917233 670007 657572 2061154 2154243 11288031 10729048 0.001 0.001 5000000 5000000 0 0 0 0 0.001 0.001 300000000 300000000 100108000 100108000 100108 100108 2173521 2173521 -6403051 -5821519 -270962 -233487 -1280794 -1205073 -5681178 -4986450 5606853 5742598 155364 46593 14448 32794 169812 79387 335004 133948 28219 19141 479540 584504 842763 737593 -672951 -658206 -16166 -822 40957 678 24791 -144 -648160 -658350 800 -648160 -659150 -66628 -134393 -581532 -524757 -0.01 -0.01 100108000 99108000 -581532 -524757 -46568 -108456 -46568 -108456 -9093 -28212 -37475 -80244 -619007 -605001 100108000 100108 2173521 -5821519 -233487 -1205073 -4986450 -581532 -66628 -648160 -37475 -9093 -46568 100108000 100108 2173521 -6403051 -270962 -1280794 -5681178 99108000 99108 2154521 -3568185 -55146 -917489 -2287191 -524757 -134393 -659150 -80244 -28212 -108456 99108000 99108 2154521 -4092942 -135390 -1080094 -3054797 -648160 -659150 28219 19141 -733 -116580 21729 -2497 87962 -74757 -87026 -123017 12607 55881 75203 35152 -76 -39003 -62101 6997 6534 -412091 -505572 26924 14660 127928 -127928 12264 60000 25156 21257 469995 506288 529995 510187 130 2540 -9894 19419 54178 65277 44284 84696 800 10462 44946 <p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zcjAx1JfGqol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 1. <span id="xdx_825_zteIWxFo8vne">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. The financial statements and notes are the responsibility of the Company’s management. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied in the preparation of the financial statements. This disclosure should be read in conjunction with our audited financial statements for the year ended July 31, 2021, including footnotes, contained in our Annual Report on Form 10-K,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_ecustom--OrganizationPolicyTextBlock_zMFJrArTypB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20201231__us-gaap--BusinessAcquisitionAxis__custom--HangzhouLongjingQiaoFuVacationHotelCoLtdMember_z0ne6NYYXHgg">60 </span></span><span style="font: 10pt Times New Roman, Times, Serif">percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”) and its <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20201231__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiHartfordComprehensiveHealthManagementLtdMember_zRQvZiAs81ak">90 </span></span><span style="font: 10pt Times New Roman, Times, Serif">percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020, see note 3 Acquisitions, Joint Ventures and Deconsolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20200323__dei--LegalEntityAxis__custom--ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember_zfp4hbkBx79f" title="Equity ownership percentage"><span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20190724__dei--LegalEntityAxis__custom--PudongHaojinChildhoodEducationLtdMember_zKO5NEhFjRtl" title="Equity ownership percentage">100%</span></span> owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zuUHtgsAA1Th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Basis of Presentation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation. The Company’s net income (loss) excludes income (loss) attributable to the noncontrolling interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zVea4zW3id6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zB1kRsXWCWH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Reclassifications</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain amounts on the prior-year consolidated balance sheet, consolidated statement of operations and cash flows were reclassified to conform to current-year presentation, with no effect on ending stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z0mcq1kHtlJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--IncomeTaxExaminationDescription_c20210801__20211031_zUL4tA6F6qT1" title="Income tax examination description">The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises.</span> The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zL9LNMLhzw12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company adopted ASC Topic 606 Revenue from Contracts with Customers (“Topic 606) on August 1, 2019, applying the modified retrospective method to all contracts that were not completed as of August 1, 2019. The Company is building up its core business upon the completion of multiple acquisitions in March 2019 and limited operations occurred during the years ended July 31, 2021 due to the impact of COVID-19 pandemic. The revenue for the three months period ended October 31, 2021 and 2020 were mainly generated from HZLJ, PDHJ and Gelinke.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is recognized when control of promised goods or services is transferred to our customers in an amount of consideration to which we expect to be entitled to in exchange for those goods or services. We follow the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. ASC 606 has no material impacts on the Company’s financial positions. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms. The Company recorded $<span id="xdx_908_eus-gaap--EnergyMarketingContractLiabilitiesCurrent_iI_pp0p0_c20211031_zKHKXgXVP663" title="Contract liabilities">606,383</span> and $<span id="xdx_904_eus-gaap--EnergyMarketingContractLiabilitiesCurrent_iI_pp0p0_c20210731_zyldgBLjOoJ" title="Contract liabilities">545,346</span> unsatisfied performance obligations and contract liabilities as of October 31 and July 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Early childhood education services: HF Int’l Education generates revenue from childhood education classes provided to its customers. The educational services consist of parent-child and bilingual childcare classes. Each contract of educational classes is accounted for as a single performance obligation which is satisfied proportionately over the service period. Tuition fee is generally collected in advance and is initially recorded as deferred revenue and transferred to contract liabilities after trial period. Refunds are provided to parents if they decide within the trial period that they no longer want to take the class. After the trial period, if a parent withdraws from a class, usually only that unearned portion of the fee is available to be returned. For the three months ended October 31, 2021 and 2020, $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210801__20211031__srt--ProductOrServiceAxis__custom--EarlyChildhoodEducationServicesMember_zLzwtb11JAji" title="Revenue">155,364</span> and $<span id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__srt--ProductOrServiceAxis__custom--EarlyChildhoodEducationServicesMember_zy8hBAVr8ehk" title="Revenue">46,593</span>, respectively, of revenue were derived from early childhood education classes provided.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Hospitality services: HZLJ generates revenue primarily from the room rentals, sale of food and beverage and other miscellaneous hospitality services. The Company recognizes room rental and services daily as services are provided. Under ASC 606, the pattern and timing of recognition of income from hotel facility is consistent with the prior accounting model.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8Al1oyNijB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recent Accounting Pronouncements</b></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Recently adopted accounting pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes which is intended to simplify various aspects related to accounting for income taxes. The standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. The adoption of ASU No. 2019-12 did not have a material impact on the Company’s financial position, results of operations and liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Recently issued accounting pronouncements not yet adopted</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. The standard, including subsequently issued amendments (ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10 and ASU 2019-11), requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_845_ecustom--OrganizationPolicyTextBlock_zMFJrArTypB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20201231__us-gaap--BusinessAcquisitionAxis__custom--HangzhouLongjingQiaoFuVacationHotelCoLtdMember_z0ne6NYYXHgg">60 </span></span><span style="font: 10pt Times New Roman, Times, Serif">percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”) and its <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20201231__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiHartfordComprehensiveHealthManagementLtdMember_zRQvZiAs81ak">90 </span></span><span style="font: 10pt Times New Roman, Times, Serif">percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020, see note 3 Acquisitions, Joint Ventures and Deconsolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20200323__dei--LegalEntityAxis__custom--ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember_zfp4hbkBx79f" title="Equity ownership percentage"><span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_c20190724__dei--LegalEntityAxis__custom--PudongHaojinChildhoodEducationLtdMember_zKO5NEhFjRtl" title="Equity ownership percentage">100%</span></span> owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0.60 0.90 1 1 <p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zuUHtgsAA1Th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Basis of Presentation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation. The Company’s net income (loss) excludes income (loss) attributable to the noncontrolling interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zVea4zW3id6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zB1kRsXWCWH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Reclassifications</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain amounts on the prior-year consolidated balance sheet, consolidated statement of operations and cash flows were reclassified to conform to current-year presentation, with no effect on ending stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z0mcq1kHtlJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--IncomeTaxExaminationDescription_c20210801__20211031_zUL4tA6F6qT1" title="Income tax examination description">The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises.</span> The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. <p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zL9LNMLhzw12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company adopted ASC Topic 606 Revenue from Contracts with Customers (“Topic 606) on August 1, 2019, applying the modified retrospective method to all contracts that were not completed as of August 1, 2019. The Company is building up its core business upon the completion of multiple acquisitions in March 2019 and limited operations occurred during the years ended July 31, 2021 due to the impact of COVID-19 pandemic. The revenue for the three months period ended October 31, 2021 and 2020 were mainly generated from HZLJ, PDHJ and Gelinke.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is recognized when control of promised goods or services is transferred to our customers in an amount of consideration to which we expect to be entitled to in exchange for those goods or services. We follow the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. ASC 606 has no material impacts on the Company’s financial positions. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms. The Company recorded $<span id="xdx_908_eus-gaap--EnergyMarketingContractLiabilitiesCurrent_iI_pp0p0_c20211031_zKHKXgXVP663" title="Contract liabilities">606,383</span> and $<span id="xdx_904_eus-gaap--EnergyMarketingContractLiabilitiesCurrent_iI_pp0p0_c20210731_zyldgBLjOoJ" title="Contract liabilities">545,346</span> unsatisfied performance obligations and contract liabilities as of October 31 and July 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Early childhood education services: HF Int’l Education generates revenue from childhood education classes provided to its customers. The educational services consist of parent-child and bilingual childcare classes. Each contract of educational classes is accounted for as a single performance obligation which is satisfied proportionately over the service period. Tuition fee is generally collected in advance and is initially recorded as deferred revenue and transferred to contract liabilities after trial period. Refunds are provided to parents if they decide within the trial period that they no longer want to take the class. After the trial period, if a parent withdraws from a class, usually only that unearned portion of the fee is available to be returned. For the three months ended October 31, 2021 and 2020, $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210801__20211031__srt--ProductOrServiceAxis__custom--EarlyChildhoodEducationServicesMember_zLzwtb11JAji" title="Revenue">155,364</span> and $<span id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__srt--ProductOrServiceAxis__custom--EarlyChildhoodEducationServicesMember_zy8hBAVr8ehk" title="Revenue">46,593</span>, respectively, of revenue were derived from early childhood education classes provided.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Hospitality services: HZLJ generates revenue primarily from the room rentals, sale of food and beverage and other miscellaneous hospitality services. The Company recognizes room rental and services daily as services are provided. Under ASC 606, the pattern and timing of recognition of income from hotel facility is consistent with the prior accounting model.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 606383 545346 155364 46593 <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8Al1oyNijB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recent Accounting Pronouncements</b></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Recently adopted accounting pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes which is intended to simplify various aspects related to accounting for income taxes. The standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. The adoption of ASU No. 2019-12 did not have a material impact on the Company’s financial position, results of operations and liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Recently issued accounting pronouncements not yet adopted</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. The standard, including subsequently issued amendments (ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10 and ASU 2019-11), requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_802_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zAGKHmN1D2L2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 2. <span id="xdx_82C_zZqj4m2tpkOb">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp. has incurred losses since inception, resulting in an accumulated deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211031_zgyfjC3EJDsb" title="Accumulated deficit">6,403,051</span> as of October 31, 2021. These conditions raise substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.’s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> -6403051 <p id="xdx_804_eus-gaap--BusinessCombinationDisclosureTextBlock_zVW10Ehpje3e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 3. <span id="xdx_826_zkUaDz4T9Hpf">ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Joint Venture – HF Int’l Education</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On March 22, 2019, HFSH entered into a joint venture agreement (the “JV agreement”) with Shanghai Jingyu Education Tech Ltd. (“SH Jingyu”) and one individual investor, to form a new entity - HF Int’l Education to provide childcare education services. HFSH initially owned <span id="xdx_90D_ecustom--JointVentureAcquiredOwnershipInterest_iI_pid_dp_c20190322__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember_zFm7Bi8ObaY7" title="Joint venture acquired ownership interest">65.0%</span> ownership HF Int’l Education, and reduced to <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_c20200731__srt--TitleOfIndividualAxis__custom--ShareholdersMember__srt--OwnershipAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember_zW0H7wBjKnz6" title="Noncontrolling ownership interest">61.0%</span> during the year ended on July 31, 2020 because of equity transactions between noncontrolling shareholders. On June 19, 2020, the board of HF Int’l Education decided to increase registered capital to RMB<span id="xdx_906_eus-gaap--Capital_iI_pn6n6_uRMB_c20200619__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember__srt--RangeAxis__srt--MaximumMember_zkx916Diuk6d" title="Registered capital">10</span> million from RMB<span id="xdx_904_eus-gaap--Capital_iI_pn6n6_uRMB_c20200619__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember__srt--RangeAxis__srt--MinimumMember_z3Pg0LaRGYC6" title="Registered capital">5</span> million, and three out of four noncontrolling shareholders gave up the subscription rights. <span id="xdx_90A_ecustom--NoncontrollingShareholdersDescription_c20210801__20211031__us-gaap--BusinessAcquisitionAxis__custom--HFIntlEducationMember_zcbB8aIjUdJ2" title="Noncontrolling shareholders, description">As a result, HFSH held 75.5% of HF Int’l Education and a total of 24.5% equity was held by noncontrolling shareholders</span>. <span id="xdx_906_ecustom--NoncontrollingShareholdersDescription_c20210530__20210601__us-gaap--BusinessAcquisitionAxis__custom--HFIntlEducationMember_zzgbxmRIn5T3" title="Noncontrolling shareholders, description">Pursuant to the board meeting held on June 1, 2021, the noncontrolling shareholders sold a total 14.5% equity at zero consideration to HFSH. As a result, HFSH holds 90.0% of HF Int’l Education and $403,131 noncontrolling loss was absorbed by HFSH as a result of the ownership restructure at HF Int’l Education.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Continuous operation losses caused by the market uncertainties including pandemic and government regulations, HF Int’l Education entered agreements to sell the copyrights of seven education textbooks and ten “HaiDeFuDe” registered trademarks owned for RMB<span id="xdx_902_eus-gaap--Capital_iI_pn5n6_uRMB_c20190322__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--SevenEducationTextbooksMember_zartMTyk48q7" title="Registered capital">1.2</span> million and RMB<span id="xdx_90F_eus-gaap--Capital_iI_pn5n6_uRMB_c20190322__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TenHaiDeFuDeMember_zpbq8ShNY0g6" title="Registered capital">1.0</span> million, respectively, to Hartford Health Management (Shanghai) Co., Ltd (“HFHM”) in March 2021 with approval of the board of directors. The CEO of HFHM is a shareholder of the Company who owns more than <span id="xdx_90D_ecustom--JointVentureAcquiredOwnershipInterest_iI_pid_dp_c20210331__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zPwIvb4ZD6c" title="Joint venture acquired ownership interest">5%</span> of the Company’s common stocks.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operation result of HF Int’l Education are included in the Company’s consolidated financial statements commencing on the formation date. The Company classifies the ownership interest held by other four parties as “Noncontrolling interest” on the consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Acquisition of Gelinke</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Gelinke, who engages at early childhood education services in Changning District, Shanghai. The results of operations of the acquired entities are included in the Company’s consolidated financial statements commencing on the acquisition date. The Company has recorded an allocation of purchase price to Gelinke’s tangible and identifiable intangible assets acquired and liabilities assumed based on their fair value at the acquisition date. The Company accounted the acquisition transaction in accordance with FASB ASC 805, Business Combinations, under acquisition accounting method. The related transaction costs were immaterial and included in General and administrative expenses in the accompanying consolidated statements of operations. The acquisition was completed on August 31, 2021. The calculation of purchase price and purchase price allocation is as follows:</span></p> <p id="xdx_890_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z5R5azJKLqVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B4_zJyRrnq6C4I2" style="display: none">SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_zrlIqOsR0f3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Assets Acquired and</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities Assumed</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_maBCRIAzEmL_zsEVKWB2a1Ji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,809</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash_iI_pp0p0_maBCRIAzEmL_zCfI6v8X2GW8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">25,009</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_maBCRIAzEmL_zQ2C0FzIVlD9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid and Other current receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_maBCRIAzEmL_zevKXgQRH1i4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Property and Equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,294</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di_msBCRIAzEmL_zCNnxqKR79ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Unearned revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(78,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pp0p0_maBCRIAzEmL_zLwqAhyKaA7l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">67,712</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pp0p0_mtBCRIAzEmL_z33bqenP0Fkd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_F43_z3Fkkmeuqxd6" style="font: 10pt Times New Roman, Times, Serif">Total consideration*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">24,824</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F06_zyWmukvVNZaj" style="width: 15pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span id="xdx_F15_z99U63QxMGj1" style="font: 10pt Times New Roman, Times, Serif">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesGross_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_pp0p0" title="Purchase price">10,462</span> (RMB<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PaymentsToAcquireBusinessesGross_pp0p0_uRMB_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_zLYftRmjPimd" title="Purchase price">70,000</span>) payable to the acquiree plus $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--OtherPaymentsToAcquireBusinesses_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_pp0p0" title="Cash payments to acquire business">14,362</span> (RMB<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--OtherPaymentsToAcquireBusinesses_pp0p0_uRMB_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_z4R0Kt7xbvph" title="Cash payments to acquire business">100,000</span>) cash payment totaled $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_pp0p0" title="Total consideration">24,824</span> consideration for the acquisition.</span></td> </tr></table> <p id="xdx_8A9_zTXXOk0dnnt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Goodwill is mainly attributable to synergies expected from the acquisition of license, list of customers and teacher workforce. Due to unfavorable operation result of Gelinke during the year ended July 31, 2021, management determined that $<span id="xdx_908_eus-gaap--Goodwill_c20210731__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_pp0p0" title="Goodwill">67,712</span> goodwill generated from Gelinke Acquisition was fully impaired and temporally ease the operation of Gelinke by the end of August, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Other Acquisitions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In January and February 2019, HFSH entered agreements to acquire <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20190228__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiSeniorHealthConsultingLtdMember_zNwJOkgFwyJe" title="Business acquired ownership interest"><span id="xdx_902_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20190131__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiSeniorHealthConsultingLtdMember_zFP6tHvKppG8" title="Business acquired ownership interest">85</span></span> percent ownership of Shanghai Senior Health Consulting Ltd. (“SH Senior”) and <span id="xdx_90E_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20190228__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiPasadenaLtdMember_zE0jvVOqO5e8" title="Business acquired ownership interest"><span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20190131__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiPasadenaLtdMember_zaVhKJWpzl21" title="Business acquired ownership interest">55</span></span> percent ownership of Shanghai Pasadena Ltd. (“SH Pasadena”). On December 31, 2020, HFSH withdrew from the two acquisition agreements. No penalty results from the withdrawn.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In January 2019, HFSH entered agreements to acquire <span id="xdx_905_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20190131__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiLuoShengInternationalTradeLtdMember_zUyGKz5qnOVj" title="Business acquired ownership interest">100</span> percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”), As of October 31, 2021, the agreement has not yet taken effect as no consideration has been paid toward this acquisition. The agreement will be executed when the Company is financially ready to move forward, and the purchase price will be calculated based on the net assets of each entity on executing dates. There was no penalty levied or to be levied due to delayed execution or inexecution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Disposal of subsidiary</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On December 31, 2020, HFSH disposed its <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20201231__us-gaap--BusinessAcquisitionAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember__srt--OwnershipAxis__custom--QiaoGardenInternationalTravelAgencyMember_zfZQMcrUfQic" title="Business acquired ownership interest">90</span> percent owned subsidiary - Qiao Garden Int’l Travel to an individual (the “Disposal”). The individual is a relative of the CEO, Qiao Garden Int’l Travel became a related party after deconsolidation. The operation results, assets and liabilities, and cash flows of Qiao Garden Int’l Travel were deconsolidated from the Company’s consolidated financial statements effective on December 31, 2020. The Disposal of Qiao Garden was consummated through a three-party settlement among HFSH, SH Qiaohong and Qiao Garden Int’l Travel (the “Three-Party Settlement”): the original investment RMB <span id="xdx_906_ecustom--InvestmentFromNoncontrollingInterests_pn5n6_uRMB_c20201230__20201231__dei--LegalEntityAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember__srt--OwnershipAxis__custom--QiaoGardenInternationalTravelAgencyMember_zt7Tnu1UbmXf" title="Investment from noncontrolling interest">4.5</span> million plus RMB <span title="Investment income"><span id="xdx_901_eus-gaap--InvestmentIncomeNet_pn5n6_uRMB_c20201230__20201231__dei--LegalEntityAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember__srt--OwnershipAxis__custom--QiaoGardenInternationalTravelAgencyMember_zisrIMBlXk1a" title="Investment income">0.5</span></span> million investment income were agreed to returned from Qiao Garden Int’l Travel as a result of the Disposal and settled with a payable due to SH Qiaohong at SHHF, who was a debtor of Qiao Garden Int’l Travel, see Note 14, Related Party Transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_899_ecustom--ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryTableTextBlock_ziyGQWxI0kSe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Net assets (liabilities) disposed of: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B5_zvUuQgNcyMt4" style="display: none">SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Net assets (liabilities) disposed of:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_zkuxPRicSXte" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">172</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--DisposalGroupIncludingDiscontinuedOperationRestrictedCash_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">29,944</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Related party receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">782,224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyPayable_iI_pp0p0_zbYtz7krk1gl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Related party payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(98,615</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iNI_pp0p0_di_zyBTCow2TFEj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other current payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,876</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(60,812</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net assets of the subsidiary, excluding noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">649,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">753,354</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on disposal of the subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_pp0p0_c20201229__20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_zcAP9aWo8PV" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on disposal of the subsidiary"><span style="font: 10pt Times New Roman, Times, Serif">(104,317</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on disposal of noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_pp0p0_c20201229__20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_z3wAiKgqNIgb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on disposal of noncontrolling interest"><span style="font: 10pt Times New Roman, Times, Serif">(60,812</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on disposal of the subsidiary, excluding noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_pp0p0_c20201229__20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_ziG7b5eEwAua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on disposal of the subsidiary, excluding noncontrolling interest"><span style="font: 10pt Times New Roman, Times, Serif">(43,505</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> <p id="xdx_8A9_zCuoVwtfd3Kd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zdsrjoedkVYd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Net inflow / (outflow) of cash and cash equivalents in respect of the disposal subsidiary: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B2_z32HfMAGSgm5" style="display: none">SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_494_20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_z8ZMTUBCkQe3" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iNI_pp0p0_di_maDGIDOzAgL_zOQdPcrbM3Cc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(172</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRestrictedCash_iNI_pp0p0_di_maDGIDOzAgL_z0xvcIeWJmab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(29,944</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_404_ecustom--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalentsAndRestrictedCash_iI_pp0p0_z1apa2gTGlB5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents deconsolidated</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(30,116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> <p id="xdx_8A5_z6eWBIbzMwkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 0.650 0.610 10000000 5000000 As a result, HFSH held 75.5% of HF Int’l Education and a total of 24.5% equity was held by noncontrolling shareholders Pursuant to the board meeting held on June 1, 2021, the noncontrolling shareholders sold a total 14.5% equity at zero consideration to HFSH. As a result, HFSH holds 90.0% of HF Int’l Education and $403,131 noncontrolling loss was absorbed by HFSH as a result of the ownership restructure at HF Int’l Education. 1200000 1000000.0 0.05 <p id="xdx_890_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z5R5azJKLqVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B4_zJyRrnq6C4I2" style="display: none">SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_zrlIqOsR0f3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Assets Acquired and</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities Assumed</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_maBCRIAzEmL_zsEVKWB2a1Ji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 72%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,809</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash_iI_pp0p0_maBCRIAzEmL_zCfI6v8X2GW8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">25,009</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_maBCRIAzEmL_zQ2C0FzIVlD9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid and Other current receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_maBCRIAzEmL_zevKXgQRH1i4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Property and Equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,294</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di_msBCRIAzEmL_zCNnxqKR79ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Unearned revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(78,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pp0p0_maBCRIAzEmL_zLwqAhyKaA7l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">67,712</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pp0p0_mtBCRIAzEmL_z33bqenP0Fkd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_F43_z3Fkkmeuqxd6" style="font: 10pt Times New Roman, Times, Serif">Total consideration*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">24,824</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F06_zyWmukvVNZaj" style="width: 15pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span id="xdx_F15_z99U63QxMGj1" style="font: 10pt Times New Roman, Times, Serif">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesGross_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_pp0p0" title="Purchase price">10,462</span> (RMB<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PaymentsToAcquireBusinessesGross_pp0p0_uRMB_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_zLYftRmjPimd" title="Purchase price">70,000</span>) payable to the acquiree plus $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--OtherPaymentsToAcquireBusinesses_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_pp0p0" title="Cash payments to acquire business">14,362</span> (RMB<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--OtherPaymentsToAcquireBusinesses_pp0p0_uRMB_c20200719__20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_z4R0Kt7xbvph" title="Cash payments to acquire business">100,000</span>) cash payment totaled $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEFDUVVJU0lUSU9OUywgSk9JTlQgVkVOVFVSRVMgQU5EIERFQ09OU09MSURBVElPTiAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgSURFTlRJRklFRCBBU1NFVFMgQUNRVUlSRUQgQU5EIExJQUJJTElUSUVTIEFTU1VNRUQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20200720__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember_pp0p0" title="Total consideration">24,824</span> consideration for the acquisition.</span></td> </tr></table> 1809 25009 4696 4294 78696 67712 24824 10462 70000 14362 100000 24824 67712 0.85 0.85 0.55 0.55 1 0.90 4500000 500000 <p id="xdx_899_ecustom--ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryTableTextBlock_ziyGQWxI0kSe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Net assets (liabilities) disposed of: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B5_zvUuQgNcyMt4" style="display: none">SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Net assets (liabilities) disposed of:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_zkuxPRicSXte" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">172</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--DisposalGroupIncludingDiscontinuedOperationRestrictedCash_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">29,944</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Related party receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">782,224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--DisposalGroupIncludingDiscontinuedOperationRelatedPartyPayable_iI_pp0p0_zbYtz7krk1gl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Related party payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(98,615</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iNI_pp0p0_di_zyBTCow2TFEj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other current payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,876</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(60,812</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net assets of the subsidiary, excluding noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">649,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">753,354</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on disposal of the subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_pp0p0_c20201229__20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_zcAP9aWo8PV" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on disposal of the subsidiary"><span style="font: 10pt Times New Roman, Times, Serif">(104,317</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on disposal of noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_pp0p0_c20201229__20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_z3wAiKgqNIgb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on disposal of noncontrolling interest"><span style="font: 10pt Times New Roman, Times, Serif">(60,812</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on disposal of the subsidiary, excluding noncontrolling interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_pp0p0_c20201229__20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_ziG7b5eEwAua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on disposal of the subsidiary, excluding noncontrolling interest"><span style="font: 10pt Times New Roman, Times, Serif">(43,505</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> 172 29944 782224 -98615 3876 -60812 649037 753354 -104317 -60812 -43505 <p id="xdx_89A_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zdsrjoedkVYd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Net inflow / (outflow) of cash and cash equivalents in respect of the disposal subsidiary: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B2_z32HfMAGSgm5" style="display: none">SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_494_20201231__srt--ConsolidatedEntitiesAxis__custom--QiaoGardenIntelTravelMember_z8ZMTUBCkQe3" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iNI_pp0p0_di_maDGIDOzAgL_zOQdPcrbM3Cc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(172</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRestrictedCash_iNI_pp0p0_di_maDGIDOzAgL_z0xvcIeWJmab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(29,944</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_404_ecustom--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalentsAndRestrictedCash_iI_pp0p0_z1apa2gTGlB5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents deconsolidated</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(30,116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> 172 29944 -30116 <p id="xdx_807_eus-gaap--RestrictedAssetsDisclosureTextBlock_zeY3mTCof5Oh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 4. <span id="xdx_82B_zQ84jx6GikNk">RESTRICTED CASH</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company early adopted ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, and includes restricted cash with cash and cash equivalents when reconciling the beginning of year and end of year total amounts shown on the statements of cash flows. The restricted cash are collaterals required by the local government in China for the early education license Gelinke held as of July 31, 2021, subsequently on August 26, the restricted cash had been withdrawal and transferred to other bank accounts as a result of operation halt at Gelinke.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_z7d4dWySrEMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows. </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B1_zSUl1u4HO2r" style="display: none">SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211031_zku0D4ZC6ePb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021 <br/>(unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20210731_zUtC0UjUx033" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_maCCERCztQC_zDfHo1ax2jb4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">44,284</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">27,612</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--RestrictedCash_iI_pp0p0_maCCERCztQC_zveA9z0L7Shb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0556"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">26,566</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pp0p0_mtCCERCztQC_z5ZJ73gFDkbh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total cash, cash equivalents and restricted cash shown in the statement of cash flows</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">44,284</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">54,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zBYc3tg2Wk33" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_z7d4dWySrEMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows. </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B1_zSUl1u4HO2r" style="display: none">SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211031_zku0D4ZC6ePb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021 <br/>(unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20210731_zUtC0UjUx033" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_maCCERCztQC_zDfHo1ax2jb4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">44,284</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">27,612</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--RestrictedCash_iI_pp0p0_maCCERCztQC_zveA9z0L7Shb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0556"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">26,566</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pp0p0_mtCCERCztQC_z5ZJ73gFDkbh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total cash, cash equivalents and restricted cash shown in the statement of cash flows</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">44,284</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">54,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 44284 27612 26566 44284 54178 <p id="xdx_80B_ecustom--PrepaidAndOtherCurrentReceivableTextBlock_zdQ8rb7BHmv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 5. <span id="xdx_82C_zQgndMRZWEib">PREPAID AND OTHER CURRENT RECEIVABLES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid and other current receivable amounts of $<span id="xdx_907_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pp0p0_c20211031_zm2siGczqvz" title="Prepaid and other current receivables">173,825</span> and $<span id="xdx_90E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pp0p0_c20210731_zjPcITBJdJT1" title="Prepaid and other current receivables">286,232</span> as of October 31 and July 31, 2021, respectively, mainly consist of advances for purchase and renovation project, employee operating advances and others.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 173825 286232 <p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_z2eyLCTARTdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 6. <span id="xdx_822_zEqZ8aSUWgN4">INVENTORY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventory mainly consists of books, the early childhood education materials. Inventory is stated at the lower of cost or net realizable value. As of October 31 and July 31, 2021, inventory balance was $<span id="xdx_906_eus-gaap--InventoryNet_iI_pp0p0_c20211031_zkACCcsjcp99" title="Inventory's net">324,120</span> and $<span id="xdx_902_eus-gaap--InventoryNet_iI_pdp0_c20210731_zty3yM0J8hSg" title="Inventory's net">323,814</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 324120 323814 <p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zSyMnlhHhEGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 7. <span id="xdx_82E_zyelUWkr7HYb">PROPERTY AND EQUIPMENT, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_zKA2PvLmweR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Property and equipment, net consists of the following at October 31 and July 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B7_zJZ2MfFp1MS9" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20211031_zvPhkNgNRLub" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20210731_zIVrMpmBQnU" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z0O3WTbNVER" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">419,181</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">214,184</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FinanceLeaseAssetsMember_zRq9wpHcgyN2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">293,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">290,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAapqtRXb2v1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">311,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">289,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentVehiclesMember_zMarMlvNqam8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Office equipment and vehicles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">163,312</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">161,529</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_z0RIHNn3mMx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Construction in progress</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">18,702</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">67,044</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Property and equipment, gross</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,205,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,022,471</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_zPxt9lwh0O51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less: accumulated depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(461,114</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(428,954</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTIC_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">744,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">593,517</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zbDTNqMxADH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation expense for the three months ended October 31, 2021 and 2020, was $<span id="xdx_901_eus-gaap--Depreciation_pp0p0_c20210801__20211031_zTGdzJFjS72g" title="Depreciation expense">28,219</span> and $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20200801__20201031_zsKilBhFivuk">19,141</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_894_eus-gaap--PropertyPlantAndEquipmentTextBlock_zKA2PvLmweR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Property and equipment, net consists of the following at October 31 and July 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B7_zJZ2MfFp1MS9" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20211031_zvPhkNgNRLub" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20210731_zIVrMpmBQnU" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z0O3WTbNVER" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">419,181</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">214,184</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FinanceLeaseAssetsMember_zRq9wpHcgyN2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">293,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">290,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zAapqtRXb2v1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">311,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">289,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeEquipmentVehiclesMember_zMarMlvNqam8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Office equipment and vehicles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">163,312</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">161,529</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_z0RIHNn3mMx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Construction in progress</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">18,702</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">67,044</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Property and equipment, gross</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,205,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,022,471</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_zPxt9lwh0O51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less: accumulated depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(461,114</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(428,954</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTIC_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">744,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">593,517</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 419181 214184 293247 290714 311064 289000 163312 161529 18702 67044 1205506 1022471 461114 428954 744392 593517 28219 19141 <p id="xdx_809_eus-gaap--OtherAssetsDisclosureTextBlock_zDGvJEy5VmG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 8. <span id="xdx_820_zR0WMS80YiV2">OTHER ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zt4ydrooIuXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Other assets consist of the following at October 31 and July 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B2_z98EW7j77ori" style="display: none">SCHEDULE OF OTHER ASSETS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20211031_z8r55sTDwJk1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20210731_z3JgftYjwa5a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--OtherAssetsMiscellaneous_iI_pp0p0_maOANz3oZ_zEtZnUNlRVEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other miscellaneous assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">30,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">32,308</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--RentalDeposits_iI_pp0p0_maOANz3oZ_zmXG45LB2006" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Rental deposits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">216,580</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">289,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--OtherAssetsNoncurrent_iTI_pp0p0_mtOANz3oZ_z6FBJSqL8ovh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Other assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">246,785</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">321,807</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AA_zNctxZq8uHxi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zt4ydrooIuXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Other assets consist of the following at October 31 and July 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B2_z98EW7j77ori" style="display: none">SCHEDULE OF OTHER ASSETS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20211031_z8r55sTDwJk1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20210731_z3JgftYjwa5a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--OtherAssetsMiscellaneous_iI_pp0p0_maOANz3oZ_zEtZnUNlRVEh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other miscellaneous assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">30,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">32,308</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--RentalDeposits_iI_pp0p0_maOANz3oZ_zmXG45LB2006" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Rental deposits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">216,580</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">289,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--OtherAssetsNoncurrent_iTI_pp0p0_mtOANz3oZ_z6FBJSqL8ovh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Other assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">246,785</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">321,807</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 30205 32308 216580 289499 246785 321807 <p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zK4e9CkVGZQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 9. <span id="xdx_823_zlJ9LGeXBvH8">OTHER CURRENT PAYABLES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_891_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zu3kz1tiR87h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">The following is a breakdown of the accounts and other payables as of October 31 and July 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B4_zcPymqdrLyra" style="display: none">SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20211031_z5Vgc9EuMwN8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20210731_zzwZ3SQGSiy8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--PayableToAcquiree_iI_pp0p0_maONPCzT4h_zmiX7JGg0bI1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Payable to acquirees</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">152,636</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">151,317</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maONPCzT4h_z8A1t4VL9Zec" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Accrued payroll</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,553</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">11,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--PayableToPublisherCurrent_iI_pp0p0_maONPCzT4h_z2L3UMgVYOad" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Payable to publisher</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">140,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">139,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maONPCzT4h_zoDsEUgME88d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">253,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">169,935</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--OtherNotesPayableCurrent_iTI_pp0p0_mtONPCzT4h_zWzIAkGWE8Kl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Other Current Payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">556,298</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">471,603</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zPf9ccI14WSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Payable to acquiree is the unpaid consideration for the acquisitions described in Note 3 Acquisitions and Joint Venture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zu3kz1tiR87h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">The following is a breakdown of the accounts and other payables as of October 31 and July 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B4_zcPymqdrLyra" style="display: none">SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20211031_z5Vgc9EuMwN8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20210731_zzwZ3SQGSiy8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--PayableToAcquiree_iI_pp0p0_maONPCzT4h_zmiX7JGg0bI1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Payable to acquirees</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">152,636</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">151,317</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maONPCzT4h_z8A1t4VL9Zec" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Accrued payroll</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,553</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">11,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--PayableToPublisherCurrent_iI_pp0p0_maONPCzT4h_z2L3UMgVYOad" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Payable to publisher</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">140,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">139,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maONPCzT4h_zoDsEUgME88d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">253,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">169,935</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--OtherNotesPayableCurrent_iTI_pp0p0_mtONPCzT4h_zWzIAkGWE8Kl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> Other Current Payables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">556,298</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">471,603</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 152636 151317 9553 11064 140500 139287 253609 169935 556298 471603 <p id="xdx_801_eus-gaap--LesseeOperatingLeasesTextBlock_zO499cXX5V94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 10. <span id="xdx_821_znX3z2GCCgdf">LEASES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. Leases are classified as either finance leases or operating leases based on criteria in Accounting Standards Codification (“ASC”) 842. Operating leases are included in ROU assets-Operating lease, Current Operating Lease liabilities and Operating lease liabilities, finance leases are included in Property and Equipment and Other Liabilities in the condensed Consolidated Balance Sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Right-of-use (“ROU”) assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the lease did not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in China market. ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases, consisting of lease payments, is recognized on a straight-line basis over the lease term. Lease expense for finance leases consists of the amortization of the ROU asset on a straight-line basis over the asset’s estimated useful life and interest expense is calculated using the amortized cost basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of July 31, 2021, the Company has multiple operating leases for office spaces and a finance lease of land and hotel building. Our operating leases have remaining lease terms ranging from <span id="xdx_901_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dt_c20210731__srt--RangeAxis__srt--MinimumMember_zkSmlngF3wy1" title="Operating leases remaining term">one year</span> to <span id="xdx_902_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dt_c20210731__srt--RangeAxis__srt--MaximumMember_zCEO1tSnmUv6" title="Operating leases remaining term">five years</span>, with various term extensions available. Our finance lease has remaining lease term of <span id="xdx_90C_eus-gaap--LesseeFinanceLeaseRemainingLeaseTerm_iI_dt_c20210731_zn5435P3XWg4" title="Finance leases remaining term">thirty years</span>. The Company has elected not to recognize ROU assets and lease liabilities for short-term operating leases that have a term of twelve months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2018 and January 2019, HFSH and HF Int’l Education entered two lease agreements with Shanghai Longjin Corporate Management Co., Ltd (the “Sublessor”) to lease office spaces (the “Subleases”). HFSH and HF Int’l Education received Notices of Lease Termination from the Sublessor for late payments on April 13, 2020 and filed a civil lawsuit against the Sublessor on July 10, 2020 (see Note 16). And the original lease agreement entered between the Sublessor and the landlord of the office building (the “Landlord”) was terminated by the Landlord on June 1, 2020 due to payment default. The two sublease agreements entered with the Sublessor was terminated on June 1, 2020 and approximately $<span id="xdx_909_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20200531__us-gaap--TypeOfArrangementAxis__custom--TwoSubleaseAgreementsMember_z5DKxBcD7Ruk" title="ROU of lease liability">921,000</span> ROU and $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20200531__us-gaap--TypeOfArrangementAxis__custom--TwoSubleaseAgreementsMember_z64ZOzLyNXtl" title="Lease liability">891,000</span> lease liability associated with the two Subleases as of May 31, 2020 were eliminated and $<span id="xdx_903_eus-gaap--OtherExpenses_pp0p0_c20200529__20200531__us-gaap--TypeOfArrangementAxis__custom--TwoSubleaseAgreementsMember_zKC1xiBfDSq1" title="Other expenses">29,000</span> other expenses was recognized as a result. HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces with a <span id="xdx_900_eus-gaap--LessorOperatingLeaseTermOfContract_iI_dtYxL_c20200601__us-gaap--TypeOfArrangementAxis__custom--NewleaseAgreementMember_zXy430MUc9nb" title="Lease term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0651">five</span></span>-year term. <span id="xdx_902_eus-gaap--LesseeOperatingSubleaseOptionToExtend_c20210801__20211031__us-gaap--TypeOfArrangementAxis__custom--SubleaseAgreementsMember__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember_zLkvJRmGLOH8" title="Sublease term description">On July 13, 2021, HF Int’l Education entered a sublease agreement with sub-lessee (a third party) for some office space with two-year term, amount of $34,711 was recognized as sublease income, included under other income, for the three months ended October 31, 2021.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On September 1, 2020, Gelinke entered a <span id="xdx_908_eus-gaap--LessorOperatingLeaseTermOfContract_iI_dtYxL_c20200902__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember__us-gaap--TypeOfArrangementAxis__custom--FiveYearNewleaseAgreementMember_z3zR9oUuOIU3" title="Lease term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0655">five</span></span>-year new lease agreement at the original office location upon the completion of the acquisition. Approximately $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn5n6_c20200902__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember__us-gaap--TypeOfArrangementAxis__custom--FiveYearNewleaseAgreementMember_zcSDsrk2yzH9" title="ROU of lease liability"><span id="xdx_90B_eus-gaap--OperatingLeaseLiability_iI_pn5n6_c20200902__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember__us-gaap--TypeOfArrangementAxis__custom--FiveYearNewleaseAgreementMember_zTGGIxlN3t04" title="Lease liability">1.2</span></span> million ROU and lease liability, respectively, were recognized with the new lease at lease commencement date. On August 15, 2021, an early termination agreement was entered to terminate this lease on August 30, 2021. As a result, approximately $<span id="xdx_902_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn6n6_c20210731__us-gaap--TypeOfArrangementAxis__custom--EarlyTerminationAgreementMember_zsbnEzdn7mhi" title="ROU of lease liability"><span id="xdx_901_eus-gaap--OperatingLeaseLiability_iI_pn6n6_c20210731__us-gaap--TypeOfArrangementAxis__custom--EarlyTerminationAgreementMember_zj0ZSALQIOMd" title="Lease liability">1</span></span> million ROU and lease liability, respectively, associated with this lease as of July 31, 2021 were eliminated and $<span id="xdx_908_eus-gaap--GainLossOnTerminationOfLease_pp0p0_c20210701__20210731__us-gaap--BusinessAcquisitionAxis__custom--ShanghaiGelinkeChildcareEducationCenterMember__us-gaap--TypeOfArrangementAxis__custom--EarlyTerminationAgreementMember_z3hxTqQ6DPtk" title="Gain on termination of lease">40,005</span> gain was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">HZHF terminated its original office lease on January 6, 2021. Approximately $<span id="xdx_90A_eus-gaap--OperatingLeaseRightOfUseAsset_c20210106__us-gaap--BusinessAcquisitionAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_pp0p0" title="ROU of lease liability">287,000</span> ROU and $<span id="xdx_909_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20210106__us-gaap--BusinessAcquisitionAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zYtS7oXS8saa" title="Lease liability">258,000</span> lease liability associated with the original lease agreement were eliminated. On January 9, 2021, HFHZ entered into a <span id="xdx_901_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtYxL_c20210109__us-gaap--BusinessAcquisitionAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zGegRI26HhQ9" title="Operating leases remaining term::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl0671">two</span></span>-year new lease with smaller space at the same location. Approximately $<span id="xdx_902_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20210109__us-gaap--BusinessAcquisitionAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_zpWYKHV8sdm2" title="ROU of lease liability"><span id="xdx_905_eus-gaap--OperatingLeaseLiability_c20210109__us-gaap--BusinessAcquisitionAxis__custom--HangzhouHartfordComprehensiveHealthManagementLtdMember_pp0p0" title="Lease liability">49,000</span></span> ROU and lease liability, respectively, were recognized with the new lease at lease commencement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The finance lease was obtained through HZLJ acquisition on March 22, 2019. On October 1, 2010, HZLJ took over the lease of the land and hotel building for <span id="xdx_90C_eus-gaap--LesseeFinanceLeaseRemainingLeaseTerm_iI_dtY_c20101001__us-gaap--BusinessAcquisitionAxis__custom--HangzhouLongjingQiaoFuVacationHotelCoLtdMember_zEZEWyaicLb5" title="Finance leases remaining term">41</span> years. Finance lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_ecustom--ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock_zJfWrkSFCDy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Lease-related assets and liabilities at October 31 and July 31, 2021 were as follows: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8BA_z03BcO4kZbb9" style="display: none">SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211031_zRzpgD1mr3fk" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20210731_z7a88Sftx0e8" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_pp0p0_maFLROUzouc_zEAoyUcrXTte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease right-of-use assets, cost (Note 7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">293,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">290,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseRightOfUseAssetAccumulatedAmortization_iNI_pp0p0_di_msFLROUzouc_z7DkpUpHHLL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(80,814</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(80,547</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseRightOfUseAsset_iTI_pp0p0_mtFLROUzouc_maTLROUzMFN_zGhabcz3hILf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease right-of-use assets, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">212,433</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">210,167</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_maTLROUzMFN_zfy0dwYCkVt3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">ROU assets-Operating lease</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,642,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,837,186</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_ecustom--TotalLeaseRightOfUseAssets_iTI_pp0p0_mtTLROUzMFN_zPN5JMxq7Pv1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total Lease ROU assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,854,524</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,047,353</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maLLzXQ0_zfQNl8IrwnSk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Current Operating Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,460,483</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,508,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maLLzXQ0_zLuTGYj6Rmpg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating lease liabilities, noncurrent</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,682,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,785,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_maLLzXQ0_zWOEGD4Agqjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease liabilities, noncurrent</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">378,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">368,715</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--LeaseLiabilities_iTI_pp0p0_mtLLzXQ0_z4IoUXz3cY06" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,521,637</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,663,202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zmmFYuBXGNPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zygL2cKbzUt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">The components of lease cost for the three months ended October 31, 2021 and 2020: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B4_zJaaOaaec6ae" style="display: none">SCHEDULE OF COMPONENTS OF LEASE COST</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_496_20210801__20211031_z0niVsjKUL4e" style="border-bottom: Black 1.5pt solid; display: none; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_493_20200801__20201031_zvtHWWhJMF5j" style="border-bottom: Black 1.5pt solid; display: none; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">2020 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three months ended October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseCost_maLCz9Pe_zkebXU3xEnKd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">306,544</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">345,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance leases:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseRightOfUseAssetAmortization_maLCz9Pe_zVVLvX3NnLOc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Amortization of ROU assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,712</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseInterestExpense_maLCz9Pe_zzB1S2sg7ih" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Interest on finance lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,661</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--FinanceLeaseCost_maLCz9Pe_zeH1m0C2Riv4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,373</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--LeaseCost_iT_pp0p0_mtLCz9Pe_z2mFhjuqJrB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">315,316</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">354,086</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_zkG7mDEfv6s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_za4i872uMkhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Supplemental cash flow information for leases for the three months ended October 31, 2021 and 2020: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B1_z9A5gyyT6yB5" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three months ended October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating cash flows paid for operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--OperatingLeasePayments_pp0p0_c20210801__20211031_z7o30kQ0Daq6" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Operating cash flows paid for operating leases"><span style="font: 10pt Times New Roman, Times, Serif">186,127</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--OperatingLeasePayments_pp0p0_c20200801__20201031_za96TMJSAuB7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Operating cash flows paid for operating leases"><span style="font: 10pt Times New Roman, Times, Serif">54,230</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Financing cash flows paid for finance leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--FinanceLeaseInterestPaymentOnLiability_pp0p0_c20210801__20211031_zV3M5Zx9Qyz1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financing cash flows paid for finance leases"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0731">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--FinanceLeaseInterestPaymentOnLiability_pp0p0_c20200801__20201031_zcTbKiOZdLyg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financing cash flows paid for finance leases"><span style="font: 10pt Times New Roman, Times, Serif">21,257</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_ziwqU99M6rdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_897_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingAndFinanceLeasesTableTextBlock_z7KyTPRpxqYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases at October 31, 2021 was as follows: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B8_zNWfSLLEc0g8" style="display: none">SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Operating Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Finance Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average remaining lease term (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211031_zb4jlRw4opw8" title="Weighted-average remaining lease term (years) Operating Leases">3.8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211031_zxsVlF90rA4h" title="Weighted-average remaining lease term (years) Finance Leases">29.8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average discount rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211031_z5ReVOq3ti08" title="Weighted-average discount rate Operating Leases">8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211031_z68CKNkbSYTg" title="Weighted-average discount rate Finance Leases">8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> </table> <p id="xdx_8A6_z7PnkgOqaYm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_ecustom--ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesTableTextBlock_zIqFN7s7p7Qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table reconciles the undiscounted future minimum lease payments for operating and finance leases executed at October 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8BE_zaBW8uBtc3Jj" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Operating Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Finance Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20211031_zn3Wdrzs6Bn9" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Operating Leases, 2022"><span style="font: 10pt Times New Roman, Times, Serif">1,211,921</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20211031_zydseQz1x8I2" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Finance Leases, 2022"><span style="font: 10pt Times New Roman, Times, Serif">23,417</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20211031_z2jCpatywgmh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2023"><span style="font: 10pt Times New Roman, Times, Serif">1,153,762</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20211031_zDwgtU3RFkT4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2023"><span style="font: 10pt Times New Roman, Times, Serif">24,197</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20211031_zFyFPktlI6l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2024"><span style="font: 10pt Times New Roman, Times, Serif">1,206,431</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20211031_zw3xrfLOyspf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2024"><span style="font: 10pt Times New Roman, Times, Serif">24,978</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20211031_zB7m3YtLNPxb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2025"><span style="font: 10pt Times New Roman, Times, Serif">1,117,410</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20211031_zSwtEqoZSxYe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2025"><span style="font: 10pt Times New Roman, Times, Serif">25,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20211031_zwRarJbA2Hjd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2026"><span style="font: 10pt Times New Roman, Times, Serif">88,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20211031_z4yZJ95mGab4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2026"><span style="font: 10pt Times New Roman, Times, Serif">26,539</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2027 and thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pdp0_c20211031_zLa9ApPasVb6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2027 and thereafter"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20211031_zmE8wSDjSr88" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2027 and thereafter"><span style="font: 10pt Times New Roman, Times, Serif">963,985</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Total lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20211031_z6UTbz6y30x9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, Total lease payments"><span style="font: 10pt Times New Roman, Times, Serif">4,778,319</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_c20211031_zAgdSFb8yEAg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, Total lease payments"><span style="font: 10pt Times New Roman, Times, Serif">1,088,874</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Less interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20211031_zlJT53htGYB3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less interest"><span style="font: 10pt Times New Roman, Times, Serif">(635,658</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20211031_zEch6jTEGNaj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less interest"><span style="font: 10pt Times New Roman, Times, Serif">(709,898</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Present value of future lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20211031_zsYe5h3mjkCl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Present value of future lease payments"><span style="font: 10pt Times New Roman, Times, Serif">4,142,661</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiability_iI_pp0p0_c20211031_zyBDxv0IOvTa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Present value of future lease payments"><span style="font: 10pt Times New Roman, Times, Serif">378,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Current Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20211031_zhU5NV45gfL8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: current lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,460,483</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pdp0_c20211031_zcSDsNtS3iui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: current lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Noncurrent Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20211031_zdiSueWCIaG5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: noncurrent lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif">1,682,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_c20211031_zDkgdiiVP0c6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: noncurrent lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif">378,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_zWyeV3BbvTGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> P1Y P5Y P30Y 921000 891000 29000 On July 13, 2021, HF Int’l Education entered a sublease agreement with sub-lessee (a third party) for some office space with two-year term, amount of $34,711 was recognized as sublease income, included under other income, for the three months ended October 31, 2021. 1200000 1200000 1000000 1000000 40005 287000 258000 49000 49000 P41Y <p id="xdx_895_ecustom--ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock_zJfWrkSFCDy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Lease-related assets and liabilities at October 31 and July 31, 2021 were as follows: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8BA_z03BcO4kZbb9" style="display: none">SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211031_zRzpgD1mr3fk" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20210731_z7a88Sftx0e8" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_iI_pp0p0_maFLROUzouc_zEAoyUcrXTte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease right-of-use assets, cost (Note 7)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">293,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">290,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--FinanceLeaseRightOfUseAssetAccumulatedAmortization_iNI_pp0p0_di_msFLROUzouc_z7DkpUpHHLL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(80,814</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(80,547</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseRightOfUseAsset_iTI_pp0p0_mtFLROUzouc_maTLROUzMFN_zGhabcz3hILf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease right-of-use assets, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">212,433</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">210,167</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_maTLROUzMFN_zfy0dwYCkVt3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">ROU assets-Operating lease</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,642,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,837,186</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_ecustom--TotalLeaseRightOfUseAssets_iTI_pp0p0_mtTLROUzMFN_zPN5JMxq7Pv1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total Lease ROU assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,854,524</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,047,353</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maLLzXQ0_zfQNl8IrwnSk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Current Operating Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,460,483</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,508,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maLLzXQ0_zLuTGYj6Rmpg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating lease liabilities, noncurrent</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,682,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,785,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_maLLzXQ0_zWOEGD4Agqjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease liabilities, noncurrent</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">378,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">368,715</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--LeaseLiabilities_iTI_pp0p0_mtLLzXQ0_z4IoUXz3cY06" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,521,637</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,663,202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 293247 290714 80814 80547 212433 210167 3642091 3837186 3854524 4047353 2460483 2508959 1682178 1785528 378976 368715 4521637 4663202 <p id="xdx_89E_eus-gaap--LeaseCostTableTextBlock_zygL2cKbzUt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">The components of lease cost for the three months ended October 31, 2021 and 2020: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B4_zJaaOaaec6ae" style="display: none">SCHEDULE OF COMPONENTS OF LEASE COST</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_496_20210801__20211031_z0niVsjKUL4e" style="border-bottom: Black 1.5pt solid; display: none; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_493_20200801__20201031_zvtHWWhJMF5j" style="border-bottom: Black 1.5pt solid; display: none; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">2020 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three months ended October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020 (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseCost_maLCz9Pe_zkebXU3xEnKd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">306,544</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">345,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance leases:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseRightOfUseAssetAmortization_maLCz9Pe_zVVLvX3NnLOc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Amortization of ROU assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,712</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--FinanceLeaseInterestExpense_maLCz9Pe_zzB1S2sg7ih" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Interest on finance lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,661</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--FinanceLeaseCost_maLCz9Pe_zeH1m0C2Riv4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Finance lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,373</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--LeaseCost_iT_pp0p0_mtLCz9Pe_z2mFhjuqJrB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">315,316</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">354,086</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 306544 345713 1775 1712 6997 6661 8772 8373 315316 354086 <p id="xdx_896_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_za4i872uMkhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Supplemental cash flow information for leases for the three months ended October 31, 2021 and 2020: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B1_z9A5gyyT6yB5" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three months ended October 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating cash flows paid for operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--OperatingLeasePayments_pp0p0_c20210801__20211031_z7o30kQ0Daq6" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Operating cash flows paid for operating leases"><span style="font: 10pt Times New Roman, Times, Serif">186,127</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--OperatingLeasePayments_pp0p0_c20200801__20201031_za96TMJSAuB7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Operating cash flows paid for operating leases"><span style="font: 10pt Times New Roman, Times, Serif">54,230</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Financing cash flows paid for finance leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--FinanceLeaseInterestPaymentOnLiability_pp0p0_c20210801__20211031_zV3M5Zx9Qyz1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financing cash flows paid for finance leases"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0731">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--FinanceLeaseInterestPaymentOnLiability_pp0p0_c20200801__20201031_zcTbKiOZdLyg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financing cash flows paid for finance leases"><span style="font: 10pt Times New Roman, Times, Serif">21,257</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 186127 54230 21257 <p id="xdx_897_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingAndFinanceLeasesTableTextBlock_z7KyTPRpxqYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases at October 31, 2021 was as follows: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8B8_zNWfSLLEc0g8" style="display: none">SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Operating Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Finance Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average remaining lease term (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211031_zb4jlRw4opw8" title="Weighted-average remaining lease term (years) Operating Leases">3.8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211031_zxsVlF90rA4h" title="Weighted-average remaining lease term (years) Finance Leases">29.8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average discount rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211031_z5ReVOq3ti08" title="Weighted-average discount rate Operating Leases">8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20211031_z68CKNkbSYTg" title="Weighted-average discount rate Finance Leases">8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> </table> P3Y9M18D P29Y9M18D 0.08 0.08 <p id="xdx_89D_ecustom--ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesTableTextBlock_zIqFN7s7p7Qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table reconciles the undiscounted future minimum lease payments for operating and finance leases executed at October 31, 2021: </span></p> <p style="font: 8.5pt/107% Segoe UI,sans-serif; margin: 0 0 8pt"><span id="xdx_8BE_zaBW8uBtc3Jj" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Operating Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Finance Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20211031_zn3Wdrzs6Bn9" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Operating Leases, 2022"><span style="font: 10pt Times New Roman, Times, Serif">1,211,921</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20211031_zydseQz1x8I2" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Finance Leases, 2022"><span style="font: 10pt Times New Roman, Times, Serif">23,417</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20211031_z2jCpatywgmh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2023"><span style="font: 10pt Times New Roman, Times, Serif">1,153,762</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20211031_zDwgtU3RFkT4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2023"><span style="font: 10pt Times New Roman, Times, Serif">24,197</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20211031_zFyFPktlI6l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2024"><span style="font: 10pt Times New Roman, Times, Serif">1,206,431</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20211031_zw3xrfLOyspf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2024"><span style="font: 10pt Times New Roman, Times, Serif">24,978</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20211031_zB7m3YtLNPxb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2025"><span style="font: 10pt Times New Roman, Times, Serif">1,117,410</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20211031_zSwtEqoZSxYe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2025"><span style="font: 10pt Times New Roman, Times, Serif">25,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20211031_zwRarJbA2Hjd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2026"><span style="font: 10pt Times New Roman, Times, Serif">88,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20211031_z4yZJ95mGab4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2026"><span style="font: 10pt Times New Roman, Times, Serif">26,539</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2027 and thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pdp0_c20211031_zLa9ApPasVb6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, 2027 and thereafter"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20211031_zmE8wSDjSr88" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, 2027 and thereafter"><span style="font: 10pt Times New Roman, Times, Serif">963,985</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Total lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20211031_z6UTbz6y30x9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating Leases, Total lease payments"><span style="font: 10pt Times New Roman, Times, Serif">4,778,319</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_c20211031_zAgdSFb8yEAg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Finance Leases, Total lease payments"><span style="font: 10pt Times New Roman, Times, Serif">1,088,874</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Less interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20211031_zlJT53htGYB3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less interest"><span style="font: 10pt Times New Roman, Times, Serif">(635,658</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20211031_zEch6jTEGNaj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Less interest"><span style="font: 10pt Times New Roman, Times, Serif">(709,898</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Present value of future lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20211031_zsYe5h3mjkCl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Present value of future lease payments"><span style="font: 10pt Times New Roman, Times, Serif">4,142,661</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiability_iI_pp0p0_c20211031_zyBDxv0IOvTa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Present value of future lease payments"><span style="font: 10pt Times New Roman, Times, Serif">378,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Current Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20211031_zhU5NV45gfL8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: current lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,460,483</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityCurrent_iI_pdp0_c20211031_zcSDsNtS3iui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: current lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0785">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Noncurrent Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20211031_zdiSueWCIaG5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: noncurrent lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif">1,682,178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0_c20211031_zDkgdiiVP0c6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Including: noncurrent lease liabilities"><span style="font: 10pt Times New Roman, Times, Serif">378,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 1211921 23417 1153762 24197 1206431 24978 1117410 25758 88795 26539 963985 4778319 1088874 635658 709898 4142661 378976 2460483 1682178 378976 <p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zWpuVakSens" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 11. <span id="xdx_82E_zrTKAK9OUnv7">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Related Party Receivables</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The original loan balance of $<span id="xdx_90D_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiQiaohongRealEstateCoLtdMember_z2vjmbsl3bG5" title="Related party receivables">721,000</span> due from Shanghai Qiaohong Real Estate Co., Ltd. (“SH Qiaohong”), the noncontrolling interest of HZLJ, was acquired through HFSH acquisition. <span id="xdx_905_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20210801__20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiQiaohongRealEstateCoLtdMember_z2DOaPeSYKu2" title="Related party receivables, description">HFSH lent the amount to SH Qiaohong for two years on June 21, 2018 bearing annual interest of six percent. On August 1, 2020, the loan has been extended to July 31, 2022.</span> The balance was settled through a Three-way settlement agreement on December 31, 2020, see following “Three-Party Settlement Agreement” paragraph for detail. For the three months ended October 31, 2021 and 2020, $<span id="xdx_90A_eus-gaap--InterestIncomeOperating_pp0p0_c20210801__20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiQiaohongRealEstateCoLtdMember_zv8CAIzutY9d" title="Interest income"><span style="-sec-ix-hidden: xdx2ixbrl0797">-</span></span> and $<span id="xdx_902_eus-gaap--InterestIncomeOperating_pp0p0_c20200801__20201031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiQiaohongRealEstateCoLtdMember_z3QP52oJ2STk" title="Interest income">9,778</span> of interest income were recognized, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">$<span id="xdx_90F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFHMMember__srt--ProductOrServiceAxis__us-gaap--LicenseMember_zC6XSA2ykpTc" title="Advance from related party">401,147</span> advances to HFHM were made pursuant to the license agreements entered by HF Int’l Education and its three subsidiaries in June 2021. See Note 14 for details. The remaining related party receivable of $<span id="xdx_905_eus-gaap--AccountsReceivableRelatedParties_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AffiliatesMember_zVIMUXLsWSa4" title="Related party receivables">30,209</span> and $<span id="xdx_907_eus-gaap--AccountsReceivableRelatedParties_c20210731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AffiliatesMember_pp0p0" title="Related party receivables">29,948</span> as of October 31 and July 31, 2021, respectively, represents the operating advances made to the affiliates which are managed by the same management team. These advances do not bear interest and are considered due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Related Party Payables and loans</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of October 31 and July 31, 2021, amounts of $621,526 and $616,159, are payable to SH Qiaohong, respectively. The balances were mainly funding support from SH Qiaohong for operation. The funding support bears no interest and due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of October 31 and July 31, 2021, amount of $<span title="Related Party Payables"><span id="xdx_908_eus-gaap--AccountsPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiQiaoGardenPropertyManagementGroupMember_z2Sqc8jd65B" title="Related Party Payables">624,445</span></span> and $<span title="Related Party Payables"><span id="xdx_90C_eus-gaap--AccountsPayableRelatedPartiesCurrentAndNoncurrent_c20210731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiQiaoGardenPropertyManagementGroupMember_pp0p0" title="Related Party Payables">619,051</span></span>, respectively, is payable to Shanghai Qiao Garden Property Management Group (“Qiao Garden Group”), an entity managed by the same management team. The balance was assumed through HZLJ acquisition. This payable balance does not bear interest and is considered due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">HFSH had payable balances to Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), an entity managed by the same management team, in the amounts of $<span id="xdx_906_eus-gaap--AccountsPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiOverseaChineseCultureMediaLtdMember_zKnitrH5wtz6">3,425,682 </span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_903_eus-gaap--AccountsPayableRelatedPartiesCurrentAndNoncurrent_c20210731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiOverseaChineseCultureMediaLtdMember_pp0p0">2,926,782 </span></span><span style="font: 10pt Times New Roman, Times, Serif">as of October 31 and July 31, 2021, respectively. The payable is funding support from SH Oversea for operation, bears no interest and due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From September 2020 to October 2021, the Company borrowed several notes in a total principal amount of $<span id="xdx_900_eus-gaap--ShortTermBorrowings_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HartfordHotelInvestmentIncMember__srt--TitleOfIndividualAxis__custom--RelatedPartyMember_zyrWU9GlhUp8" title="Short term borrowings">205,000</span>, in form of a short-term loan at <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HartfordHotelInvestmentIncMember__srt--TitleOfIndividualAxis__custom--RelatedPartyMember_zmD9GwUR8fn8" title="Short term debt interest rate, percentage">5</span>% per annum from a related party, Hartford Hotel Investment Inc., an entity managed by the same management team. $<span id="xdx_90E_eus-gaap--InterestExpenseRelatedParty_pp0p0_c20210801__20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HartfordHotelInvestmentIncMember__srt--TitleOfIndividualAxis__custom--RelatedPartyMember_zMwJx813Vn68" title="Interest expense">2,461</span> and $<span id="xdx_90B_eus-gaap--InterestExpenseRelatedParty_pp0p0_dxL_c20200801__20201031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HartfordHotelInvestmentIncMember__srt--TitleOfIndividualAxis__custom--RelatedPartyMember_z1ydq5pYijTb" title="Interest expense::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0819">nil</span></span> of interest expense, respectively, were recorded during the three months ended October 31, 2021 and 2020. The unpaid principal and interest totaling $<span id="xdx_905_ecustom--ShortTermBorrowingsAndInterest_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HartfordHotelInvestmentIncMember__srt--TitleOfIndividualAxis__custom--RelatedPartyMember_z1rxyA7TrGJe" title="Unpaid principal and interest">211,317</span> will be due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of October 31 and July 31, 2021, the Company has $<span id="xdx_907_ecustom--ShorttermAndLongtermPayable_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember_zsoTYVst4RJ4" title="Short-term and long-term payable">670,007</span> and $<span id="xdx_906_ecustom--ShorttermAndLongtermPayable_c20210731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember_pp0p0" title="Short-term and long-term payable">657,572</span>, respectively, short-term payable to Shanghai DuBian Assets Management Ltd. (“Dubian”), which is owned by the Company’s ex-CEO’s relative. The payable balance was assumed from the acquisition transaction. On April 30, 2019, both parties entered a long-term agreement to convert the payable to a long-term debt, with expiration date on <span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear_dd_c20190429__20190430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember_z451rSTPcQNe" title="Expiration date">April 30, 2021</span>, bearing approximately <span id="xdx_901_eus-gaap--RelatedPartyTransactionRate_dp_uPure_c20190429__20190430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember_zagjxyAjuSLj" title="Interest rate">2.5</span> percent of annual interest. On April 30, 2021, both parties entered a second long-term agreement to extend another two years, with expiration date on <span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear_dd_c20210429__20210430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember__us-gaap--TypeOfArrangementAxis__custom--SecondLongTermAgreementMember_zHhEbftnXLo8" title="Expiration date">April 30, 2023</span>, bearing approximately <span id="xdx_90A_eus-gaap--RelatedPartyTransactionRate_dp_uPure_c20210429__20210430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember__us-gaap--TypeOfArrangementAxis__custom--SecondLongTermAgreementMember_zEPbhdFqwNYh" title="Interest rate">4</span>% of annual interest. $<span id="xdx_90E_eus-gaap--InterestExpenseRelatedParty_pp0p0_c20210801__20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember_zP5IwVfeBkOe" title="Interest expense">6,659</span> and $<span id="xdx_90E_eus-gaap--InterestExpenseRelatedParty_pp0p0_c20200801__20201031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiDuBianAssetsManagementLtdMember_zbb71lF4FIX8" title="Interest expense">3,749</span> of interest expense were recognized during the three months ended October 31, 2021 and 2020, respectively. The unpaid principal and interest will be due on the maturity date. This loan payable is not exposed to market risk due to the stable and fixed interest rates in accordance with the loan agreements. As of October 31 and July 31, 2021, the estimated fair value of long term loan payable was approximately $<span id="xdx_900_eus-gaap--LoansPayableFairValueDisclosure_iI_pp0p0_c20211031_zHvnr35IiXCl" title="Estimated fair value of long term loans payable">668,228</span> and $<span id="xdx_909_eus-gaap--LoansPayableFairValueDisclosure_c20210731_pp0p0" title="Estimated fair value of long term loans payable">655,940</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The remaining related party payable of $<span id="xdx_907_eus-gaap--AccountsPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AffiliatesMember_zaPZ3E9U5LC4" title="Related Party Payables">50,736</span> and $<span id="xdx_90B_eus-gaap--AccountsPayableRelatedPartiesCurrentAndNoncurrent_c20210731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AffiliatesMember_pp0p0" title="Related Party Payables">80,477</span> as of October 31 and July 31, 2021, respectively, represents the unpaid portion of operating advances made to the Company by affiliates which are managed by the same management team. These advances do not bear interest and are considered due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Three-Party Settlement Agreement</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On December 31, 2020, a Three-Party Settlement agreement among HFSH, SH Qiaohong and Qiao Garden Int’l Travel was entered. Pursuant to the agreement, around $<span id="xdx_90C_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_c20201231__dei--LegalEntityAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember_pp0p0" title="Due to/from related party">721,000</span> (RMB$<span id="xdx_904_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iI_pp0p0_uRMB_c20201231__dei--LegalEntityAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember_zofGDCjlvUAl" title="Due to/from related party">5,031,699</span>) payable due to SH Qiaohong under HFSH was settled with the receivable due from the same related party under Qiao Garden Int’l Travel through withdrawal of <span id="xdx_908_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20201231__us-gaap--BusinessAcquisitionAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember__srt--OwnershipAxis__custom--QiaoGardenInternationalTravelAgencyMember_z9d0zrgp7Bhl" title="Acquired percentage">90</span>% ownership of Qiao Garden Int’l Travel HFSH owned. Total RMB<span id="xdx_90B_eus-gaap--InvestmentIncomeNet_pn5n6_uRMB_c20201229__20201231__dei--LegalEntityAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember__srt--OwnershipAxis__custom--QiaoGardenInternationalTravelAgencyMember_zz8fL5zKGFQj" title="Investment income">5.0</span> million including the original investment RMB<span id="xdx_905_ecustom--InvestmentFromNoncontrollingInterests_pn5n6_uRMB_c20201229__20201231__dei--LegalEntityAxis__custom--HartfordGreatHealthManagementShanghaiLtdMember__srt--OwnershipAxis__custom--QiaoGardenInternationalTravelAgencyMember_zLUsuAZqk5ca" title="Investment from noncontrolling interest">4.5</span> million was withdrawn from Qiao Garden Int’l Travel, and $<span id="xdx_90B_ecustom--GainOnDisposalOfSubsidiary_pp0p0_c20201229__20201231_ztbtSYg2t0ve" title="Gain on disposal of subsidiary">104,317</span> (RMB<span id="xdx_90D_ecustom--GainOnDisposalOfSubsidiary_pp0p0_uRMB_c20201229__20201231_zbhcgdoFEzc" title="Gain on disposal of subsidiary">697,000</span>) gain on disposal was recognized at disposal date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Other Related Party Transactions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Office space at Rosemead, CA is provided to Hartford Great Health Corp. at no cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On September 30, 2019, HF Int’l Education entered two debt agreements with the related parties, SH Qiao Hong and SH Oversea. Each debt agreement provides a line of credit up to RMB<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFIntlEducationMember__us-gaap--TypeOfArrangementAxis__custom--TwoDebtAgreementsMember_zGOJDDPL7Mgi" title="Line of credit facility, maximum borrowing capacity">9.0</span> million with <span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtYxL_c20190929__20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFIntlEducationMember__us-gaap--TypeOfArrangementAxis__custom--TwoDebtAgreementsMember_zRwaj2Nw3As1" title="Debt instrument, term::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl0863">two</span></span>-year term, bearing <span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_iI_dp_uPure_c20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFIntlEducationMember__us-gaap--TypeOfArrangementAxis__custom--TwoDebtAgreementsMember_zCG369L0ee2i" title="Line of credit facility, annum interest rate">3.0</span>% annum interest rate. The unpaid principal and interest will be due on the maturity dates. As of October 31, 2021, no balance was withdrawn from the two lines of credits by HF Int’l Education.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 721000 HFSH lent the amount to SH Qiaohong for two years on June 21, 2018 bearing annual interest of six percent. On August 1, 2020, the loan has been extended to July 31, 2022. 9778 401147 30209 29948 624445 619051 3425682 2926782 205000 0.05 2461 211317 670007 657572 2021-04-30 0.025 2023-04-30 0.04 6659 3749 668228 655940 50736 80477 721000 5031699 0.90 5000000.0 4500000 104317 697000 9000000.0 0.030 <p id="xdx_80D_eus-gaap--MinorityInterestDisclosureTextBlock_zmrM06dQHLT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 12. <span id="xdx_827_zZeAiop5Yx89">NONCONTROLLING INTERESTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_89B_ecustom--ScheduleOfNoncontrollingInterestsTableTextBlock_z0gW0URZ90a5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Noncontrolling interests consisted of the following as of October 31, 2021 and July 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B1_zEVjdkzImYsi" style="display: none">SCHEDULE OF NONCONTROLLING INTERESTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Name of Entity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">% of Non-Controlling Interests</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; display: none; text-align: center">Restructure of subsidiary</td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; display: none; text-align: center">Disposal of subsidiary</td> <td style="display: none; padding-bottom: 1pt"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Foreign currency translation adjustment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021<br/> (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 37%"><span style="font: 10pt Times New Roman, Times, Serif">HZLJ</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20211031__srt--OwnershipAxis__custom--HZLJMember_zFoVsHnV0eX2" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="% of Non-Controlling Interests"><span style="font: 10pt Times New Roman, Times, Serif">40.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--MinorityInterest_iS_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zqNXKv1lNyHf" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Non-Controlling Interests beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">(962,998</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zKmtNKbzaOFa" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Net loss"><span style="font: 10pt Times New Roman, Times, Serif">(12,858</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none; width: 1%"/> <td id="xdx_989_ecustom--RestructureOfSubsidary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zADZLoodkuc9" style="display: none; text-align: right; width: 5%"><span style="-sec-ix-hidden: xdx2ixbrl0876">-</span></td> <td style="display: none; width: 1%"/> <td style="display: none; width: 2%"> </td> <td style="display: none; width: 1%"/> <td id="xdx_988_ecustom--DisposalOfSubsidiary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_z4Md5vV8VNEg" style="display: none; text-align: right; width: 5%"><span style="-sec-ix-hidden: xdx2ixbrl0877">-</span></td> <td style="display: none; width: 1%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zkAUBexXMKm3" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Foreign currency translation adjustment"><span style="font: 10pt Times New Roman, Times, Serif">(6,977</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--MinorityInterest_iE_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zETXUoIdcTTb" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Non-Controlling Interests ending balance"><span style="font: 10pt Times New Roman, Times, Serif">(982,833</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">HF Int’l Education<br/> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zBRm2rMV7BYg" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="% of Non-Controlling Interests"><span style="font: 10pt Times New Roman, Times, Serif">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--MinorityInterest_iS_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zk21tRIgus5h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">(242,075</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zFl4doCAG1A2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font: 10pt Times New Roman, Times, Serif">(53,770</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none"> </td> <td id="xdx_986_ecustom--RestructureOfSubsidary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zwUEuUUyzXuh" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0888">-</span></td> <td style="display: none"> </td> <td style="display: none"> </td> <td style="display: none"> </td> <td id="xdx_98A_ecustom--DisposalOfSubsidiary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zZEBE6ogdFwd" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0889">-</span></td> <td style="display: none"> </td> <td> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zWHcjzJJrM54" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation adjustment"><span style="font: 10pt Times New Roman, Times, Serif">(2,116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--MinorityInterest_iE_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zzptQA5zz1sa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests ending balance"><span style="font: 10pt Times New Roman, Times, Serif">(297,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="% of Non-Controlling Interests"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--MinorityInterest_iS_pp0p0_c20210801__20211031_zX2zeW7Pi1O3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">(1,205,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031_zSXY92XE64Cb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font: 10pt Times New Roman, Times, Serif">(66,628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none"> </td> <td id="xdx_98D_ecustom--RestructureOfSubsidary_pp0p0_c20210801__20211031_zNNUTASrlQF5" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0898">-</span></td> <td style="display: none"> </td> <td style="display: none"> </td> <td style="display: none"> </td> <td id="xdx_98A_ecustom--DisposalOfSubsidiary_pp0p0_c20210801__20211031_z8bxpb8XRV2l" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0899">-</span></td> <td style="display: none"> </td> <td> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031_zU3sqsbp33Qh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation adjustment"><span style="font: 10pt Times New Roman, Times, Serif">(9,093</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--MinorityInterest_iE_pp0p0_c20210801__20211031_zazQiBQ01azf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests ending balance"><span style="font: 10pt Times New Roman, Times, Serif">(1,280,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Name of Entity</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">% of Non-Controlling Interests</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">July 31, 2020</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net loss</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Restructure of subsidiary</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Disposal of subsidiary</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">July 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%">HZLJ</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20210731__srt--OwnershipAxis__custom--HZLJMember_z0zTw6h0SpK1" style="width: 5%; text-align: right" title="% of Non-Controlling Interests">40.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_zqBfltJmb1dk" style="width: 5%; text-align: right" title="Non-Controlling Interests beginning balance">(889,068</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Net loss">(42,285</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RestructureOfSubsidary_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Restructure of subsidary"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--DisposalOfSubsidiary_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Disposal of subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0913">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Foreign currency translation adjustment">(31,645</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_zD6GRpqjpCKf" style="width: 5%; text-align: right" title="Non-Controlling Interests ending balance">(962,998</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">HF Int’l Education</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">*<span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_fKg_____zRay3hjCp9G8" title="% of Non-Controlling Interests">10.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_zacGqqEHzf9e" style="text-align: right" title="Non-Controlling Interests beginning balance">(88,692</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Net loss">(548,547</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--RestructureOfSubsidary_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Restructure of subsidary">403,131</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--DisposalOfSubsidiary_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Disposal of subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Foreign currency translation adjustment">(7,967</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_zZjcMXv50cgh" style="text-align: right" title="Non-Controlling Interests ending balance">(242,075</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Qiao Garden Intl Travel</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="% of Non-Controlling Interests">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_zgUzc777qgma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-Controlling Interests beginning balance">60,271</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net loss">1,827</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--RestructureOfSubsidary_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Restructure of subsidary"><span style="-sec-ix-hidden: xdx2ixbrl0937">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DisposalOfSubsidiary_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Disposal of subsidiary">(62,098</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation adjustment"><span style="-sec-ix-hidden: xdx2ixbrl0941">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_zNxqHr8kJL16" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-Controlling Interests ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0943">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731_zCGlsvpb7ae" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Controlling Interests beginning balance">(917,489</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(589,005</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--RestructureOfSubsidary_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Restructure of subsidary">403,131</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--DisposalOfSubsidiary_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Disposal of subsidiary">(62,098</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign currency translation adjustment">(39,612</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731_z9kmbeUhMtha" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Controlling Interests ending balance">(1,205,073</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0B_zYd7eW6Reag8" style="font: 10pt Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span id="xdx_F10_zXSDQ7uzBffl" style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PTkNPTlRST0xMSU5HIElOVEVSRVNUUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210731__dei--LegalEntityAxis__custom--SHHZJMember_zTejpSivxZrb" title="Equity ownership percentage">90</span>% equity of SHHZJ, a limited partnership and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PTkNPTlRST0xMSU5HIElOVEVSRVNUUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_zHvwXcn09RHd" title="Equity ownership percentage">10</span>% shareholder of HF Int’l Education, is held by Mr. Song, ex-CEO of the Company on behalf of an unrelated individual. However, HF Int’l Education does not have the obligation to absorb losses of SHHZJ or a right to receive benefits from SHHZJ that could potentially be significant to SHHZJ, thus, SHHZJ is not considered a VIE of HF Int’l Education. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PTkNPTlRST0xMSU5HIElOVEVSRVNUUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_ecustom--NoncontrollingShareholdersDescription_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember" title="Noncontrolling shareholders, description">In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation</span><b>.</b></span></td> </tr></table> <p id="xdx_8AC_zBxKKkpJ2hqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfNoncontrollingInterestsTableTextBlock_z0gW0URZ90a5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Noncontrolling interests consisted of the following as of October 31, 2021 and July 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B1_zEVjdkzImYsi" style="display: none">SCHEDULE OF NONCONTROLLING INTERESTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Name of Entity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">% of Non-Controlling Interests</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">July 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; display: none; text-align: center">Restructure of subsidiary</td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="display: none; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; display: none; text-align: center">Disposal of subsidiary</td> <td style="display: none; padding-bottom: 1pt"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Foreign currency translation adjustment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">October 31, 2021<br/> (unaudited)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 37%"><span style="font: 10pt Times New Roman, Times, Serif">HZLJ</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20211031__srt--OwnershipAxis__custom--HZLJMember_zFoVsHnV0eX2" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="% of Non-Controlling Interests"><span style="font: 10pt Times New Roman, Times, Serif">40.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--MinorityInterest_iS_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zqNXKv1lNyHf" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Non-Controlling Interests beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">(962,998</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zKmtNKbzaOFa" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Net loss"><span style="font: 10pt Times New Roman, Times, Serif">(12,858</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none; width: 1%"/> <td id="xdx_989_ecustom--RestructureOfSubsidary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zADZLoodkuc9" style="display: none; text-align: right; width: 5%"><span style="-sec-ix-hidden: xdx2ixbrl0876">-</span></td> <td style="display: none; width: 1%"/> <td style="display: none; width: 2%"> </td> <td style="display: none; width: 1%"/> <td id="xdx_988_ecustom--DisposalOfSubsidiary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_z4Md5vV8VNEg" style="display: none; text-align: right; width: 5%"><span style="-sec-ix-hidden: xdx2ixbrl0877">-</span></td> <td style="display: none; width: 1%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zkAUBexXMKm3" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Foreign currency translation adjustment"><span style="font: 10pt Times New Roman, Times, Serif">(6,977</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--MinorityInterest_iE_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HZLJMember_zETXUoIdcTTb" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Non-Controlling Interests ending balance"><span style="font: 10pt Times New Roman, Times, Serif">(982,833</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">HF Int’l Education<br/> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zBRm2rMV7BYg" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="% of Non-Controlling Interests"><span style="font: 10pt Times New Roman, Times, Serif">10.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--MinorityInterest_iS_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zk21tRIgus5h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">(242,075</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zFl4doCAG1A2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font: 10pt Times New Roman, Times, Serif">(53,770</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none"> </td> <td id="xdx_986_ecustom--RestructureOfSubsidary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zwUEuUUyzXuh" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0888">-</span></td> <td style="display: none"> </td> <td style="display: none"> </td> <td style="display: none"> </td> <td id="xdx_98A_ecustom--DisposalOfSubsidiary_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zZEBE6ogdFwd" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0889">-</span></td> <td style="display: none"> </td> <td> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zWHcjzJJrM54" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation adjustment"><span style="font: 10pt Times New Roman, Times, Serif">(2,116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--MinorityInterest_iE_pp0p0_c20210801__20211031__srt--OwnershipAxis__custom--HFIntlEducationMember_zzptQA5zz1sa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests ending balance"><span style="font: 10pt Times New Roman, Times, Serif">(297,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="% of Non-Controlling Interests"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--MinorityInterest_iS_pp0p0_c20210801__20211031_zX2zeW7Pi1O3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">(1,205,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031_zSXY92XE64Cb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font: 10pt Times New Roman, Times, Serif">(66,628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td style="display: none"> </td> <td id="xdx_98D_ecustom--RestructureOfSubsidary_pp0p0_c20210801__20211031_zNNUTASrlQF5" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0898">-</span></td> <td style="display: none"> </td> <td style="display: none"> </td> <td style="display: none"> </td> <td id="xdx_98A_ecustom--DisposalOfSubsidiary_pp0p0_c20210801__20211031_z8bxpb8XRV2l" style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0899">-</span></td> <td style="display: none"> </td> <td> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_pp0p0_c20210801__20211031_zU3sqsbp33Qh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency translation adjustment"><span style="font: 10pt Times New Roman, Times, Serif">(9,093</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--MinorityInterest_iE_pp0p0_c20210801__20211031_zazQiBQ01azf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-Controlling Interests ending balance"><span style="font: 10pt Times New Roman, Times, Serif">(1,280,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Name of Entity</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">% of Non-Controlling Interests</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">July 31, 2020</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net loss</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Restructure of subsidiary</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Disposal of subsidiary</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">July 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%">HZLJ</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20210731__srt--OwnershipAxis__custom--HZLJMember_z0zTw6h0SpK1" style="width: 5%; text-align: right" title="% of Non-Controlling Interests">40.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_zqBfltJmb1dk" style="width: 5%; text-align: right" title="Non-Controlling Interests beginning balance">(889,068</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Net loss">(42,285</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--RestructureOfSubsidary_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Restructure of subsidary"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--DisposalOfSubsidiary_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Disposal of subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0913">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_pp0p0" style="width: 5%; text-align: right" title="Foreign currency translation adjustment">(31,645</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HZLJMember_zD6GRpqjpCKf" style="width: 5%; text-align: right" title="Non-Controlling Interests ending balance">(962,998</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">HF Int’l Education</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">*<span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_uPure_c20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_fKg_____zRay3hjCp9G8" title="% of Non-Controlling Interests">10.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_zacGqqEHzf9e" style="text-align: right" title="Non-Controlling Interests beginning balance">(88,692</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Net loss">(548,547</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--RestructureOfSubsidary_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Restructure of subsidary">403,131</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--DisposalOfSubsidiary_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Disposal of subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_pp0p0" style="text-align: right" title="Foreign currency translation adjustment">(7,967</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_zZjcMXv50cgh" style="text-align: right" title="Non-Controlling Interests ending balance">(242,075</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Qiao Garden Intl Travel</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="% of Non-Controlling Interests">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_zgUzc777qgma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-Controlling Interests beginning balance">60,271</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net loss">1,827</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--RestructureOfSubsidary_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Restructure of subsidary"><span style="-sec-ix-hidden: xdx2ixbrl0937">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DisposalOfSubsidiary_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Disposal of subsidiary">(62,098</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign currency translation adjustment"><span style="-sec-ix-hidden: xdx2ixbrl0941">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731__srt--OwnershipAxis__custom--QiaoGardenIntTravelMember_zNxqHr8kJL16" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-Controlling Interests ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0943">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--MinorityInterest_iS_pp0p0_c20200801__20210731_zCGlsvpb7ae" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Controlling Interests beginning balance">(917,489</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(589,005</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--RestructureOfSubsidary_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Restructure of subsidary">403,131</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--DisposalOfSubsidiary_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Disposal of subsidiary">(62,098</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_c20200801__20210731_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Foreign currency translation adjustment">(39,612</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--MinorityInterest_iE_pp0p0_c20200801__20210731_z9kmbeUhMtha" style="border-bottom: Black 2.5pt double; text-align: right" title="Non-Controlling Interests ending balance">(1,205,073</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0B_zYd7eW6Reag8" style="font: 10pt Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span id="xdx_F10_zXSDQ7uzBffl" style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PTkNPTlRST0xMSU5HIElOVEVSRVNUUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210731__dei--LegalEntityAxis__custom--SHHZJMember_zTejpSivxZrb" title="Equity ownership percentage">90</span>% equity of SHHZJ, a limited partnership and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PTkNPTlRST0xMSU5HIElOVEVSRVNUUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210731__srt--OwnershipAxis__custom--HFIntlEducationMember_zHvwXcn09RHd" title="Equity ownership percentage">10</span>% shareholder of HF Int’l Education, is held by Mr. Song, ex-CEO of the Company on behalf of an unrelated individual. However, HF Int’l Education does not have the obligation to absorb losses of SHHZJ or a right to receive benefits from SHHZJ that could potentially be significant to SHHZJ, thus, SHHZJ is not considered a VIE of HF Int’l Education. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PTkNPTlRST0xMSU5HIElOVEVSRVNUUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_ecustom--NoncontrollingShareholdersDescription_c20200801__20210731__srt--OwnershipAxis__custom--HFIntlEducationMember" title="Noncontrolling shareholders, description">In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation</span><b>.</b></span></td> </tr></table> 0.400 -962998 -12858 -6977 -982833 0.100 -242075 -53770 -2116 -297961 -1205073 -66628 -9093 -1280794 0.400 -889068 -42285 -31645 -962998 0.100 -88692 -548547 403131 -7967 -242075 60271 1827 -62098 -917489 -589005 403131 -62098 -39612 -1205073 0.90 0.10 In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation <p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zGk6FbmXB3Tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 13. <span id="xdx_822_zpe9p5vrGTce">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">There has been below material contractual obligations and other commitments except the lease commitments disclosed in Note 10 Leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Lawsuits related to lease agreements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2018 and January 2019, HFSH and HF Int’l Education entered two lease agreements with Shanghai Longjin Corporate Management Co., Ltd (the “Sublessor”) to lease some office spaces. On April 13, 2020, HFSH and HF Int’l Education received Notices of Lease Termination from the Tenant for late payments. HFSH and HF Int’l Education then filed a civil case against the Sublessor for over-charged rent fees because of fictitious office size and requested refund in the total amount approximately $<span id="xdx_902_ecustom--RefundOfFictitiousOfficePropertyRequested_c20200412__20200413__us-gaap--TypeOfArrangementAxis__custom--TwoLeaseAgreementsMember_pp0p0" title="Refund of fictitious office property requested">481,000</span> (RMB<span id="xdx_907_ecustom--RefundOfFictitiousOfficePropertyRequested_pn5n6_uRMB_c20200412__20200413__us-gaap--TypeOfArrangementAxis__custom--TwoLeaseAgreementsMember_z85uPSwGzt85" title="Refund of fictitious office property requested">3.3</span> million) till <span id="xdx_901_eus-gaap--LeaseExpirationDate1_dd_c20200412__20200413__us-gaap--TypeOfArrangementAxis__custom--TwoLeaseAgreementsMember_zR1JZ5ZuV2s5" title="Lease agreement, date">July 10, 2020</span>. The Sublessor was further in default under the lease agreements due to its lease agreement with the landlord of the office properties (the “Landlord”) was terminated on June 1, 2020 by the Landlord. <span id="xdx_906_ecustom--LeaseAgreementDescription_c20210801__20211031__us-gaap--TypeOfArrangementAxis__custom--TwoLeaseAgreementsMember_zB76zgKbzAU6" title="Lease agreement, description">HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces in a five-year term.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 7, 2021, the district court verdict the final ruling and awarded HFSH and HF Int’l Education total amounts of RMB<span id="xdx_90B_eus-gaap--LitigationSettlementAmountAwardedFromOtherParty_pp0p0_uRMB_c20210706__20210707__dei--LegalEntityAxis__custom--HFSHMember__srt--TitleOfIndividualAxis__custom--SublessorMember_zUnOHmRTqSl5">870,336 </span></span><span style="font: 10pt Times New Roman, Times, Serif">and RMB<span id="xdx_909_eus-gaap--LitigationSettlementAmountAwardedFromOtherParty_pp0p0_uRMB_c20210706__20210707__dei--LegalEntityAxis__custom--HartfordInternationalEducationTechnologyCoLtdMember__srt--TitleOfIndividualAxis__custom--SublessorMember_z395TuFehqIi">268,450 </span></span><span style="font: 10pt Times New Roman, Times, Serif">to be returned by the Sublessor. However, the rental deposits of RMB<span id="xdx_900_eus-gaap--PaymentsForRent_pp0p0_uRMB_c20210706__20210707__us-gaap--TypeOfArrangementAxis__custom--TwoLeaseAgreementsMember__srt--StatementScenarioAxis__custom--NonrefundableRentalDepoitMember_zd6y9Ats1rwl">313,286 </span></span><span style="font: 10pt Times New Roman, Times, Serif">paid to the Sublessor are non-refundable. No further appeal on these rental dispute cases will be granted. These final ruling proceedings are pending execution by the district court, which has not yet executed as of October 31, 2021. Associated with this Sublessor under the two lease agreements, the Company previously accrued $<span id="xdx_901_eus-gaap--OtherIncome_pp0p0_c20210706__20210707__dei--LegalEntityAxis__custom--HFSHMember__srt--TitleOfIndividualAxis__custom--SublessorMember_zgtfkGAvOqHd">165,698 </span></span><span style="font: 10pt Times New Roman, Times, Serif">rental payable net with deposit. As a result of the final ruling, the total $<span id="xdx_90C_eus-gaap--OtherIncome_pp0p0_c20210706__20210707__dei--LegalEntityAxis__custom--HFSHMember__srt--TitleOfIndividualAxis__custom--SublessorMember_zl23S4NuIdI6">165,698 </span></span><span style="font: 10pt Times New Roman, Times, Serif">rental payable, net with deposit, accrued at HFSH and HF Int’l Education was written off and recognized as other income during the year ended July 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">License agreements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2021, HF Int’l Education and its three subsidiaries: PDHJ, HDFD and Gelinke entered license agreements with HFHM for the rights to use the intellectual Properties (the “IPs”) HFHM owns. The IPs cover in the license agreements are four set of curriculum structure designed and fifteen trademarks including “HaiDeFuDe” registered trademarks purchased from HF Int’l Education. <span id="xdx_904_ecustom--LicenseDescription_c20210801__20211031__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntellectualPropertiesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFHMMember_zhBfFFzV7Tx1">As a return, on a monthly basis, HF Int’l Education and its subsidiaries pays 90% of its tuition revenue generated to HFHM as license usage fee. For the three months ended October 31, 2021, the Company incurred total $</span></span><span id="xdx_90F_eus-gaap--FiniteLivedLicenseAgreementsGross_iI_pp0p0_c20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFHMMember__srt--ProductOrServiceAxis__us-gaap--LicenseMember_zg7DefsPWCHf" style="font: 10pt Times New Roman, Times, Serif">139,827 </span><span style="font: 10pt Times New Roman, Times, Serif">license fees pursuant to the license contracts. As of October 31 and July 31, 2021, the Company advanced $</span><span id="xdx_90C_ecustom--PaymentToLicenseFee_pp0p0_c20210801__20211031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFHMMember__srt--ProductOrServiceAxis__us-gaap--LicenseMember_zXTyahhJmgr3" style="font: 10pt Times New Roman, Times, Serif">401,147 </span><span style="font: 10pt Times New Roman, Times, Serif">and $</span><span id="xdx_902_ecustom--PaymentToLicenseFee_pp0p0_c20200801__20210731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HFHMMember__srt--ProductOrServiceAxis__us-gaap--LicenseMember_zHFJ18l3adLf" style="font: 10pt Times New Roman, Times, Serif">295,916</span><span style="font: 10pt Times New Roman, Times, Serif">, respectively, to HFHM for the future license fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 481000 3300000 2020-07-10 HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces in a five-year term. 870336 268450 313286 165698 165698 As a return, on a monthly basis, HF Int’l Education and its subsidiaries pays 90% of its tuition revenue generated to HFHM as license usage fee. For the three months ended October 31, 2021, the Company incurred total $ 139827 401147 295916 <p id="xdx_802_eus-gaap--SegmentReportingDisclosureTextBlock_zIOaR0UabC6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 14. <span id="xdx_82F_zgoyNPbwVuJ1">SEGMENT INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company currently operates in following industry segments: hospitality (hotel and travel agency) and early childhood education industry in China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zo4VmgSLgyR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Segment information on assets as of October 31, 2021 and revenue generated during the three months ended October 31, 2021, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BA_zcVNxoVmCIpc" style="display: none">SCHEDULE OF SEGMENT INFORMATION</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Hospitality</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Education</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Corporate and unallocated</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font: 10pt Times New Roman, Times, Serif">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">14,448</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">155,364</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0991">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210801__20211031_zEfEVdU0oOTd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">169,812</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(47,748</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(578,361</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(46,842</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_pp0p0_c20210801__20211031_zao06JEQOgZ9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(672,951</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Loss before tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(61,150</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_z1T8O0wU6Y0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(537,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(49,303</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20210801__20211031_z9N2YNWcDRSj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(648,160</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net Loss Attributable to Hartford Great Health Corp</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(48,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pp0p0_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zCImqT7ZTqp5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(483,936</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(49,304</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20210801__20211031_z8YYq82e4pHj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(581,532</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total assets (excluding Intercompany balances)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--Assets_iI_pp0p0_c20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zEeWDZIsHAW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">351,627</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--Assets_iI_pp0p0_c20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zA7BRqEYMSY6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">5,286,171</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zn1pnwyYaTw2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">(30,945</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--Assets_iI_pp0p0_c20211031_zjcRhJdKmTu7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">5,606,853</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Segment information on assets as of October 31, 2020 and revenue generated during the three months ended October 31, 2020, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Hospitality</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Education</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Corporate</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">and unallocated</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font: 10pt Times New Roman, Times, Serif">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zhxIrp061kA" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">32,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_z9KFXCOT25B6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">46,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zBYityycZEv2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1031">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031_zSyeGriLPZs6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">79,387</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zIoHbDTCfqSg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(97,826</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zrNMV0xbB2X5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(505,921</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_z05ylj0xwGT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(54,459</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031_zFkqppHwRdud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(658,206</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Loss before tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_z0IoY3TJ9Dlf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(97,814</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zfS3QXv2JXld" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(505,921</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zBwDuBGSC1O9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(54,615</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031_zPL4kFrliX4f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(658,350</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net Loss Attributable to Hartford Great Health Corp</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zMPEIiPG76yc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(87,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_z8MFwJqojgAh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(381,970</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_z5QSu6oyRf23" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(55,415</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031_zQ6bhojYGcc8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(524,757</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total assets (excluding Intercompany balances)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--Assets_iI_pp0p0_c20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_z39lwZLU7UIe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">1,426,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--Assets_iI_pp0p0_c20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zDueqyqiX5mh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">6,403,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--Assets_iI_pp0p0_c20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zY5WXAKOQsM8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">49,296</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--Assets_iI_pp0p0_c20201031_z96TaJYIi1Ec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">7,879,119</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A9_zkXwLhTGi0T3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zo4VmgSLgyR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Segment information on assets as of October 31, 2021 and revenue generated during the three months ended October 31, 2021, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BA_zcVNxoVmCIpc" style="display: none">SCHEDULE OF SEGMENT INFORMATION</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Hospitality</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Education</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Corporate and unallocated</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font: 10pt Times New Roman, Times, Serif">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">14,448</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">155,364</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0991">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210801__20211031_zEfEVdU0oOTd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">169,812</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(47,748</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(578,361</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(46,842</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_pp0p0_c20210801__20211031_zao06JEQOgZ9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(672,951</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Loss before tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(61,150</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_z1T8O0wU6Y0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(537,707</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(49,303</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20210801__20211031_z9N2YNWcDRSj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(648,160</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net Loss Attributable to Hartford Great Health Corp</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(48,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pp0p0_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zCImqT7ZTqp5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(483,936</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20210801__20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(49,304</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20210801__20211031_z8YYq82e4pHj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(581,532</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total assets (excluding Intercompany balances)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--Assets_iI_pp0p0_c20211031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zEeWDZIsHAW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">351,627</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--Assets_iI_pp0p0_c20211031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zA7BRqEYMSY6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">5,286,171</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20211031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zn1pnwyYaTw2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">(30,945</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--Assets_iI_pp0p0_c20211031_zjcRhJdKmTu7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">5,606,853</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Segment information on assets as of October 31, 2020 and revenue generated during the three months ended October 31, 2020, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Hospitality</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Education</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Corporate</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">and unallocated</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font: 10pt Times New Roman, Times, Serif">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zhxIrp061kA" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">32,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_z9KFXCOT25B6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">46,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zBYityycZEv2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1031">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200801__20201031_zSyeGriLPZs6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenue"><span style="font: 10pt Times New Roman, Times, Serif">79,387</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Operating loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zIoHbDTCfqSg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(97,826</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zrNMV0xbB2X5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(505,921</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_z05ylj0xwGT5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(54,459</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pp0p0_c20200801__20201031_zFkqppHwRdud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating loss"><span style="font: 10pt Times New Roman, Times, Serif">(658,206</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Loss before tax</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_z0IoY3TJ9Dlf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(97,814</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zfS3QXv2JXld" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(505,921</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zBwDuBGSC1O9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(54,615</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200801__20201031_zPL4kFrliX4f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss before tax"><span style="font: 10pt Times New Roman, Times, Serif">(658,350</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net Loss Attributable to Hartford Great Health Corp</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_zMPEIiPG76yc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(87,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_z8MFwJqojgAh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(381,970</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_z5QSu6oyRf23" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(55,415</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--NetIncomeLoss_pp0p0_c20200801__20201031_zQ6bhojYGcc8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Loss Attributable to Hartford Great Health Corp"><span style="font: 10pt Times New Roman, Times, Serif">(524,757</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total assets (excluding Intercompany balances)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--Assets_iI_pp0p0_c20201031__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalityMember_z39lwZLU7UIe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">1,426,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--Assets_iI_pp0p0_c20201031__us-gaap--StatementBusinessSegmentsAxis__custom--EducationMember_zDueqyqiX5mh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">6,403,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--Assets_iI_pp0p0_c20201031__us-gaap--StatementBusinessSegmentsAxis__custom--CorporateAndUnallocatedMember_zY5WXAKOQsM8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">49,296</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--Assets_iI_pp0p0_c20201031_z96TaJYIi1Ec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets (excluding Intercompany balances)"><span style="font: 10pt Times New Roman, Times, Serif">7,879,119</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 14448 155364 169812 -47748 -578361 -46842 -672951 -61150 -537707 -49303 -648160 -48292 -483936 -49304 -581532 351627 5286171 -30945 5606853 32794 46593 79387 -97826 -505921 -54459 -658206 -97814 -505921 -54615 -658350 -87372 -381970 -55415 -524757 1426445 6403378 49296 7879119 <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zKqST08AXre6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 15. <span id="xdx_82F_z7wjFP2w8s8k">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In accordance with ASC 855<i>, “Subsequent Events”</i>, the Company has evaluated subsequent events through the date of issuance of these unaudited financial statements and no subsequent events were noted.</span></p> 90% equity of SHHZJ, a limited partnership and 10% shareholder of HF Int’l Education, is held by Mr. Song, ex-CEO of the Company on behalf of an unrelated individual. However, HF Int’l Education does not have the obligation to absorb losses of SHHZJ or a right to receive benefits from SHHZJ that could potentially be significant to SHHZJ, thus, SHHZJ is not considered a VIE of HF Int’l Education. In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation. XML 11 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover - shares
3 Months Ended
Oct. 31, 2021
Dec. 15, 2021
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Oct. 31, 2021  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2021  
Current Fiscal Year End Date --07-31  
Entity File Number 000-54439  
Entity Registrant Name HARTFORD GREAT HEALTH CORP.  
Entity Central Index Key 0001482554  
Entity Tax Identification Number 51-0675116  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 8832 Glendon Way  
Entity Address, City or Town Rosemead  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 91770  
City Area Code (626)  
Local Phone Number 321-1915  
Title of 12(b) Security Common stock, par value $0.001 par value  
Trading Symbol HFUS  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   100,108,000
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Current Assets    
Cash and cash equivalents $ 44,284 $ 27,612
Restricted cash 26,566
Prepaid and Other current receivables 173,825 286,232
Related party receivable 431,356 325,864
Inventory 324,120 323,814
Total Current Assets 973,585 990,088
Non-current Assets    
Property and equipment, net 744,392 593,517
ROU assets-operating lease 3,642,091 3,837,186
Other assets 246,785 321,807
Total Non-current Assets 4,633,268 4,752,510
TOTAL ASSETS 5,606,853 5,742,598
Current Liabilities    
Related party loan and payables 4,933,706 4,391,325
Contract liabilities 606,383 545,346
Current operating Lease liabilities 2,460,483 2,508,959
Other current payable 556,298 471,603
Total Current Liabilities 8,556,870 7,917,233
Long-term loan from related party 670,007 657,572
Lease liabilities, noncurrent 2,061,154 2,154,243
TOTAL LIABILITIES 11,288,031 10,729,048
Commitments and contingencies (Note 13)
Stockholders’ Equity (Deficit)    
Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding
Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of October 31 and July 31, 2021 100,108 100,108
Additional paid-in capital 2,173,521 2,173,521
Accumulated deficit (6,403,051) (5,821,519)
Accumulated other comprehensive loss (270,962) (233,487)
Noncontrolling interest (1,280,794) (1,205,073)
Total Stockholders’ Deficit (5,681,178) (4,986,450)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 5,606,853 $ 5,742,598
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Oct. 31, 2021
Jul. 31, 2021
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares outstanding 100,108,000 100,108,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Total revenue $ 169,812 $ 79,387
Operating cost and expenses    
Cost of revenue 335,004 133,948
Depreciation and amortization 28,219 19,141
Selling, general and administrative 479,540 584,504
Total Operating Cost and Expenses 842,763 737,593
Operating Loss (672,951) (658,206)
Other Income (Expense)    
Interest (expense), net (16,166) (822)
Other income, net 40,957 678
Other income (expense), net 24,791 (144)
Loss before income taxes (648,160) (658,350)
Income Tax Expense 800
Net Loss (648,160) (659,150)
Less: net loss attributable to noncontrolling Interest (66,628) (134,393)
Net Loss Attributable to Hartford Great Health Corp $ (581,532) $ (524,757)
Basic and Diluted $ (0.01) $ (0.01)
Basic and diluted 100,108,000 99,108,000
Tuition [Member]    
Total revenue $ 155,364 $ 46,593
Service [Member]    
Total revenue $ 14,448 $ 32,794
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Income Statement [Abstract]    
Net Loss $ (581,532) $ (524,757)
Other Comprehensive income (loss), net of income tax    
Foreign currency translation adjustments (46,568) (108,456)
Total other comprehensive loss (46,568) (108,456)
Less: total other comprehensive loss attributable to noncontrolling interest (9,093) (28,212)
Total Other Comprehensive Loss Attributable to Hartford Great Health Corp (37,475) (80,244)
Total Comprehensive Loss $ (619,007) $ (605,001)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Jul. 31, 2020 $ 99,108 $ 2,154,521 $ (3,568,185) $ (55,146) $ (917,489) $ (2,287,191)
Beginning balance, shares at Jul. 31, 2020 99,108,000          
Net (loss) (524,757) (134,393) (659,150)
Foreign currency translation adjustment (80,244) (28,212) (108,456)
Ending balance, value at Oct. 31, 2020 $ 99,108 2,154,521 (4,092,942) (135,390) (1,080,094) (3,054,797)
Ending balance, shares at Oct. 31, 2020 99,108,000          
Beginning balance, value at Jul. 31, 2021 $ 100,108 2,173,521 (5,821,519) (233,487) (1,205,073) (4,986,450)
Beginning balance, shares at Jul. 31, 2021 100,108,000          
Net (loss) (581,532) (66,628) (648,160)
Foreign currency translation adjustment (37,475) (9,093) (46,568)
Ending balance, value at Oct. 31, 2021 $ 100,108 $ 2,173,521 $ (6,403,051) $ (270,962) $ (1,280,794) $ (5,681,178)
Ending balance, shares at Oct. 31, 2021 100,108,000          
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Cash flows from operating activities:    
Net loss including noncontrolling interests $ (648,160) $ (659,150)
Adjustments to reconcile net loss including noncontrolling interests to net cash (used in) operating activities:    
Depreciation and amortization 28,219 19,141
Loss on disposal of property and equipment 733
Changes in operating assets and liabilities:    
Prepaid and other current receivables 116,580 (21,729)
Inventory 2,497 (87,962)
Other assets 74,757 87,026
Related party receivables and payables (123,017) 12,607
Contract liabilities 55,881 75,203
Other current payable 35,152 (76)
Operating lease assets and liabilities 39,003 62,101
Other liabilities 6,997 6,534
Net cash (used in) operating activities (412,091) (505,572)
Cash flows from investing activities:    
Cash proceeds from Acquisitions 26,924
Cash used in Acquisitions (14,660)
Purchases of property and equipment (127,928)
Net cash (used in) provided by investing activities (127,928) 12,264
Cash flows from financing activities:    
Proceeds of related party notes payable 60,000 25,156
Principal payments on finance lease (21,257)
Advances from related parties 469,995 506,288
Net cash provided by financing activities 529,995 510,187
Effect of exchange rate changes on cash 130 2,540
Net change in cash, cash equivalents and restricted cash (9,894) 19,419
Cash, cash equivalents and restricted cash at beginning of period 54,178 65,277
Cash, cash equivalents and restricted cash at end of period 44,284 84,696
Supplemental Cash Flow Information    
Interest paid
Income taxes paid 800
Non-cash investing and financing activities:    
Payable to acquiree 10,462
Unpaid bills for leaseholder improvements $ 44,946
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Oct. 31, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. The financial statements and notes are the responsibility of the Company’s management. These accounting policies conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied in the preparation of the financial statements. This disclosure should be read in conjunction with our audited financial statements for the year ended July 31, 2021, including footnotes, contained in our Annual Report on Form 10-K,

 

Organization

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.

 

Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s 60 percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”) and its 90 percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020, see note 3 Acquisitions, Joint Ventures and Deconsolidation.

 

The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two 100% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”).

 

Basis of Presentation

 

The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation. The Company’s net income (loss) excludes income (loss) attributable to the noncontrolling interests.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Reclassifications

 

Certain amounts on the prior-year consolidated balance sheet, consolidated statement of operations and cash flows were reclassified to conform to current-year presentation, with no effect on ending stockholders’ equity.

 

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.

 

Revenue Recognition

 

The Company adopted ASC Topic 606 Revenue from Contracts with Customers (“Topic 606) on August 1, 2019, applying the modified retrospective method to all contracts that were not completed as of August 1, 2019. The Company is building up its core business upon the completion of multiple acquisitions in March 2019 and limited operations occurred during the years ended July 31, 2021 due to the impact of COVID-19 pandemic. The revenue for the three months period ended October 31, 2021 and 2020 were mainly generated from HZLJ, PDHJ and Gelinke.

 

Revenue is recognized when control of promised goods or services is transferred to our customers in an amount of consideration to which we expect to be entitled to in exchange for those goods or services. We follow the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. ASC 606 has no material impacts on the Company’s financial positions. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms. The Company recorded $606,383 and $545,346 unsatisfied performance obligations and contract liabilities as of October 31 and July 31, 2021, respectively.

 

a.Early childhood education services: HF Int’l Education generates revenue from childhood education classes provided to its customers. The educational services consist of parent-child and bilingual childcare classes. Each contract of educational classes is accounted for as a single performance obligation which is satisfied proportionately over the service period. Tuition fee is generally collected in advance and is initially recorded as deferred revenue and transferred to contract liabilities after trial period. Refunds are provided to parents if they decide within the trial period that they no longer want to take the class. After the trial period, if a parent withdraws from a class, usually only that unearned portion of the fee is available to be returned. For the three months ended October 31, 2021 and 2020, $155,364 and $46,593, respectively, of revenue were derived from early childhood education classes provided.

 

b.Hospitality services: HZLJ generates revenue primarily from the room rentals, sale of food and beverage and other miscellaneous hospitality services. The Company recognizes room rental and services daily as services are provided. Under ASC 606, the pattern and timing of recognition of income from hotel facility is consistent with the prior accounting model.

 

 

Recent Accounting Pronouncements.

 

Recently adopted accounting pronouncements

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes which is intended to simplify various aspects related to accounting for income taxes. The standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. The adoption of ASU No. 2019-12 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

Recently issued accounting pronouncements not yet adopted

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. The standard, including subsequently issued amendments (ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10 and ASU 2019-11), requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.2
GOING CONCERN
3 Months Ended
Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 2. GOING CONCERN

 

The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp. has incurred losses since inception, resulting in an accumulated deficit of $6,403,051 as of October 31, 2021. These conditions raise substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern.

 

In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.’s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation.

 

The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.2
ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION
3 Months Ended
Oct. 31, 2021
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION

NOTE 3. ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION

 

Joint Venture – HF Int’l Education

 

On March 22, 2019, HFSH entered into a joint venture agreement (the “JV agreement”) with Shanghai Jingyu Education Tech Ltd. (“SH Jingyu”) and one individual investor, to form a new entity - HF Int’l Education to provide childcare education services. HFSH initially owned 65.0% ownership HF Int’l Education, and reduced to 61.0% during the year ended on July 31, 2020 because of equity transactions between noncontrolling shareholders. On June 19, 2020, the board of HF Int’l Education decided to increase registered capital to RMB10 million from RMB5 million, and three out of four noncontrolling shareholders gave up the subscription rights. As a result, HFSH held 75.5% of HF Int’l Education and a total of 24.5% equity was held by noncontrolling shareholders. Pursuant to the board meeting held on June 1, 2021, the noncontrolling shareholders sold a total 14.5% equity at zero consideration to HFSH. As a result, HFSH holds 90.0% of HF Int’l Education and $403,131 noncontrolling loss was absorbed by HFSH as a result of the ownership restructure at HF Int’l Education.

 

Continuous operation losses caused by the market uncertainties including pandemic and government regulations, HF Int’l Education entered agreements to sell the copyrights of seven education textbooks and ten “HaiDeFuDe” registered trademarks owned for RMB1.2 million and RMB1.0 million, respectively, to Hartford Health Management (Shanghai) Co., Ltd (“HFHM”) in March 2021 with approval of the board of directors. The CEO of HFHM is a shareholder of the Company who owns more than 5% of the Company’s common stocks.

 

Operation result of HF Int’l Education are included in the Company’s consolidated financial statements commencing on the formation date. The Company classifies the ownership interest held by other four parties as “Noncontrolling interest” on the consolidated balance sheet.

 

 

Acquisition of Gelinke

 

On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Gelinke, who engages at early childhood education services in Changning District, Shanghai. The results of operations of the acquired entities are included in the Company’s consolidated financial statements commencing on the acquisition date. The Company has recorded an allocation of purchase price to Gelinke’s tangible and identifiable intangible assets acquired and liabilities assumed based on their fair value at the acquisition date. The Company accounted the acquisition transaction in accordance with FASB ASC 805, Business Combinations, under acquisition accounting method. The related transaction costs were immaterial and included in General and administrative expenses in the accompanying consolidated statements of operations. The acquisition was completed on August 31, 2021. The calculation of purchase price and purchase price allocation is as follows:

 

   Assets Acquired and 
   Liabilities Assumed 
Cash and cash equivalents   1,809 
Restricted Cash   25,009 
Prepaid and Other current receivables   4,696 
Property and Equipment, net   4,294 
Unearned revenue   (78,696)
Goodwill   67,712 
Total consideration*   24,824 

 

*$10,462 (RMB70,000) payable to the acquiree plus $14,362 (RMB100,000) cash payment totaled $24,824 consideration for the acquisition.

 

Goodwill is mainly attributable to synergies expected from the acquisition of license, list of customers and teacher workforce. Due to unfavorable operation result of Gelinke during the year ended July 31, 2021, management determined that $67,712 goodwill generated from Gelinke Acquisition was fully impaired and temporally ease the operation of Gelinke by the end of August, 2021.

 

Other Acquisitions

 

In January and February 2019, HFSH entered agreements to acquire 85 percent ownership of Shanghai Senior Health Consulting Ltd. (“SH Senior”) and 55 percent ownership of Shanghai Pasadena Ltd. (“SH Pasadena”). On December 31, 2020, HFSH withdrew from the two acquisition agreements. No penalty results from the withdrawn.

 

In January 2019, HFSH entered agreements to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”), As of October 31, 2021, the agreement has not yet taken effect as no consideration has been paid toward this acquisition. The agreement will be executed when the Company is financially ready to move forward, and the purchase price will be calculated based on the net assets of each entity on executing dates. There was no penalty levied or to be levied due to delayed execution or inexecution.

 

Disposal of subsidiary

 

On December 31, 2020, HFSH disposed its 90 percent owned subsidiary - Qiao Garden Int’l Travel to an individual (the “Disposal”). The individual is a relative of the CEO, Qiao Garden Int’l Travel became a related party after deconsolidation. The operation results, assets and liabilities, and cash flows of Qiao Garden Int’l Travel were deconsolidated from the Company’s consolidated financial statements effective on December 31, 2020. The Disposal of Qiao Garden was consummated through a three-party settlement among HFSH, SH Qiaohong and Qiao Garden Int’l Travel (the “Three-Party Settlement”): the original investment RMB 4.5 million plus RMB 0.5 million investment income were agreed to returned from Qiao Garden Int’l Travel as a result of the Disposal and settled with a payable due to SH Qiaohong at SHHF, who was a debtor of Qiao Garden Int’l Travel, see Note 14, Related Party Transactions.

 

Net assets (liabilities) disposed of: 

Net assets (liabilities) disposed of:    
Cash and cash equivalents   172 
Restricted cash   29,944 
Related party receivable   782,224 
Related party payable   (98,615)
Other current payable   (3,876)
Noncontrolling interest   (60,812)
Net assets of the subsidiary, excluding noncontrolling interest   649,037 
Consideration   753,354 
Gain on disposal of the subsidiary   (104,317)
Gain on disposal of noncontrolling interest   (60,812)
Gain on disposal of the subsidiary, excluding noncontrolling interest   (43,505)

 

Net inflow / (outflow) of cash and cash equivalents in respect of the disposal subsidiary: 

     
Cash and cash equivalents   (172)
Restricted cash   (29,944)
Cash and cash equivalents deconsolidated   (30,116)

 

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.2
RESTRICTED CASH
3 Months Ended
Oct. 31, 2021
Receivables [Abstract]  
RESTRICTED CASH

NOTE 4. RESTRICTED CASH

 

The Company early adopted ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, and includes restricted cash with cash and cash equivalents when reconciling the beginning of year and end of year total amounts shown on the statements of cash flows. The restricted cash are collaterals required by the local government in China for the early education license Gelinke held as of July 31, 2021, subsequently on August 26, the restricted cash had been withdrawal and transferred to other bank accounts as a result of operation halt at Gelinke.

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows. 

   October 31, 2021
(unaudited)
   July 31, 2021 
Cash and cash equivalents  $44,284   $27,612 
Restricted cash   -    26,566 
Total cash, cash equivalents and restricted cash shown in the statement of cash flows  $44,284   $54,178 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2
PREPAID AND OTHER CURRENT RECEIVABLES
3 Months Ended
Oct. 31, 2021
Prepaid And Other Current Receivables  
PREPAID AND OTHER CURRENT RECEIVABLES

NOTE 5. PREPAID AND OTHER CURRENT RECEIVABLES

 

Prepaid and other current receivable amounts of $173,825 and $286,232 as of October 31 and July 31, 2021, respectively, mainly consist of advances for purchase and renovation project, employee operating advances and others.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.21.2
INVENTORY
3 Months Ended
Oct. 31, 2021
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 6. INVENTORY

 

Inventory mainly consists of books, the early childhood education materials. Inventory is stated at the lower of cost or net realizable value. As of October 31 and July 31, 2021, inventory balance was $324,120 and $323,814, respectively.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
PROPERTY AND EQUIPMENT, NET
3 Months Ended
Oct. 31, 2021
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

NOTE 7. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consists of the following at October 31 and July 31, 2021: 

   October 31,   July 31, 
   2021 (unaudited)   2021 
Leasehold improvements  $419,181   $214,184 
Finance lease assets   293,247    290,714 
Furniture and fixtures   311,064    289,000 
Office equipment and vehicles   163,312    161,529 
Construction in progress   18,702    67,044 
 Property and equipment, gross   1,205,506    1,022,471 
Less: accumulated depreciation and amortization   (461,114)   (428,954)
 Property and equipment, net  $744,392   $593,517 

 

Depreciation expense for the three months ended October 31, 2021 and 2020, was $28,219 and $19,141, respectively.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER ASSETS
3 Months Ended
Oct. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER ASSETS

NOTE 8. OTHER ASSETS

 

Other assets consist of the following at October 31 and July 31, 2021: 

   October 31, 2021 (unaudited)   July 31, 2021 
Other miscellaneous assets  $30,205   $32,308 
Rental deposits   216,580    289,499 
 Other assets  $246,785   $321,807 

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER CURRENT PAYABLES
3 Months Ended
Oct. 31, 2021
Payables and Accruals [Abstract]  
OTHER CURRENT PAYABLES

NOTE 9. OTHER CURRENT PAYABLES

 

The following is a breakdown of the accounts and other payables as of October 31 and July 31, 2021: 

   October 31, 2021 (unaudited)   July 31, 2021 
Payable to acquirees  $152,636   $151,317 
Accrued payroll   9,553    11,064 
Payable to publisher   140,500    139,287 
Other payables   253,609    169,935 
 Other Current Payables  $556,298   $471,603 

 

Payable to acquiree is the unpaid consideration for the acquisitions described in Note 3 Acquisitions and Joint Venture.

 

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.21.2
LEASES
3 Months Ended
Oct. 31, 2021
Leases  
LEASES

NOTE 10. LEASES

 

At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. Leases are classified as either finance leases or operating leases based on criteria in Accounting Standards Codification (“ASC”) 842. Operating leases are included in ROU assets-Operating lease, Current Operating Lease liabilities and Operating lease liabilities, finance leases are included in Property and Equipment and Other Liabilities in the condensed Consolidated Balance Sheet.

 

Right-of-use (“ROU”) assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the lease did not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in China market. ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases, consisting of lease payments, is recognized on a straight-line basis over the lease term. Lease expense for finance leases consists of the amortization of the ROU asset on a straight-line basis over the asset’s estimated useful life and interest expense is calculated using the amortized cost basis.

 

As of July 31, 2021, the Company has multiple operating leases for office spaces and a finance lease of land and hotel building. Our operating leases have remaining lease terms ranging from one year to five years, with various term extensions available. Our finance lease has remaining lease term of thirty years. The Company has elected not to recognize ROU assets and lease liabilities for short-term operating leases that have a term of twelve months or less.

 

In June 2018 and January 2019, HFSH and HF Int’l Education entered two lease agreements with Shanghai Longjin Corporate Management Co., Ltd (the “Sublessor”) to lease office spaces (the “Subleases”). HFSH and HF Int’l Education received Notices of Lease Termination from the Sublessor for late payments on April 13, 2020 and filed a civil lawsuit against the Sublessor on July 10, 2020 (see Note 16). And the original lease agreement entered between the Sublessor and the landlord of the office building (the “Landlord”) was terminated by the Landlord on June 1, 2020 due to payment default. The two sublease agreements entered with the Sublessor was terminated on June 1, 2020 and approximately $921,000 ROU and $891,000 lease liability associated with the two Subleases as of May 31, 2020 were eliminated and $29,000 other expenses was recognized as a result. HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces with a five-year term. On July 13, 2021, HF Int’l Education entered a sublease agreement with sub-lessee (a third party) for some office space with two-year term, amount of $34,711 was recognized as sublease income, included under other income, for the three months ended October 31, 2021.

 

On September 1, 2020, Gelinke entered a five-year new lease agreement at the original office location upon the completion of the acquisition. Approximately $1.2 million ROU and lease liability, respectively, were recognized with the new lease at lease commencement date. On August 15, 2021, an early termination agreement was entered to terminate this lease on August 30, 2021. As a result, approximately $1 million ROU and lease liability, respectively, associated with this lease as of July 31, 2021 were eliminated and $40,005 gain was recognized.

 

HZHF terminated its original office lease on January 6, 2021. Approximately $287,000 ROU and $258,000 lease liability associated with the original lease agreement were eliminated. On January 9, 2021, HFHZ entered into a two-year new lease with smaller space at the same location. Approximately $49,000 ROU and lease liability, respectively, were recognized with the new lease at lease commencement date.

 

The finance lease was obtained through HZLJ acquisition on March 22, 2019. On October 1, 2010, HZLJ took over the lease of the land and hotel building for 41 years. Finance lease right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease.

 

 

Lease-related assets and liabilities at October 31 and July 31, 2021 were as follows: 

   October 31,   July 31, 
   2021 (unaudited)   2021 
Assets          
Finance lease right-of-use assets, cost (Note 7)  $293,247   $290,714 
Less: accumulated amortization   (80,814)   (80,547)
Finance lease right-of-use assets, net   212,433    210,167 
ROU assets-Operating lease   3,642,091    3,837,186 
Total Lease ROU assets  $3,854,524   $4,047,353 
Liabilities          
Current Operating Lease liabilities  $2,460,483   $2,508,959 
Operating lease liabilities, noncurrent   1,682,178    1,785,528 
Finance lease liabilities, noncurrent   378,976    368,715 
Total Lease liabilities  $4,521,637   $4,663,202 

 

The components of lease cost for the three months ended October 31, 2021 and 2020: 

       
   Three months ended October 31, 
   2021 (unaudited)   2020 (unaudited) 
Operating lease cost  $306,544   $345,713 
Finance leases:          
Amortization of ROU assets   1,775    1,712 
Interest on finance lease liabilities   6,997    6,661 
Finance lease cost   8,772    8,373 
Total lease cost  $315,316   $354,086 

 

Supplemental cash flow information for leases for the three months ended October 31, 2021 and 2020: 

  Three months ended October 31, 
   2021   2020 
Operating cash flows paid for operating leases  $186,127   $54,230 
Financing cash flows paid for finance leases   -    21,257 

 

The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases at October 31, 2021 was as follows: 

   October 31, 2021 
  Operating Leases   Finance Leases 
Weighted-average remaining lease term (years)   3.8    29.8 
Weighted-average discount rate   8%   8%

 

The following table reconciles the undiscounted future minimum lease payments for operating and finance leases executed at October 31, 2021: 

   Operating Leases   Finance Leases 
2022  $1,211,921   $23,417 
2023   1,153,762    24,197 
2024   1,206,431    24,978 
2025   1,117,410    25,758 
2026   88,795    26,539 
2027 and thereafter   -    963,985 
Total lease payments  $4,778,319   $1,088,874 
Less interest   (635,658)   (709,898)
Present value of future lease payments  $4,142,661   $378,976 
Current Lease liabilities   2,460,483    - 
Noncurrent Lease liabilities   1,682,178    378,976 

 

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS
3 Months Ended
Oct. 31, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 11. RELATED PARTY TRANSACTIONS

 

Related Party Receivables

 

The original loan balance of $721,000 due from Shanghai Qiaohong Real Estate Co., Ltd. (“SH Qiaohong”), the noncontrolling interest of HZLJ, was acquired through HFSH acquisition. HFSH lent the amount to SH Qiaohong for two years on June 21, 2018 bearing annual interest of six percent. On August 1, 2020, the loan has been extended to July 31, 2022. The balance was settled through a Three-way settlement agreement on December 31, 2020, see following “Three-Party Settlement Agreement” paragraph for detail. For the three months ended October 31, 2021 and 2020, $- and $9,778 of interest income were recognized, respectively.

 

$401,147 advances to HFHM were made pursuant to the license agreements entered by HF Int’l Education and its three subsidiaries in June 2021. See Note 14 for details. The remaining related party receivable of $30,209 and $29,948 as of October 31 and July 31, 2021, respectively, represents the operating advances made to the affiliates which are managed by the same management team. These advances do not bear interest and are considered due on demand.

 

Related Party Payables and loans

 

As of October 31 and July 31, 2021, amounts of $621,526 and $616,159, are payable to SH Qiaohong, respectively. The balances were mainly funding support from SH Qiaohong for operation. The funding support bears no interest and due on demand.

 

As of October 31 and July 31, 2021, amount of $624,445 and $619,051, respectively, is payable to Shanghai Qiao Garden Property Management Group (“Qiao Garden Group”), an entity managed by the same management team. The balance was assumed through HZLJ acquisition. This payable balance does not bear interest and is considered due on demand.

 

HFSH had payable balances to Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), an entity managed by the same management team, in the amounts of $3,425,682 and $2,926,782 as of October 31 and July 31, 2021, respectively. The payable is funding support from SH Oversea for operation, bears no interest and due on demand.

 

From September 2020 to October 2021, the Company borrowed several notes in a total principal amount of $205,000, in form of a short-term loan at 5% per annum from a related party, Hartford Hotel Investment Inc., an entity managed by the same management team. $2,461 and $nil of interest expense, respectively, were recorded during the three months ended October 31, 2021 and 2020. The unpaid principal and interest totaling $211,317 will be due on demand.

 

As of October 31 and July 31, 2021, the Company has $670,007 and $657,572, respectively, short-term payable to Shanghai DuBian Assets Management Ltd. (“Dubian”), which is owned by the Company’s ex-CEO’s relative. The payable balance was assumed from the acquisition transaction. On April 30, 2019, both parties entered a long-term agreement to convert the payable to a long-term debt, with expiration date on April 30, 2021, bearing approximately 2.5 percent of annual interest. On April 30, 2021, both parties entered a second long-term agreement to extend another two years, with expiration date on April 30, 2023, bearing approximately 4% of annual interest. $6,659 and $3,749 of interest expense were recognized during the three months ended October 31, 2021 and 2020, respectively. The unpaid principal and interest will be due on the maturity date. This loan payable is not exposed to market risk due to the stable and fixed interest rates in accordance with the loan agreements. As of October 31 and July 31, 2021, the estimated fair value of long term loan payable was approximately $668,228 and $655,940, respectively.

 

The remaining related party payable of $50,736 and $80,477 as of October 31 and July 31, 2021, respectively, represents the unpaid portion of operating advances made to the Company by affiliates which are managed by the same management team. These advances do not bear interest and are considered due on demand.

 

Three-Party Settlement Agreement

 

On December 31, 2020, a Three-Party Settlement agreement among HFSH, SH Qiaohong and Qiao Garden Int’l Travel was entered. Pursuant to the agreement, around $721,000 (RMB$5,031,699) payable due to SH Qiaohong under HFSH was settled with the receivable due from the same related party under Qiao Garden Int’l Travel through withdrawal of 90% ownership of Qiao Garden Int’l Travel HFSH owned. Total RMB5.0 million including the original investment RMB4.5 million was withdrawn from Qiao Garden Int’l Travel, and $104,317 (RMB697,000) gain on disposal was recognized at disposal date.

 

Other Related Party Transactions

 

Office space at Rosemead, CA is provided to Hartford Great Health Corp. at no cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material.

 

On September 30, 2019, HF Int’l Education entered two debt agreements with the related parties, SH Qiao Hong and SH Oversea. Each debt agreement provides a line of credit up to RMB9.0 million with two-year term, bearing 3.0% annum interest rate. The unpaid principal and interest will be due on the maturity dates. As of October 31, 2021, no balance was withdrawn from the two lines of credits by HF Int’l Education.

 

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.21.2
NONCONTROLLING INTERESTS
3 Months Ended
Oct. 31, 2021
Noncontrolling Interest [Abstract]  
NONCONTROLLING INTERESTS

NOTE 12. NONCONTROLLING INTERESTS

 

Noncontrolling interests consisted of the following as of October 31, 2021 and July 31, 2021:

 

Name of Entity  % of Non-Controlling Interests   July 31, 2021   Net loss     Restructure of subsidiary       Disposal of subsidiary     Foreign currency translation adjustment   October 31, 2021
(unaudited)
 
HZLJ   40.0%  $(962,998)  $(12,858)        $(6,977)  $(982,833)
HF Int’l Education
   10.0%   (242,075)   (53,770)               (2,116)   (297,961)
Total       $(1,205,073)  $(66,628)              $(9,093)  $(1,280,794)

 

Name of Entity  % of Non-Controlling Interests   July 31, 2020   Net loss   Restructure of subsidiary   Disposal of subsidiary   Foreign currency translation adjustment   July 31, 2021 
HZLJ   40.0%  $(889,068)  $(42,285)  $-   $-   $(31,645)  $(962,998)
HF Int’l Education   *10.0%   (88,692)   (548,547)   403,131    -    (7,967)   (242,075)
Qiao Garden Intl Travel   -    60,271    1,827    -    (62,098)   -    - 
Total       $(917,489)  $(589,005)  $403,131   $(62,098)  $(39,612)  $(1,205,073)

 

*90% equity of SHHZJ, a limited partnership and 10% shareholder of HF Int’l Education, is held by Mr. Song, ex-CEO of the Company on behalf of an unrelated individual. However, HF Int’l Education does not have the obligation to absorb losses of SHHZJ or a right to receive benefits from SHHZJ that could potentially be significant to SHHZJ, thus, SHHZJ is not considered a VIE of HF Int’l Education. In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation.

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 13. COMMITMENTS AND CONTINGENCIES

 

There has been below material contractual obligations and other commitments except the lease commitments disclosed in Note 10 Leases.

 

Lawsuits related to lease agreements

 

In June 2018 and January 2019, HFSH and HF Int’l Education entered two lease agreements with Shanghai Longjin Corporate Management Co., Ltd (the “Sublessor”) to lease some office spaces. On April 13, 2020, HFSH and HF Int’l Education received Notices of Lease Termination from the Tenant for late payments. HFSH and HF Int’l Education then filed a civil case against the Sublessor for over-charged rent fees because of fictitious office size and requested refund in the total amount approximately $481,000 (RMB3.3 million) till July 10, 2020. The Sublessor was further in default under the lease agreements due to its lease agreement with the landlord of the office properties (the “Landlord”) was terminated on June 1, 2020 by the Landlord. HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces in a five-year term.

 

On July 7, 2021, the district court verdict the final ruling and awarded HFSH and HF Int’l Education total amounts of RMB870,336 and RMB268,450 to be returned by the Sublessor. However, the rental deposits of RMB313,286 paid to the Sublessor are non-refundable. No further appeal on these rental dispute cases will be granted. These final ruling proceedings are pending execution by the district court, which has not yet executed as of October 31, 2021. Associated with this Sublessor under the two lease agreements, the Company previously accrued $165,698 rental payable net with deposit. As a result of the final ruling, the total $165,698 rental payable, net with deposit, accrued at HFSH and HF Int’l Education was written off and recognized as other income during the year ended July 31, 2021.

 

License agreements

 

In June 2021, HF Int’l Education and its three subsidiaries: PDHJ, HDFD and Gelinke entered license agreements with HFHM for the rights to use the intellectual Properties (the “IPs”) HFHM owns. The IPs cover in the license agreements are four set of curriculum structure designed and fifteen trademarks including “HaiDeFuDe” registered trademarks purchased from HF Int’l Education. As a return, on a monthly basis, HF Int’l Education and its subsidiaries pays 90% of its tuition revenue generated to HFHM as license usage fee. For the three months ended October 31, 2021, the Company incurred total $139,827 license fees pursuant to the license contracts. As of October 31 and July 31, 2021, the Company advanced $401,147 and $295,916, respectively, to HFHM for the future license fees.

 

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT INFORMATION
3 Months Ended
Oct. 31, 2021
Segment Reporting [Abstract]  
SEGMENT INFORMATION

NOTE 14. SEGMENT INFORMATION

 

The Company currently operates in following industry segments: hospitality (hotel and travel agency) and early childhood education industry in China.

 

Segment information on assets as of October 31, 2021 and revenue generated during the three months ended October 31, 2021, as follows:

 

   Hospitality   Education   Corporate and unallocated   Total 
Revenue  $14,448   $155,364   $-   $169,812 
Operating loss   (47,748)   (578,361)   (46,842)   (672,951)
Loss before tax   (61,150)   (537,707)   (49,303)   (648,160)
Net Loss Attributable to Hartford Great Health Corp   (48,292)   (483,936)   (49,304)   (581,532)
Total assets (excluding Intercompany balances)   351,627    5,286,171    (30,945)   5,606,853 

 

Segment information on assets as of October 31, 2020 and revenue generated during the three months ended October 31, 2020, as follows:

 

   Hospitality   Education  

Corporate

and unallocated

   Total 
Revenue  $32,794   $46,593   $-   $79,387 
Operating loss   (97,826)   (505,921)   (54,459)   (658,206)
Loss before tax   (97,814)   (505,921)   (54,615)   (658,350)
Net Loss Attributable to Hartford Great Health Corp   (87,372)   (381,970)   (55,415)   (524,757)
Total assets (excluding Intercompany balances)   1,426,445    6,403,378    49,296    7,879,119 

 

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS
3 Months Ended
Oct. 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 15. SUBSEQUENT EVENTS

 

In accordance with ASC 855, “Subsequent Events”, the Company has evaluated subsequent events through the date of issuance of these unaudited financial statements and no subsequent events were noted.

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Oct. 31, 2021
Accounting Policies [Abstract]  
Organization

Organization

 

Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.

 

Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s 60 percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”) and its 90 percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020, see note 3 Acquisitions, Joint Ventures and Deconsolidation.

 

The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two 100% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”).

 

Basis of Presentation

Basis of Presentation

 

The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the consolidation. The Company’s net income (loss) excludes income (loss) attributable to the noncontrolling interests.

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Reclassifications

Reclassifications

 

Certain amounts on the prior-year consolidated balance sheet, consolidated statement of operations and cash flows were reclassified to conform to current-year presentation, with no effect on ending stockholders’ equity.

 

 

Income Taxes

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.

 

Revenue Recognition

Revenue Recognition

 

The Company adopted ASC Topic 606 Revenue from Contracts with Customers (“Topic 606) on August 1, 2019, applying the modified retrospective method to all contracts that were not completed as of August 1, 2019. The Company is building up its core business upon the completion of multiple acquisitions in March 2019 and limited operations occurred during the years ended July 31, 2021 due to the impact of COVID-19 pandemic. The revenue for the three months period ended October 31, 2021 and 2020 were mainly generated from HZLJ, PDHJ and Gelinke.

 

Revenue is recognized when control of promised goods or services is transferred to our customers in an amount of consideration to which we expect to be entitled to in exchange for those goods or services. We follow the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not rendered are considered deferred revenue. ASC 606 has no material impacts on the Company’s financial positions. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in duration. The Company does not have significant financing components or payment terms. The Company recorded $606,383 and $545,346 unsatisfied performance obligations and contract liabilities as of October 31 and July 31, 2021, respectively.

 

a.Early childhood education services: HF Int’l Education generates revenue from childhood education classes provided to its customers. The educational services consist of parent-child and bilingual childcare classes. Each contract of educational classes is accounted for as a single performance obligation which is satisfied proportionately over the service period. Tuition fee is generally collected in advance and is initially recorded as deferred revenue and transferred to contract liabilities after trial period. Refunds are provided to parents if they decide within the trial period that they no longer want to take the class. After the trial period, if a parent withdraws from a class, usually only that unearned portion of the fee is available to be returned. For the three months ended October 31, 2021 and 2020, $155,364 and $46,593, respectively, of revenue were derived from early childhood education classes provided.

 

b.Hospitality services: HZLJ generates revenue primarily from the room rentals, sale of food and beverage and other miscellaneous hospitality services. The Company recognizes room rental and services daily as services are provided. Under ASC 606, the pattern and timing of recognition of income from hotel facility is consistent with the prior accounting model.

 

 

Recent Accounting Pronouncements.

Recent Accounting Pronouncements.

 

Recently adopted accounting pronouncements

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes which is intended to simplify various aspects related to accounting for income taxes. The standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. The adoption of ASU No. 2019-12 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

Recently issued accounting pronouncements not yet adopted

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. The standard, including subsequently issued amendments (ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10 and ASU 2019-11), requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements.

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2
ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Tables)
3 Months Ended
Oct. 31, 2021
Business Combination and Asset Acquisition [Abstract]  
SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED

 

   Assets Acquired and 
   Liabilities Assumed 
Cash and cash equivalents   1,809 
Restricted Cash   25,009 
Prepaid and Other current receivables   4,696 
Property and Equipment, net   4,294 
Unearned revenue   (78,696)
Goodwill   67,712 
Total consideration*   24,824 

 

*$10,462 (RMB70,000) payable to the acquiree plus $14,362 (RMB100,000) cash payment totaled $24,824 consideration for the acquisition.
SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY

Net assets (liabilities) disposed of: 

Net assets (liabilities) disposed of:    
Cash and cash equivalents   172 
Restricted cash   29,944 
Related party receivable   782,224 
Related party payable   (98,615)
Other current payable   (3,876)
Noncontrolling interest   (60,812)
Net assets of the subsidiary, excluding noncontrolling interest   649,037 
Consideration   753,354 
Gain on disposal of the subsidiary   (104,317)
Gain on disposal of noncontrolling interest   (60,812)
Gain on disposal of the subsidiary, excluding noncontrolling interest   (43,505)
SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY

Net inflow / (outflow) of cash and cash equivalents in respect of the disposal subsidiary: 

     
Cash and cash equivalents   (172)
Restricted cash   (29,944)
Cash and cash equivalents deconsolidated   (30,116)
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.2
RESTRICTED CASH (Tables)
3 Months Ended
Oct. 31, 2021
Receivables [Abstract]  
SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows. 

   October 31, 2021
(unaudited)
   July 31, 2021 
Cash and cash equivalents  $44,284   $27,612 
Restricted cash   -    26,566 
Total cash, cash equivalents and restricted cash shown in the statement of cash flows  $44,284   $54,178 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
PROPERTY AND EQUIPMENT, NET (Tables)
3 Months Ended
Oct. 31, 2021
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT, NET

Property and equipment, net consists of the following at October 31 and July 31, 2021: 

   October 31,   July 31, 
   2021 (unaudited)   2021 
Leasehold improvements  $419,181   $214,184 
Finance lease assets   293,247    290,714 
Furniture and fixtures   311,064    289,000 
Office equipment and vehicles   163,312    161,529 
Construction in progress   18,702    67,044 
 Property and equipment, gross   1,205,506    1,022,471 
Less: accumulated depreciation and amortization   (461,114)   (428,954)
 Property and equipment, net  $744,392   $593,517 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER ASSETS (Tables)
3 Months Ended
Oct. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
SCHEDULE OF OTHER ASSETS

Other assets consist of the following at October 31 and July 31, 2021: 

   October 31, 2021 (unaudited)   July 31, 2021 
Other miscellaneous assets  $30,205   $32,308 
Rental deposits   216,580    289,499 
 Other assets  $246,785   $321,807 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER CURRENT PAYABLES (Tables)
3 Months Ended
Oct. 31, 2021
Payables and Accruals [Abstract]  
SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

The following is a breakdown of the accounts and other payables as of October 31 and July 31, 2021: 

   October 31, 2021 (unaudited)   July 31, 2021 
Payable to acquirees  $152,636   $151,317 
Accrued payroll   9,553    11,064 
Payable to publisher   140,500    139,287 
Other payables   253,609    169,935 
 Other Current Payables  $556,298   $471,603 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
LEASES (Tables)
3 Months Ended
Oct. 31, 2021
Leases  
SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES

Lease-related assets and liabilities at October 31 and July 31, 2021 were as follows: 

   October 31,   July 31, 
   2021 (unaudited)   2021 
Assets          
Finance lease right-of-use assets, cost (Note 7)  $293,247   $290,714 
Less: accumulated amortization   (80,814)   (80,547)
Finance lease right-of-use assets, net   212,433    210,167 
ROU assets-Operating lease   3,642,091    3,837,186 
Total Lease ROU assets  $3,854,524   $4,047,353 
Liabilities          
Current Operating Lease liabilities  $2,460,483   $2,508,959 
Operating lease liabilities, noncurrent   1,682,178    1,785,528 
Finance lease liabilities, noncurrent   378,976    368,715 
Total Lease liabilities  $4,521,637   $4,663,202 
SCHEDULE OF COMPONENTS OF LEASE COST

The components of lease cost for the three months ended October 31, 2021 and 2020: 

       
   Three months ended October 31, 
   2021 (unaudited)   2020 (unaudited) 
Operating lease cost  $306,544   $345,713 
Finance leases:          
Amortization of ROU assets   1,775    1,712 
Interest on finance lease liabilities   6,997    6,661 
Finance lease cost   8,772    8,373 
Total lease cost  $315,316   $354,086 
SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES

Supplemental cash flow information for leases for the three months ended October 31, 2021 and 2020: 

  Three months ended October 31, 
   2021   2020 
Operating cash flows paid for operating leases  $186,127   $54,230 
Financing cash flows paid for finance leases   -    21,257 
SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES

The weighted-average remaining lease term and weighted-average discount rate for operating and finance leases at October 31, 2021 was as follows: 

   October 31, 2021 
  Operating Leases   Finance Leases 
Weighted-average remaining lease term (years)   3.8    29.8 
Weighted-average discount rate   8%   8%
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES

The following table reconciles the undiscounted future minimum lease payments for operating and finance leases executed at October 31, 2021: 

   Operating Leases   Finance Leases 
2022  $1,211,921   $23,417 
2023   1,153,762    24,197 
2024   1,206,431    24,978 
2025   1,117,410    25,758 
2026   88,795    26,539 
2027 and thereafter   -    963,985 
Total lease payments  $4,778,319   $1,088,874 
Less interest   (635,658)   (709,898)
Present value of future lease payments  $4,142,661   $378,976 
Current Lease liabilities   2,460,483    - 
Noncurrent Lease liabilities   1,682,178    378,976 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.2
NONCONTROLLING INTERESTS (Tables)
3 Months Ended
Oct. 31, 2021
Noncontrolling Interest [Abstract]  
SCHEDULE OF NONCONTROLLING INTERESTS

Noncontrolling interests consisted of the following as of October 31, 2021 and July 31, 2021:

 

Name of Entity  % of Non-Controlling Interests   July 31, 2021   Net loss     Restructure of subsidiary       Disposal of subsidiary     Foreign currency translation adjustment   October 31, 2021
(unaudited)
 
HZLJ   40.0%  $(962,998)  $(12,858)        $(6,977)  $(982,833)
HF Int’l Education
   10.0%   (242,075)   (53,770)               (2,116)   (297,961)
Total       $(1,205,073)  $(66,628)              $(9,093)  $(1,280,794)

 

Name of Entity  % of Non-Controlling Interests   July 31, 2020   Net loss   Restructure of subsidiary   Disposal of subsidiary   Foreign currency translation adjustment   July 31, 2021 
HZLJ   40.0%  $(889,068)  $(42,285)  $-   $-   $(31,645)  $(962,998)
HF Int’l Education   *10.0%   (88,692)   (548,547)   403,131    -    (7,967)   (242,075)
Qiao Garden Intl Travel   -    60,271    1,827    -    (62,098)   -    - 
Total       $(917,489)  $(589,005)  $403,131   $(62,098)  $(39,612)  $(1,205,073)

 

*90% equity of SHHZJ, a limited partnership and 10% shareholder of HF Int’l Education, is held by Mr. Song, ex-CEO of the Company on behalf of an unrelated individual. However, HF Int’l Education does not have the obligation to absorb losses of SHHZJ or a right to receive benefits from SHHZJ that could potentially be significant to SHHZJ, thus, SHHZJ is not considered a VIE of HF Int’l Education. In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation.
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT INFORMATION (Tables)
3 Months Ended
Oct. 31, 2021
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT INFORMATION

Segment information on assets as of October 31, 2021 and revenue generated during the three months ended October 31, 2021, as follows:

 

   Hospitality   Education   Corporate and unallocated   Total 
Revenue  $14,448   $155,364   $-   $169,812 
Operating loss   (47,748)   (578,361)   (46,842)   (672,951)
Loss before tax   (61,150)   (537,707)   (49,303)   (648,160)
Net Loss Attributable to Hartford Great Health Corp   (48,292)   (483,936)   (49,304)   (581,532)
Total assets (excluding Intercompany balances)   351,627    5,286,171    (30,945)   5,606,853 

 

Segment information on assets as of October 31, 2020 and revenue generated during the three months ended October 31, 2020, as follows:

 

   Hospitality   Education  

Corporate

and unallocated

   Total 
Revenue  $32,794   $46,593   $-   $79,387 
Operating loss   (97,826)   (505,921)   (54,459)   (658,206)
Loss before tax   (97,814)   (505,921)   (54,615)   (658,350)
Net Loss Attributable to Hartford Great Health Corp   (87,372)   (381,970)   (55,415)   (524,757)
Total assets (excluding Intercompany balances)   1,426,445    6,403,378    49,296    7,879,119 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Jul. 31, 2021
Dec. 31, 2020
Mar. 23, 2020
Jul. 24, 2019
Product Information [Line Items]            
Income tax examination description The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises.          
Contract liabilities $ 606,383   $ 545,346      
Revenue 169,812 $ 79,387        
Early Childhood Education Services [Member]            
Product Information [Line Items]            
Revenue $ 155,364 $ 46,593        
Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd [Member]            
Product Information [Line Items]            
Equity ownership percentage         100.00%  
Pudong Haojin Childhood Education Ltd [Member]            
Product Information [Line Items]            
Equity ownership percentage           100.00%
Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. [Member]            
Product Information [Line Items]            
Business Acquisition, Percentage of Voting Interests Acquired       60.00%    
Shanghai Hartford Comprehensive Health Management, Ltd. [Member]            
Product Information [Line Items]            
Business Acquisition, Percentage of Voting Interests Acquired       90.00%    
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.2
GOING CONCERN (Details Narrative) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 6,403,051 $ 5,821,519
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) - Shanghai Gelinke Childcare Education Center [Member]
Jul. 20, 2020
USD ($)
Business Acquisition [Line Items]  
Cash and cash equivalents $ 1,809
Restricted Cash 25,009
Prepaid and Other current receivables 4,696
Property and Equipment, net 4,294
Unearned revenue (78,696)
Goodwill 67,712
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net, Total $ 24,824
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) - Jul. 20, 2020 - Shanghai Gelinke Childcare Education Center [Member]
USD ($)
CNY (¥)
Business Acquisition [Line Items]    
Purchase price $ 10,462 ¥ 70,000
Cash payments to acquire business 14,362 ¥ 100,000
Total consideration $ 24,824  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) - Qiao Garden Intel Travel [Member]
Dec. 31, 2020
USD ($)
Cash and cash equivalents $ 172
Restricted cash 29,944
Related party receivable 782,224
Related party payable (98,615)
Other current payable (3,876)
Noncontrolling interest (60,812)
Net assets of the subsidiary, excluding noncontrolling interest 649,037
Consideration 753,354
Gain on disposal of the subsidiary (104,317)
Gain on disposal of noncontrolling interest (60,812)
Gain on disposal of the subsidiary, excluding noncontrolling interest $ (43,505)
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY (Details) - Qiao Garden Intel Travel [Member]
Dec. 31, 2020
USD ($)
Cash and cash equivalents $ (172)
Restricted cash (29,944)
Cash and cash equivalents deconsolidated $ (30,116)
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.2
ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Details Narrative)
¥ in Millions
3 Months Ended
Jun. 01, 2021
Dec. 31, 2020
CNY (¥)
Dec. 31, 2020
CNY (¥)
Oct. 31, 2021
Jul. 31, 2021
USD ($)
Mar. 31, 2021
Jul. 31, 2020
Jun. 19, 2020
CNY (¥)
Mar. 22, 2019
CNY (¥)
Feb. 28, 2019
Jan. 31, 2019
HF Int'l Education [Member]                      
Business Acquisition [Line Items]                      
Noncontrolling shareholders, description Pursuant to the board meeting held on June 1, 2021, the noncontrolling shareholders sold a total 14.5% equity at zero consideration to HFSH. As a result, HFSH holds 90.0% of HF Int’l Education and $403,131 noncontrolling loss was absorbed by HFSH as a result of the ownership restructure at HF Int’l Education.     As a result, HFSH held 75.5% of HF Int’l Education and a total of 24.5% equity was held by noncontrolling shareholders              
Shanghai Gelinke Childcare Education Center [Member]                      
Business Acquisition [Line Items]                      
Goodwill | $         $ 67,712            
Shanghai Senior Health Consulting Ltd. [Member]                      
Business Acquisition [Line Items]                      
Business acquired ownership interest                   85.00% 85.00%
Shanghai Pasadena Ltd. [Member]                      
Business Acquisition [Line Items]                      
Business acquired ownership interest                   55.00% 55.00%
Shanghai Luo Sheng International Trade Ltd. [Member]                      
Business Acquisition [Line Items]                      
Business acquired ownership interest                     100.00%
Qiao Garden International Travel Agency [Member] | Hartford Great Health Management (Shanghai) Ltd. [Member]                      
Business Acquisition [Line Items]                      
Investment from noncontrolling interest   ¥ 4.5 ¥ 4.5                
Investment income   ¥ 5.0 ¥ 0.5                
Qiao Garden International Travel Agency [Member] | Hartford Great Health Management (Shanghai) Ltd. [Member]                      
Business Acquisition [Line Items]                      
Business acquired ownership interest   90.00% 90.00%                
Shareholders [Member] | Hartford Great Health Management (Shanghai) Ltd. [Member]                      
Business Acquisition [Line Items]                      
Noncontrolling ownership interest             61.00%        
Joint Venture Agreement [Member]                      
Business Acquisition [Line Items]                      
Joint venture acquired ownership interest                 65.00%    
Joint Venture Agreement [Member] | Hartford International Education Technology Co., Ltd [Member] | Seven Education Textbooks [Member]                      
Business Acquisition [Line Items]                      
Registered capital                 ¥ 1.2    
Joint Venture Agreement [Member] | Hartford International Education Technology Co., Ltd [Member] | Ten “HaiDeFuDe” [Member]                      
Business Acquisition [Line Items]                      
Registered capital                 ¥ 1.0    
Joint Venture Agreement [Member] | Maximum [Member]                      
Business Acquisition [Line Items]                      
Registered capital               ¥ 10.0      
Joint Venture Agreement [Member] | Minimum [Member]                      
Business Acquisition [Line Items]                      
Registered capital               ¥ 5.0      
Joint Venture Agreement [Member] | Chief Executive Officer [Member] | Hartford International Education Technology Co., Ltd [Member]                      
Business Acquisition [Line Items]                      
Joint venture acquired ownership interest           5.00%          
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Receivables [Abstract]    
Cash and cash equivalents $ 44,284 $ 27,612
Restricted cash 26,566
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 44,284 $ 54,178
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.2
PREPAID AND OTHER CURRENT RECEIVABLES (Details Narrative) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Prepaid And Other Current Receivables    
Prepaid and other current receivables $ 173,825 $ 286,232
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.21.2
INVENTORY (Details Narrative) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Inventory Disclosure [Abstract]    
Inventory's net $ 324,120 $ 323,814
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Property, Plant and Equipment [Line Items]    
 Property and equipment, gross $ 1,205,506 $ 1,022,471
Less: accumulated depreciation and amortization (461,114) (428,954)
 Property and equipment, net 744,392 593,517
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
 Property and equipment, gross 419,181 214,184
Finance Lease Assets [Member]    
Property, Plant and Equipment [Line Items]    
 Property and equipment, gross 293,247 290,714
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
 Property and equipment, gross 311,064 289,000
Office Equipment Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
 Property and equipment, gross 163,312 161,529
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
 Property and equipment, gross $ 18,702 $ 67,044
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.21.2
PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 28,219 $ 19,141
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF OTHER ASSETS (Details) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Other miscellaneous assets $ 30,205 $ 32,308
Rental deposits 216,580 289,499
 Other assets $ 246,785 $ 321,807
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Payables and Accruals [Abstract]    
Payable to acquirees $ 152,636 $ 151,317
Accrued payroll 9,553 11,064
Payable to publisher 140,500 139,287
Other payables 253,609 169,935
 Other Current Payables $ 556,298 $ 471,603
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES (Details) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Leases    
Finance lease right-of-use assets, cost (Note 7) $ 293,247 $ 290,714
Less: accumulated amortization (80,814) (80,547)
Finance lease right-of-use assets, net 212,433 210,167
ROU assets-Operating lease 3,642,091 3,837,186
Total Lease ROU assets 3,854,524 4,047,353
Current Operating Lease liabilities 2,460,483 2,508,959
Operating lease liabilities, noncurrent 1,682,178 1,785,528
Finance lease liabilities, noncurrent 378,976 368,715
Total Lease liabilities $ 4,521,637 $ 4,663,202
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF COMPONENTS OF LEASE COST (Details) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Leases    
Operating lease cost $ 306,544 $ 345,713
Amortization of ROU assets 1,775 1,712
Interest on finance lease liabilities 6,997 6,661
Finance lease cost 8,772 8,373
Total lease cost $ 315,316 $ 354,086
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES (Details) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Leases    
Operating cash flows paid for operating leases $ 186,127 $ 54,230
Financing cash flows paid for finance leases $ 21,257
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES (Details)
Oct. 31, 2021
Leases  
Weighted-average remaining lease term (years) Operating Leases 3 years 9 months 18 days
Weighted-average remaining lease term (years) Finance Leases 29 years 9 months 18 days
Weighted-average discount rate Operating Leases 8.00%
Weighted-average discount rate Finance Leases 8.00%
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES (Details) - USD ($)
Oct. 31, 2021
Jul. 31, 2021
Leases    
Operating Leases, 2022 $ 1,211,921  
Finance Leases, 2022 23,417  
Operating Leases, 2023 1,153,762  
Finance Leases, 2023 24,197  
Operating Leases, 2024 1,206,431  
Finance Leases, 2024 24,978  
Operating Leases, 2025 1,117,410  
Finance Leases, 2025 25,758  
Operating Leases, 2026 88,795  
Finance Leases, 2026 26,539  
Operating Leases, 2027 and thereafter  
Finance Leases, 2027 and thereafter 963,985  
Operating Leases, Total lease payments 4,778,319  
Finance Leases, Total lease payments 1,088,874  
Less interest (635,658)  
Less interest (709,898)  
Present value of future lease payments 4,142,661  
Present value of future lease payments 378,976  
Including: current lease liabilities 2,460,483 $ 2,508,959
Including: current lease liabilities  
Including: noncurrent lease liabilities 1,682,178 1,785,528
Including: noncurrent lease liabilities $ 378,976 $ 368,715
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.21.2
LEASES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
May 31, 2020
Jul. 31, 2021
Oct. 31, 2021
Jan. 09, 2021
Jan. 06, 2021
Sep. 02, 2020
Jun. 01, 2020
Oct. 01, 2010
Finance leases remaining term   30 years            
ROU of lease liability   $ 3,837,186 $ 3,642,091          
Lease liability     $ 4,142,661          
Hangzhou Hartford Comprehensive Health Management, Ltd [Member]                
Operating leases remaining term       2 years        
ROU of lease liability       $ 49,000 $ 287,000      
Lease liability       $ 49,000 $ 258,000      
Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. [Member]                
Finance leases remaining term               41 years
Two Sublease Agreements [Member]                
ROU of lease liability $ 921,000              
Lease liability 891,000              
Other expenses $ 29,000              
New Lease Agreement [Member]                
Lease term             5 years  
Sublease Agreements [Member] | Hartford International Education Technology Co., Ltd [Member]                
Sublease term description     On July 13, 2021, HF Int’l Education entered a sublease agreement with sub-lessee (a third party) for some office space with two-year term, amount of $34,711 was recognized as sublease income, included under other income, for the three months ended October 31, 2021.          
Five-Year New Lease Agreement [Member] | Shanghai Gelinke Childcare Education Center [Member]                
ROU of lease liability           $ 1,200,000    
Lease liability           $ 1,200,000    
Lease term           5 years    
Early Termination Agreement [Member]                
ROU of lease liability   1,000,000            
Lease liability   1,000,000            
Early Termination Agreement [Member] | Shanghai Gelinke Childcare Education Center [Member]                
Gain on termination of lease   $ 40,005            
Minimum [Member]                
Operating leases remaining term   1 year            
Maximum [Member]                
Operating leases remaining term   5 years            
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS (Details Narrative)
3 Months Ended
Apr. 30, 2021
Dec. 31, 2020
USD ($)
Dec. 31, 2020
CNY (¥)
Dec. 31, 2020
CNY (¥)
Sep. 30, 2019
USD ($)
Apr. 30, 2019
Oct. 31, 2021
USD ($)
Oct. 31, 2020
USD ($)
Jul. 31, 2021
USD ($)
Dec. 31, 2020
CNY (¥)
Related Party Transaction [Line Items]                    
Estimated fair value of long term loans payable             $ 668,228   $ 655,940  
Gain on disposal of subsidiary   $ 104,317 ¥ 697,000              
Hartford Great Health Management (Shanghai) Ltd. [Member] | Qiao Garden International Travel Agency [Member]                    
Related Party Transaction [Line Items]                    
Acquired percentage   90.00%               90.00%
Hartford Great Health Management (Shanghai) Ltd. [Member]                    
Related Party Transaction [Line Items]                    
Due to/from related party   $ 721,000               ¥ 5,031,699
Hartford Great Health Management (Shanghai) Ltd. [Member] | Qiao Garden International Travel Agency [Member]                    
Related Party Transaction [Line Items]                    
Investment income | ¥     5,000,000.0 ¥ 500,000            
Investment from noncontrolling interest | ¥     ¥ 4,500,000 ¥ 4,500,000            
Shanghai Qiaohong Real Estate Co., Ltd. [Member]                    
Related Party Transaction [Line Items]                    
Related party receivables             $ 721,000      
Related party receivables, description             HFSH lent the amount to SH Qiaohong for two years on June 21, 2018 bearing annual interest of six percent. On August 1, 2020, the loan has been extended to July 31, 2022.      
Interest income             $ 9,778    
HFHM [Member] | License [Member]                    
Related Party Transaction [Line Items]                    
Advance from related party             401,147      
Affiliates [Member]                    
Related Party Transaction [Line Items]                    
Related party receivables             30,209   29,948  
Related Party Payables             50,736   80,477  
Shanghai Qiao Garden Property Management Group [Member]                    
Related Party Transaction [Line Items]                    
Related Party Payables             624,445   619,051  
Shanghai Oversea Chinese Culture Media Ltd. [Member]                    
Related Party Transaction [Line Items]                    
Related Party Payables             3,425,682   2,926,782  
Hartford Hotel Investment Inc [Member] | Related Party [Member]                    
Related Party Transaction [Line Items]                    
Short term borrowings             $ 205,000      
Short term debt interest rate, percentage             5.00%      
Interest expense             $ 2,461    
Unpaid principal and interest             211,317      
Shanghai DuBian Assets Management Ltd. [Member]                    
Related Party Transaction [Line Items]                    
Interest expense             6,659 $ 3,749    
Short-term and long-term payable             $ 670,007   $ 657,572  
Expiration date           Apr. 30, 2021        
Interest rate           2.50%        
Shanghai DuBian Assets Management Ltd. [Member] | Second Long Term Agreement [Member]                    
Related Party Transaction [Line Items]                    
Expiration date Apr. 30, 2023                  
Interest rate 4.00%                  
HF Int'l Education [Member] | Two Debt Agreements [Member]                    
Related Party Transaction [Line Items]                    
Line of credit facility, maximum borrowing capacity         $ 9,000,000.0          
Debt instrument, term         2 years          
Line of credit facility, annum interest rate         3.00%          
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF NONCONTROLLING INTERESTS (Details) - USD ($)
3 Months Ended 12 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Jul. 31, 2021
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Non-Controlling Interests beginning balance $ (1,205,073) $ (917,489) $ (917,489)
Net loss (66,628) (134,393) (589,005)
Restructure of subsidary   403,131
Disposal of subsidiary   (62,098)
Foreign currency translation adjustment (9,093)   (39,612)
Non-Controlling Interests ending balance $ (1,280,794)   $ (1,205,073)
HZLJ [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
% of Non-Controlling Interests 40.00%   40.00%
Non-Controlling Interests beginning balance $ (962,998) (889,068) $ (889,068)
Net loss (12,858)   (42,285)
Restructure of subsidary  
Disposal of subsidiary  
Foreign currency translation adjustment (6,977)   (31,645)
Non-Controlling Interests ending balance $ (982,833)   $ (962,998)
HF Int'l Education [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
% of Non-Controlling Interests 10.00%   10.00% [1]
Non-Controlling Interests beginning balance $ (242,075) (88,692) $ (88,692)
Net loss (53,770)   (548,547)
Restructure of subsidary   403,131
Disposal of subsidiary  
Foreign currency translation adjustment (2,116)   (7,967)
Non-Controlling Interests ending balance (297,961)   (242,075)
Qiao Garden Intl Travel [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Non-Controlling Interests beginning balance $ 60,271 60,271
Net loss     1,827
Restructure of subsidary    
Disposal of subsidiary     (62,098)
Foreign currency translation adjustment    
Non-Controlling Interests ending balance    
[1] 90% equity of SHHZJ, a limited partnership and 10% shareholder of HF Int’l Education, is held by Mr. Song, ex-CEO of the Company on behalf of an unrelated individual. However, HF Int’l Education does not have the obligation to absorb losses of SHHZJ or a right to receive benefits from SHHZJ that could potentially be significant to SHHZJ, thus, SHHZJ is not considered a VIE of HF Int’l Education. In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation.
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF NONCONTROLLING INTERESTS (Details) (Parenthetical)
12 Months Ended
Jul. 31, 2021
HF Int'l Education [Member]  
Noncontrolling Interest [Line Items]  
Equity ownership percentage 10.00%
Noncontrolling shareholders, description In June 2021, SHHZJ and one individual shareholder transferred a total 14.5% noncontrolling interest of HF Int’l Education to SHHF at zero cost, see note 4 Acquisitions, joint ventures and deconsolidation
SHHZJ [Member]  
Noncontrolling Interest [Line Items]  
Equity ownership percentage 90.00%
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
3 Months Ended 12 Months Ended
Jul. 07, 2021
USD ($)
Jul. 07, 2021
CNY (¥)
Apr. 13, 2020
USD ($)
Apr. 13, 2020
CNY (¥)
Oct. 31, 2021
USD ($)
Jul. 31, 2021
USD ($)
HFHM [Member] | License [Member]            
Product Liability Contingency [Line Items]            
Finite-Lived License Agreements, Gross | $         $ 139,827  
[custom:PaymentToLicenseFee] | $         $ 401,147 $ 295,916
Intellectual Properties [Member] | HFHM [Member]            
Product Liability Contingency [Line Items]            
[custom:LicenseDescription]         As a return, on a monthly basis, HF Int’l Education and its subsidiaries pays 90% of its tuition revenue generated to HFHM as license usage fee. For the three months ended October 31, 2021, the Company incurred total $  
HFSH [Member] | Sublessor [Member]            
Product Liability Contingency [Line Items]            
Litigation Settlement, Amount Awarded from Other Party | ¥   ¥ 870,336        
Other Income | $ $ 165,698          
Hartford International Education Technology Co., Ltd [Member] | Sublessor [Member]            
Product Liability Contingency [Line Items]            
Litigation Settlement, Amount Awarded from Other Party | ¥   268,450        
Two Lease Agreements [Member]            
Product Liability Contingency [Line Items]            
Refund of fictitious office property requested     $ 481,000 ¥ 3,300,000    
Lease agreement, date     Jul. 10, 2020 Jul. 10, 2020    
Lease agreement, description         HF Int’l Education entered a new lease agreement with the Landlord on June 1, 2020 for the same office spaces in a five-year term.  
Two Lease Agreements [Member] | Nonrefundable Rental Depoit [Member]            
Product Liability Contingency [Line Items]            
Payments for Rent | ¥   ¥ 313,286        
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)
3 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Jul. 31, 2021
Segment Reporting Information [Line Items]      
Revenue $ 169,812 $ 79,387  
Operating loss (672,951) (658,206)  
Loss before tax (648,160) (658,350)  
Net Loss Attributable to Hartford Great Health Corp (581,532) (524,757)  
Total assets (excluding Intercompany balances) 5,606,853 7,879,119 $ 5,742,598
Hospitality [Member]      
Segment Reporting Information [Line Items]      
Revenue 14,448 32,794  
Operating loss (47,748) (97,826)  
Loss before tax (61,150) (97,814)  
Net Loss Attributable to Hartford Great Health Corp (48,292) (87,372)  
Total assets (excluding Intercompany balances) 351,627 1,426,445  
Education [Member]      
Segment Reporting Information [Line Items]      
Revenue 155,364 46,593  
Operating loss (578,361) (505,921)  
Loss before tax (537,707) (505,921)  
Net Loss Attributable to Hartford Great Health Corp (483,936) (381,970)  
Total assets (excluding Intercompany balances) 5,286,171 6,403,378  
Corporate and Unallocated [Member]      
Segment Reporting Information [Line Items]      
Revenue  
Operating loss (46,842) (54,459)  
Loss before tax (49,303) (54,615)  
Net Loss Attributable to Hartford Great Health Corp (49,304) (55,415)  
Total assets (excluding Intercompany balances) $ (30,945) $ 49,296  
EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

1376O@D7PM;>QP1S/;U3[XC>^U$$]9]%/M1%C MM??PQK)JP)GKJ@&H4Q3JEH::J\=T?/!AZ.&FN@8@P@'T6[W4A"P.0LCODOC] M2(+ZSR0?:Z=FC=LGDJ[::N]]\R@^FGVA0A=U"5*VT+;PPM8]3#$7N M]L0& !<' & 'AL+W=O7-9';1OEO(V878Z(HW;"&1VM0UE<_7K!*/EQ,\>7GQ M@S^LM'DQG5VLZ0.[9?INO9#P--UI*7G-&L5%@R1;7DZN\/D\3,V 5N)/SA[5 MWG=D3+D7XJ=YN"DO)X%!Q"I6:*."PL>6S5E5&4V XU>O=+*;TPS<__ZB_4MK M/!AS3Q6;B^HO7NK5Y22;H)(MZ:;2/\3C[ZPW*#;Z"E&I]C]Z[&6#"2HV2HNZ M'PP(:MYTG_2I=\3> -#C'D#Z >1X0#0R(.P'A*VA';+6K$]4T]F%%(](&FG0 M9KZTOFE'@S6\,6&\U1)^Y3!.S^:B*2$HK$3P38F*EU3#PZV뙝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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 149 331 1 true 65 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://hartfordhealthcare.org/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://hartfordhealthcare.org/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://hartfordhealthcare.org/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://hartfordhealthcare.org/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) Sheet http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://hartfordhealthcare.org/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://hartfordhealthcare.org/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION Sheet http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION Notes 10 false false R11.htm 00000011 - Disclosure - RESTRICTED CASH Sheet http://hartfordhealthcare.org/role/RestrictedCash RESTRICTED CASH Notes 11 false false R12.htm 00000012 - Disclosure - PREPAID AND OTHER CURRENT RECEIVABLES Sheet http://hartfordhealthcare.org/role/PrepaidAndOtherCurrentReceivables PREPAID AND OTHER CURRENT RECEIVABLES Notes 12 false false R13.htm 00000013 - Disclosure - INVENTORY Sheet http://hartfordhealthcare.org/role/Inventory INVENTORY Notes 13 false false R14.htm 00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://hartfordhealthcare.org/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 14 false false R15.htm 00000015 - Disclosure - OTHER ASSETS Sheet http://hartfordhealthcare.org/role/OtherAssets OTHER ASSETS Notes 15 false false R16.htm 00000016 - Disclosure - OTHER CURRENT PAYABLES Sheet http://hartfordhealthcare.org/role/OtherCurrentPayables OTHER CURRENT PAYABLES Notes 16 false false R17.htm 00000017 - Disclosure - LEASES Sheet http://hartfordhealthcare.org/role/Leases LEASES Notes 17 false false R18.htm 00000018 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://hartfordhealthcare.org/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 18 false false R19.htm 00000019 - Disclosure - NONCONTROLLING INTERESTS Sheet http://hartfordhealthcare.org/role/NoncontrollingInterests NONCONTROLLING INTERESTS Notes 19 false false R20.htm 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://hartfordhealthcare.org/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 00000021 - Disclosure - SEGMENT INFORMATION Sheet http://hartfordhealthcare.org/role/SegmentInformation SEGMENT INFORMATION Notes 21 false false R22.htm 00000022 - Disclosure - SUBSEQUENT EVENTS Sheet http://hartfordhealthcare.org/role/SubsequentEvents SUBSEQUENT EVENTS Notes 22 false false R23.htm 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 00000024 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Tables) Sheet http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationTables ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Tables) Tables http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation 24 false false R25.htm 00000025 - Disclosure - RESTRICTED CASH (Tables) Sheet http://hartfordhealthcare.org/role/RestrictedCashTables RESTRICTED CASH (Tables) Tables http://hartfordhealthcare.org/role/RestrictedCash 25 false false R26.htm 00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://hartfordhealthcare.org/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://hartfordhealthcare.org/role/PropertyAndEquipmentNet 26 false false R27.htm 00000027 - Disclosure - OTHER ASSETS (Tables) Sheet http://hartfordhealthcare.org/role/OtherAssetsTables OTHER ASSETS (Tables) Tables http://hartfordhealthcare.org/role/OtherAssets 27 false false R28.htm 00000028 - Disclosure - OTHER CURRENT PAYABLES (Tables) Sheet http://hartfordhealthcare.org/role/OtherCurrentPayablesTables OTHER CURRENT PAYABLES (Tables) Tables http://hartfordhealthcare.org/role/OtherCurrentPayables 28 false false R29.htm 00000029 - Disclosure - LEASES (Tables) Sheet http://hartfordhealthcare.org/role/LeasesTables LEASES (Tables) Tables http://hartfordhealthcare.org/role/Leases 29 false false R30.htm 00000030 - Disclosure - NONCONTROLLING INTERESTS (Tables) Sheet http://hartfordhealthcare.org/role/NoncontrollingInterestsTables NONCONTROLLING INTERESTS (Tables) Tables http://hartfordhealthcare.org/role/NoncontrollingInterests 30 false false R31.htm 00000031 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://hartfordhealthcare.org/role/SegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://hartfordhealthcare.org/role/SegmentInformation 31 false false R32.htm 00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies 32 false false R33.htm 00000033 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://hartfordhealthcare.org/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://hartfordhealthcare.org/role/GoingConcern 33 false false R34.htm 00000034 - Disclosure - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Details 34 false false R35.htm 00000035 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) Sheet http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) Details 35 false false R36.htm 00000036 - Disclosure - SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details) Details 36 false false R37.htm 00000037 - Disclosure - SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY (Details) Details 37 false false R38.htm 00000038 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Details Narrative) Sheet http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Details Narrative) Details http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationTables 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details) Details 39 false false R40.htm 00000040 - Disclosure - PREPAID AND OTHER CURRENT RECEIVABLES (Details Narrative) Sheet http://hartfordhealthcare.org/role/PrepaidAndOtherCurrentReceivablesDetailsNarrative PREPAID AND OTHER CURRENT RECEIVABLES (Details Narrative) Details http://hartfordhealthcare.org/role/PrepaidAndOtherCurrentReceivables 40 false false R41.htm 00000041 - Disclosure - INVENTORY (Details Narrative) Sheet http://hartfordhealthcare.org/role/InventoryDetailsNarrative INVENTORY (Details Narrative) Details http://hartfordhealthcare.org/role/Inventory 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Details 42 false false R43.htm 00000043 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) Sheet http://hartfordhealthcare.org/role/PropertyAndEquipmentNetDetailsNarrative PROPERTY AND EQUIPMENT, NET (Details Narrative) Details http://hartfordhealthcare.org/role/PropertyAndEquipmentNetTables 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF OTHER ASSETS (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails SCHEDULE OF OTHER ASSETS (Details) Details 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) Details 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES (Details) Details 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE COST (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails SCHEDULE OF COMPONENTS OF LEASE COST (Details) Details 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfSupplementalCashFlowInformationForLeasesDetails SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES (Details) Details 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfWeighted-averageRemainingLeaseTermAndWeighted-averageDiscountRateForOperatingAndFinanceLeasesDetails SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES (Details) Details 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES (Details) Details 50 false false R51.htm 00000051 - Disclosure - LEASES (Details Narrative) Sheet http://hartfordhealthcare.org/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://hartfordhealthcare.org/role/LeasesTables 51 false false R52.htm 00000052 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://hartfordhealthcare.org/role/RelatedPartyTransactions 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF NONCONTROLLING INTERESTS (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails SCHEDULE OF NONCONTROLLING INTERESTS (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF NONCONTROLLING INTERESTS (Details) (Parenthetical) Sheet http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical SCHEDULE OF NONCONTROLLING INTERESTS (Details) (Parenthetical) Details 54 false false R55.htm 00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://hartfordhealthcare.org/role/CommitmentsAndContingencies 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF SEGMENT INFORMATION (Details) Sheet http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails SCHEDULE OF SEGMENT INFORMATION (Details) Details 56 false false All Reports Book All Reports form10-q.htm ex31-1.htm ex31-2.htm ex32-1.htm hfus-20211031.xsd hfus-20211031_cal.xml hfus-20211031_def.xml hfus-20211031_lab.xml hfus-20211031_pre.xml http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 15, "contextCount": 149, "dts": { "calculationLink": { "local": [ "hfus-20211031_cal.xml" ] }, "definitionLink": { "local": [ "hfus-20211031_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "hfus-20211031_lab.xml" ] }, "presentationLink": { "local": [ "hfus-20211031_pre.xml" ] }, "schema": { "local": [ "hfus-20211031.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 438, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 41, "http://hartfordhealthcare.org/20211031": 11, "http://xbrl.sec.gov/dei/2021": 4, "total": 56 }, "keyCustom": 38, "keyStandard": 293, "memberCustom": 48, "memberStandard": 13, "nsprefix": "HFUS", "nsuri": "http://hartfordhealthcare.org/20211031", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://hartfordhealthcare.org/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION", "role": "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation", "shortName": "ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - RESTRICTED CASH", "role": "http://hartfordhealthcare.org/role/RestrictedCash", "shortName": "RESTRICTED CASH", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:PrepaidAndOtherCurrentReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - PREPAID AND OTHER CURRENT RECEIVABLES", "role": "http://hartfordhealthcare.org/role/PrepaidAndOtherCurrentReceivables", "shortName": "PREPAID AND OTHER CURRENT RECEIVABLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:PrepaidAndOtherCurrentReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INVENTORY", "role": "http://hartfordhealthcare.org/role/Inventory", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET", "role": "http://hartfordhealthcare.org/role/PropertyAndEquipmentNet", "shortName": "PROPERTY AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - OTHER ASSETS", "role": "http://hartfordhealthcare.org/role/OtherAssets", "shortName": "OTHER ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - OTHER CURRENT PAYABLES", "role": "http://hartfordhealthcare.org/role/OtherCurrentPayables", "shortName": "OTHER CURRENT PAYABLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - LEASES", "role": "http://hartfordhealthcare.org/role/Leases", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://hartfordhealthcare.org/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - NONCONTROLLING INTERESTS", "role": "http://hartfordhealthcare.org/role/NoncontrollingInterests", "shortName": "NONCONTROLLING INTERESTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://hartfordhealthcare.org/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-31", "decimals": "0", "lang": null, "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://hartfordhealthcare.org/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SEGMENT INFORMATION", "role": "http://hartfordhealthcare.org/role/SegmentInformation", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUBSEQUENT EVENTS", "role": "http://hartfordhealthcare.org/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:OrganizationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:OrganizationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Tables)", "role": "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationTables", "shortName": "ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:RestrictedAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - RESTRICTED CASH (Tables)", "role": "http://hartfordhealthcare.org/role/RestrictedCashTables", "shortName": "RESTRICTED CASH (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RestrictedAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "role": "http://hartfordhealthcare.org/role/PropertyAndEquipmentNetTables", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - OTHER ASSETS (Tables)", "role": "http://hartfordhealthcare.org/role/OtherAssetsTables", "shortName": "OTHER ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - OTHER CURRENT PAYABLES (Tables)", "role": "http://hartfordhealthcare.org/role/OtherCurrentPayablesTables", "shortName": "OTHER CURRENT PAYABLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - LEASES (Tables)", "role": "http://hartfordhealthcare.org/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:ScheduleOfNoncontrollingInterestsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - NONCONTROLLING INTERESTS (Tables)", "role": "http://hartfordhealthcare.org/role/NoncontrollingInterestsTables", "shortName": "NONCONTROLLING INTERESTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:ScheduleOfNoncontrollingInterestsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - SEGMENT INFORMATION (Tables)", "role": "http://hartfordhealthcare.org/role/SegmentInformationTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - GOING CONCERN (Details Narrative)", "role": "http://hartfordhealthcare.org/role/GoingConcernDetailsNarrative", "shortName": "GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-07-20_custom_ShanghaiGelinkeChildcareEducationCenterMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-07-20_custom_ShanghaiGelinkeChildcareEducationCenterMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-07-192020-07-20_custom_ShanghaiGelinkeChildcareEducationCenterMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)", "role": "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "shortName": "ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION - SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-07-192020-07-20_custom_ShanghaiGelinkeChildcareEducationCenterMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "HFUS:ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_custom_QiaoGardenIntelTravelMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "shortName": "SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "HFUS:ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_custom_QiaoGardenIntelTravelMember", "decimals": "0", "lang": null, "name": "HFUS:DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "HFUS:ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_custom_QiaoGardenIntelTravelMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails", "shortName": "SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_custom_QiaoGardenIntelTravelMember", "decimals": "0", "lang": null, "name": "HFUS:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalentsAndRestrictedCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-05-302021-06-01_custom_HFIntlEducationMember", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:NoncontrollingShareholdersDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Details Narrative)", "role": "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "shortName": "ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-05-302021-06-01_custom_HFIntlEducationMember", "decimals": null, "first": true, "lang": "en-US", "name": "HFUS:NoncontrollingShareholdersDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails", "shortName": "SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:RestrictedAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-31", "decimals": "0", "lang": null, "name": "us-gaap:RestrictedCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://hartfordhealthcare.org/role/StatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "lang": null, "name": "HFUS:CostOfRevenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - PREPAID AND OTHER CURRENT RECEIVABLES (Details Narrative)", "role": "http://hartfordhealthcare.org/role/PrepaidAndOtherCurrentReceivablesDetailsNarrative", "shortName": "PREPAID AND OTHER CURRENT RECEIVABLES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - INVENTORY (Details Narrative)", "role": "http://hartfordhealthcare.org/role/InventoryDetailsNarrative", "shortName": "INVENTORY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)", "role": "http://hartfordhealthcare.org/role/PropertyAndEquipmentNetDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherAssetsMiscellaneous", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF OTHER ASSETS (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails", "shortName": "SCHEDULE OF OTHER ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherAssetsMiscellaneous", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "HFUS:PayableToAcquiree", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails", "shortName": "SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "HFUS:PayableToAcquiree", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "HFUS:ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "HFUS:ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE COST (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails", "shortName": "SCHEDULE OF COMPONENTS OF LEASE COST (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfSupplementalCashFlowInformationForLeasesDetails", "shortName": "SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "HFUS:ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingAndFinanceLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfWeighted-averageRemainingLeaseTermAndWeighted-averageDiscountRateForOperatingAndFinanceLeasesDetails", "shortName": "SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "HFUS:ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingAndFinanceLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited)", "role": "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss", "shortName": "Consolidated Statements of Comprehensive Income (Loss) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "HFUS:ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "HFUS:ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - LEASES (Details Narrative)", "role": "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "shortName": "LEASES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LoansPayableFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LoansPayableFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MinorityInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SCHEDULE OF NONCONTROLLING INTERESTS (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails", "shortName": "SCHEDULE OF NONCONTROLLING INTERESTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "HFUS:ScheduleOfNoncontrollingInterestsTableTextBlock", "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-08-012021-07-31", "decimals": "0", "lang": null, "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "HFUS:ScheduleOfNoncontrollingInterestsTableTextBlock", "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-31_custom_HFIntlEducationMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF NONCONTROLLING INTERESTS (Details) (Parenthetical)", "role": "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical", "shortName": "SCHEDULE OF NONCONTROLLING INTERESTS (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "HFUS:ScheduleOfNoncontrollingInterestsTableTextBlock", "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-31_custom_HFIntlEducationMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31_custom_HFHMMember_us-gaap_LicenseMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedLicenseAgreementsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-10-31_custom_HFHMMember_us-gaap_LicenseMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedLicenseAgreementsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SCHEDULE OF SEGMENT INFORMATION (Details)", "role": "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails", "shortName": "SCHEDULE OF SEGMENT INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-10-31", "decimals": "0", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-07-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)", "role": "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit", "shortName": "Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-07-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://hartfordhealthcare.org/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-08-012020-10-31", "decimals": "0", "lang": null, "name": "us-gaap:GainLossOnSaleOfPropertyPlantEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN", "role": "http://hartfordhealthcare.org/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-08-01to2021-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 65, "tag": { "HFUS_AdvancesFromRelatedParties": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advances from related parties.", "label": "Advances from related parties" } } }, "localname": "AdvancesFromRelatedParties", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "HFUS_AffiliatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affiliates [Member]", "label": "Affiliates [Member]" } } }, "localname": "AffiliatesMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restricted Cash.", "label": "Restricted Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination, recognized identifiable assets acquired and liabilities assumed, current assets, goodwill.", "label": "Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_CorporateAndUnallocatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate and Unallocated [Member]", "label": "Corporate and Unallocated [Member]" } } }, "localname": "CorporateAndUnallocatedMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "HFUS_CostOfRevenues": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of revenue.", "label": "Cost of revenue" } } }, "localname": "CostOfRevenues", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "HFUS_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Components Of Lease Cost", "verboseLabel": "Schedule Of Lease-related Assets And Liabilities" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://hartfordhealthcare.org/20211031", "xbrltype": "stringItemType" }, "HFUS_DisclosurePrepaidAndOtherCurrentReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid And Other Current Receivables" } } }, "localname": "DisclosurePrepaidAndOtherCurrentReceivablesAbstract", "nsuri": "http://hartfordhealthcare.org/20211031", "xbrltype": "stringItemType" }, "HFUS_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalentsAndRestrictedCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation, cash and cash equivalents and restricted cash.", "label": "Cash and cash equivalents deconsolidated" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalentsAndRestrictedCash", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation, net assets of the subsidiary.", "label": "Net assets of the subsidiary, excluding noncontrolling interest" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationNetAssetsOfSubsidiary", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation, noncontrolling interest.", "label": "DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest", "verboseLabel": "Noncontrolling interest" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_DisposalGroupIncludingDiscontinuedOperationRelatedPartyPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Related party payable.", "label": "Related party payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRelatedPartyPayable", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation, related party receivable.", "label": "DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable", "verboseLabel": "Related party receivable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRelatedPartyReceivable", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_DisposalGroupIncludingDiscontinuedOperationRestrictedCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operation, restricted cash.", "label": "DisposalGroupIncludingDiscontinuedOperationRestrictedCash", "negatedLabel": "Restricted cash", "verboseLabel": "Restricted cash" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRestrictedCash", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_DisposalOfSubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal of subsidiary.", "label": "Disposal of subsidiary" } } }, "localname": "DisposalOfSubsidiary", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_EarlyChildhoodEducationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Early Childhood Education Services [Member]", "label": "Early Childhood Education Services [Member]" } } }, "localname": "EarlyChildhoodEducationServicesMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_EarlyTerminationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Early Termination Agreement [Member]", "label": "Early Termination Agreement [Member]" } } }, "localname": "EarlyTerminationAgreementMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_EducationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Education [Member]", "label": "Education [Member]" } } }, "localname": "EducationMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "HFUS_FinanceLeaseAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finance Lease Assets [Member]", "label": "Finance Lease Assets [Member]" } } }, "localname": "FinanceLeaseAssetsMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "HFUS_FinanceLeaseCost": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails": { "order": 4.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance lease cost.", "label": "Finance lease cost" } } }, "localname": "FinanceLeaseCost", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_FiveYearNewleaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five-Year New Lease Agreement [Member]", "label": "Five-Year New Lease Agreement [Member]" } } }, "localname": "FiveYearNewleaseAgreementMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_GainOnDisposalOfSubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain on disposal of subsidiary.", "label": "Gain on disposal of subsidiary" } } }, "localname": "GainOnDisposalOfSubsidiary", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "HFUS_HFHMMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HFHM [Member]", "label": "HFHM [Member]" } } }, "localname": "HFHMMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_HFIntlEducationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HF Int'l Education [Member]", "label": "HF Int'l Education [Member]" } } }, "localname": "HFIntlEducationMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "HFUS_HFSHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HFSH [Member]", "label": "HFSH [Member]" } } }, "localname": "HFSHMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_HZLJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HZLJ [Member]", "label": "HZLJ [Member]" } } }, "localname": "HZLJMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "domainItemType" }, "HFUS_HangzhouHartfordComprehensiveHealthManagementLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hangzhou Hartford Comprehensive Health Management, Ltd [Member]", "label": "Hangzhou Hartford Comprehensive Health Management, Ltd [Member]" } } }, "localname": "HangzhouHartfordComprehensiveHealthManagementLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_HangzhouLongjingQiaoFuVacationHotelCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd [Member]", "label": "Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. [Member]" } } }, "localname": "HangzhouLongjingQiaoFuVacationHotelCoLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_HartfordGreatHealthManagementShanghaiLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hartford Great Health Management (Shanghai) Ltd. [Member]", "label": "Hartford Great Health Management (Shanghai) Ltd. [Member]" } } }, "localname": "HartfordGreatHealthManagementShanghaiLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_HartfordHotelInvestmentIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hartford Hotel Investment Inc [Member]", "label": "Hartford Hotel Investment Inc [Member]" } } }, "localname": "HartfordHotelInvestmentIncMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_HartfordInternationalEducationTechnologyCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hartford International Education Technology Co., Ltd [Member]", "label": "Hartford International Education Technology Co., Ltd [Member]" } } }, "localname": "HartfordInternationalEducationTechnologyCoLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_HospitalityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hospitality [Member]", "label": "Hospitality [Member]" } } }, "localname": "HospitalityMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "HFUS_IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in operating lease assets and liabilities.", "label": "Increase decrease in operating lease assets and liabilities", "negatedLabel": "Operating lease assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "HFUS_IntellectualPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intellectual Properties [Member]", "label": "Intellectual Properties [Member]" } } }, "localname": "IntellectualPropertiesMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_InvestmentFromNoncontrollingInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment from Noncontrolling Interest.", "label": "Investment from noncontrolling interest" } } }, "localname": "InvestmentFromNoncontrollingInterests", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "HFUS_JointVentureAcquiredOwnershipInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint venture acquired ownership interest.", "label": "Joint venture acquired ownership interest" } } }, "localname": "JointVentureAcquiredOwnershipInterest", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "percentItemType" }, "HFUS_JointVentureAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint Venture Agreement [Member]", "label": "Joint Venture Agreement [Member]" } } }, "localname": "JointVentureAgreementMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_LeaseAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease agreement, description.", "label": "Lease agreement, description" } } }, "localname": "LeaseAgreementDescription", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "HFUS_LeaseLiabilities": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total Lease liabilities.", "label": "LeaseLiabilities", "totalLabel": "Total Lease liabilities" } } }, "localname": "LeaseLiabilities", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_LicenseDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License Description", "label": "[custom:LicenseDescription]" } } }, "localname": "LicenseDescription", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "HFUS_NewleaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Lease Agreement [Member]", "label": "New Lease Agreement [Member]" } } }, "localname": "NewleaseAgreementMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_NoncontrollingShareholdersDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncontrolling shareholders, description.", "label": "Noncontrolling shareholders, description" } } }, "localname": "NoncontrollingShareholdersDescription", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "HFUS_NonrefundableRentalDepoitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonrefundable Rental Depoit [Member]", "label": "Nonrefundable Rental Depoit [Member]" } } }, "localname": "NonrefundableRentalDepoitMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_OfficeEquipmentVehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Equipment Vehicles [Member]", "label": "Office Equipment Vehicles [Member]" } } }, "localname": "OfficeEquipmentVehiclesMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "HFUS_OperatingAndFinanceLeaseLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating and finance lease liability noncurrent.", "label": "Lease liabilities, noncurrent" } } }, "localname": "OperatingAndFinanceLeaseLiabilityNoncurrent", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "HFUS_OrganizationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization [Policy Text Block]", "label": "Organization" } } }, "localname": "OrganizationPolicyTextBlock", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "HFUS_PayableToAcquiree": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherNotesPayableCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable to Acquiree.", "label": "Payable to acquirees" } } }, "localname": "PayableToAcquiree", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_PayableToPublisherCurrent": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherNotesPayableCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable to publisher.", "label": "Payable to publisher" } } }, "localname": "PayableToPublisherCurrent", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_PaymentToLicenseFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payment to license fee", "label": "[custom:PaymentToLicenseFee]" } } }, "localname": "PaymentToLicenseFee", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "HFUS_PrepaidAndOtherCurrentReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepaid and other current receivable [Text Block]", "label": "PREPAID AND OTHER CURRENT RECEIVABLES" } } }, "localname": "PrepaidAndOtherCurrentReceivableTextBlock", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/PrepaidAndOtherCurrentReceivables" ], "xbrltype": "textBlockItemType" }, "HFUS_PudongHaojinChildhoodEducationLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pudong Haojin Childhood Education Ltd [Member]", "label": "Pudong Haojin Childhood Education Ltd [Member]" } } }, "localname": "PudongHaojinChildhoodEducationLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_QiaoGardenIntTravelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Qiao Garden Intl Travel [Member]", "label": "Qiao Garden Intl Travel [Member]" } } }, "localname": "QiaoGardenIntTravelMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "domainItemType" }, "HFUS_QiaoGardenIntelTravelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Qiao Garden Intel Travel [Member]", "label": "Qiao Garden Intel Travel [Member]" } } }, "localname": "QiaoGardenIntelTravelMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails" ], "xbrltype": "domainItemType" }, "HFUS_QiaoGardenInternationalTravelAgencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Qiao Garden International Travel Agency [Member]", "label": "Qiao Garden International Travel Agency [Member]" } } }, "localname": "QiaoGardenInternationalTravelAgencyMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_RefundOfFictitiousOfficePropertyRequested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Refund of fictitious office property requested.", "label": "Refund of fictitious office property requested" } } }, "localname": "RefundOfFictitiousOfficePropertyRequested", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "HFUS_RelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party [Member]", "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_RentalDeposits": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rental deposits.", "label": "Rental deposits" } } }, "localname": "RentalDeposits", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_RestructureOfSubsidary": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructure of subsidary", "label": "Restructure of subsidary" } } }, "localname": "RestructureOfSubsidary", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_SHHZJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SHHZJ [Member]", "label": "SHHZJ [Member]" } } }, "localname": "SHHZJMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "HFUS_ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of future minimum lease payments for operating and finance leases [Table Text Block]", "label": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR OPERATING AND FINANCE LEASES" } } }, "localname": "ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesTableTextBlock", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "HFUS_ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of lease related assets and liabilities [Table Text Block]", "label": "SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfLeaseRelatedAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "HFUS_ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of net assets liabilities disposed of subsidiary [Table Text Block]", "label": "SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY" } } }, "localname": "ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryTableTextBlock", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationTables" ], "xbrltype": "textBlockItemType" }, "HFUS_ScheduleOfNoncontrollingInterestsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of noncontrolling interests [Table Text Block]", "label": "SCHEDULE OF NONCONTROLLING INTERESTS" } } }, "localname": "ScheduleOfNoncontrollingInterestsTableTextBlock", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/NoncontrollingInterestsTables" ], "xbrltype": "textBlockItemType" }, "HFUS_ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingAndFinanceLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of weighted average remaining lease term and weighted average discount rate for operating and finance leases [Table Text Block]", "label": "SCHEDULE OF WEIGHTED-AVERAGE REMAINING LEASE TERM AND WEIGHTED-AVERAGE DISCOUNT RATE FOR OPERATING AND FINANCE LEASES" } } }, "localname": "ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingAndFinanceLeasesTableTextBlock", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "HFUS_SecondLongTermAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Long Term Agreement [Member]", "label": "Second Long Term Agreement [Member]" } } }, "localname": "SecondLongTermAgreementMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_SevenEducationTextbooksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seven Education Textbooks [Member]", "label": "Seven Education Textbooks [Member]" } } }, "localname": "SevenEducationTextbooksMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiDuBianAssetsManagementLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai DuBian Assets Management Ltd. [Member]", "label": "Shanghai DuBian Assets Management Ltd. [Member]" } } }, "localname": "ShanghaiDuBianAssetsManagementLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiGelinkeChildcareEducationCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Gelinke Childcare Education Center [Member]", "label": "Shanghai Gelinke Childcare Education Center [Member]" } } }, "localname": "ShanghaiGelinkeChildcareEducationCenterMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiHartfordComprehensiveHealthManagementLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Hartford Comprehensive Health Management, Ltd. [Member]", "label": "Shanghai Hartford Comprehensive Health Management, Ltd. [Member]" } } }, "localname": "ShanghaiHartfordComprehensiveHealthManagementLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd [Member]", "label": "Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd [Member]" } } }, "localname": "ShanghaiHongkouHaiDeFuDeChildcareCoLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiLuoShengInternationalTradeLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Luo Sheng International Trade Ltd. [Member]", "label": "Shanghai Luo Sheng International Trade Ltd. [Member]" } } }, "localname": "ShanghaiLuoShengInternationalTradeLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiOverseaChineseCultureMediaLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Oversea Chinese Culture Media Ltd. [Member]", "label": "Shanghai Oversea Chinese Culture Media Ltd. [Member]" } } }, "localname": "ShanghaiOverseaChineseCultureMediaLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiPasadenaLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Pasadena Ltd. [Member]", "label": "Shanghai Pasadena Ltd. [Member]" } } }, "localname": "ShanghaiPasadenaLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiQiaoGardenPropertyManagementGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Qiao Garden Property Management Group [Member]", "label": "Shanghai Qiao Garden Property Management Group [Member]" } } }, "localname": "ShanghaiQiaoGardenPropertyManagementGroupMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiQiaohongRealEstateCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Qiaohong Real Estate Co., Ltd. [Member]", "label": "Shanghai Qiaohong Real Estate Co., Ltd. [Member]" } } }, "localname": "ShanghaiQiaohongRealEstateCoLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShanghaiSeniorHealthConsultingLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shanghai Senior Health Consulting Ltd [Member]", "label": "Shanghai Senior Health Consulting Ltd. [Member]" } } }, "localname": "ShanghaiSeniorHealthConsultingLtdMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShareholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholders [Member]", "label": "Shareholders [Member]" } } }, "localname": "ShareholdersMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_ShortTermBorrowingsAndInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unpaid principal and interest.", "label": "Unpaid principal and interest" } } }, "localname": "ShortTermBorrowingsAndInterest", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "HFUS_ShorttermAndLongtermPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Short-term and long-term payable.", "label": "Short-term and long-term payable" } } }, "localname": "ShorttermAndLongtermPayable", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "HFUS_SubleaseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sublease Agreements [Member]", "label": "Sublease Agreements [Member]" } } }, "localname": "SubleaseAgreementsMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_SublessorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sublessor [Member]", "label": "Sublessor [Member]" } } }, "localname": "SublessorMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_TenHaiDeFuDeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten \u201cHaiDeFuDe\u201d [Member]", "label": "Ten \u0093HaiDeFuDe\u0094 [Member]" } } }, "localname": "TenHaiDeFuDeMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_TotalLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Lease ROU assets.", "label": "TotalLeaseRightOfUseAssets", "totalLabel": "Total Lease ROU assets" } } }, "localname": "TotalLeaseRightOfUseAssets", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "HFUS_TuitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tuition [Member]", "label": "Tuition [Member]" } } }, "localname": "TuitionMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "HFUS_TwoDebtAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Debt Agreements [Member]", "label": "Two Debt Agreements [Member]" } } }, "localname": "TwoDebtAgreementsMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_TwoLeaseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Lease Agreements [Member]", "label": "Two Lease Agreements [Member]" } } }, "localname": "TwoLeaseAgreementsMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_TwoSubleaseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Sublease Agreements [Member]", "label": "Two Sublease Agreements [Member]" } } }, "localname": "TwoSubleaseAgreementsMember", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "HFUS_UnpaidBillsForLeaseholderImprovements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unpaid bills for leaseholder improvements.", "label": "Unpaid bills for leaseholder improvements" } } }, "localname": "UnpaidBillsForLeaseholderImprovements", "nsuri": "http://hartfordhealthcare.org/20211031", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r437", "r439", "r440" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Series [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r114", "r211", "r216", "r222", "r280", "r281", "r289", "r290", "r341", "r425" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r114", "r211", "r216", "r222", "r280", "r281", "r289", "r290", "r341", "r425" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r225", "r227", "r245", "r248", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r412", "r414", "r426", "r427" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r225", "r227", "r245", "r248", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r412", "r414", "r426", "r427" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r169", "r239", "r240", "r356", "r411", "r413" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/StatementsOfOperations", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r169", "r239", "r240", "r356", "r411", "r413" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/StatementsOfOperations", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r225", "r227", "r242", "r245", "r248", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r412", "r414", "r426", "r427" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r225", "r227", "r242", "r245", "r248", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r412", "r414", "r426", "r427" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r124", "r128", "r246" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r124", "r128", "r203", "r246", "r346" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r174", "r337" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "OTHER CURRENT PAYABLES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/OtherCurrentPayables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r113", "r335", "r379", "r400" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties.", "label": "Related Party Payables" } } }, "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r36", "r113", "r335", "r338", "r397" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Related party receivables" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedPartiesCurrent": { "auth_ref": [ "r56", "r113", "r335", "r338" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.", "label": "Related party receivable" } } }, "localname": "AccountsReceivableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Other current payable" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r21", "r50" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherNotesPayableCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r45", "r192" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r39", "r62", "r64", "r65", "r393", "r419", "r420" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r61", "r65", "r73", "r74", "r75", "r116", "r117", "r118", "r286", "r415", "r416", "r447" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r37", "r252", "r344" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r116", "r117", "r118", "r249", "r250", "r251", "r296" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss including noncontrolling interests to net cash (used in) operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r111", "r151", "r158", "r165", "r176", "r211", "r212", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r222", "r223", "r280", "r289", "r298", "r342", "r344", "r374", "r390" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets (excluding Intercompany balances)", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r18", "r19", "r59", "r111", "r176", "r211", "r212", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r222", "r223", "r280", "r289", "r298", "r342", "r344" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r24", "r25", "r26", "r27", "r28", "r29", "r30", "r31", "r111", "r176", "r211", "r212", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r222", "r223", "r280", "r289", "r298", "r342" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Non-current Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r244", "r247" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r244", "r247", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Acquired percentage", "verboseLabel": "Business acquired ownership interest" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "ACQUISITIONS, JOINT VENTURES AND DECONSOLIDATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r270" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r270" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "verboseLabel": "Prepaid and Other current receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r270" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "negatedLabel": "Unearned revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r269", "r270" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Total consideration", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net, Total" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r269", "r270" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Property and Equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Capital": { "auth_ref": [ "r389" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total capital as defined by regulatory framework.", "label": "Registered capital" } } }, "localname": "Capital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r105", "r106", "r107" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Payable to acquiree" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r16", "r43", "r103" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r96", "r103", "r108" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "totalLabel": "Total cash, cash equivalents and restricted cash shown in the statement of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r96", "r103", "r108" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r96", "r300" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r54", "r202", "r380", "r399" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 13)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r199", "r200", "r201", "r210", "r421" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r116", "r117", "r296" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r35", "r228" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r35", "r344" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock - $0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of October 31 and July 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r68", "r70", "r71", "r81", "r385", "r406" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r68", "r70", "r80", "r278", "r279", "r293", "r384", "r405" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Less\uff1a total other comprehensive loss attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "auth_ref": [ "r287", "r294" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear": { "auth_ref": [ "r105", "r107" ], "lang": { "en-us": { "role": { "documentation": "Expiration, mandatory redemption, or due date, in YYYY-MM-DD format, of the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction.", "label": "Expiration date" } } }, "localname": "DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r52", "r224" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Short term debt interest rate, percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r101", "r190" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r101", "r190" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "auth_ref": [ "r3", "r4", "r12", "r194" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "negatedLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Consideration" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": { "auth_ref": [ "r3", "r4", "r12", "r189", "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current", "negatedLabel": "Other current payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r113", "r214", "r216", "r217", "r221", "r222", "r223", "r335", "r378", "r401" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Advance from related party" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesNoncurrent": { "auth_ref": [ "r53", "r113", "r214", "r216", "r217", "r221", "r222", "r223", "r335" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.", "label": "Long-term loan from related party" } } }, "localname": "DueToRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and Diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r300" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EnergyMarketingContractLiabilitiesCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current liabilities attributable to energy marketing activities (trading activities). Current energy marketing (trading activities) are when entities engage in both financial and physical trading to increase profits, manage their commodity price risk and enhance system reliability. They may trade electricity, coal, natural gas and oil. These entities typically use a variety of financial instruments, including forward contracts, options and swaps.", "label": "Contract liabilities" } } }, "localname": "EnergyMarketingContractLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r73", "r74", "r75", "r116", "r117", "r118", "r120", "r125", "r127", "r131", "r177", "r228", "r229", "r249", "r250", "r251", "r261", "r262", "r296", "r301", "r302", "r303", "r304", "r305", "r308", "r415", "r416", "r417", "r447" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r313", "r319", "r327" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Interest on finance lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r315", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Financing cash flows paid for finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSupplementalCashFlowInformationForLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r312", "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "verboseLabel": "Present value of future lease payments" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Including: current lease liabilities" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r312" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "HFUS_LeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance lease liabilities, noncurrent", "verboseLabel": "Including: noncurrent lease liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails", "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Leases, Total lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Leases, 2027 and thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Leases, 2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Leases, 2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Leases, 2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Leases, 2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Leases, 2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r314", "r321" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Principal payments on finance lease" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r311" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "HFUS_TotalLeaseRightOfUseAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "totalLabel": "Finance lease right-of-use assets, net" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": { "auth_ref": [ "r313", "r319" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization", "negatedLabel": "Less: accumulated amortization" } } }, "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r313", "r319", "r327" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Amortization of ROU assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "auth_ref": [ "r311" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance lease right-of-use assets, cost (Note 7)" } } }, "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r323", "r327" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Weighted-average discount rate Finance Leases" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfWeighted-averageRemainingLeaseTermAndWeighted-averageDiscountRateForOperatingAndFinanceLeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r322", "r327" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted-average remaining lease term (years) Finance Leases" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfWeighted-averageRemainingLeaseTermAndWeighted-averageDiscountRateForOperatingAndFinanceLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r182", "r184", "r186", "r188", "r357", "r358" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r182", "r185" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedLicenseAgreementsGross": { "auth_ref": [ "r186" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount as of the balance sheet date of certain rights acquired to exercise a certain privilege or pursue a particular business or occupation and which is deemed to have a finite economic life.", "label": "Finite-Lived License Agreements, Gross" } } }, "localname": "FiniteLivedLicenseAgreementsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r101" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnTerminationOfLease": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.", "label": "Gain on termination of lease" } } }, "localname": "GainLossOnTerminationOfLease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r179", "r180", "r344", "r373" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Default Label]", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r77", "r151", "r157", "r161", "r164", "r167", "r371", "r381", "r387", "r407" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before tax", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r5", "r6", "r7", "r8", "r9", "r13", "r14", "r265", "r402" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Gain on disposal of the subsidiary" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r5", "r6", "r7", "r8", "r9", "r11", "r13", "r275", "r277" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Gain on disposal of noncontrolling interest" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r5", "r6", "r7", "r8", "r9", "r11", "r13", "r277" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Gain on disposal of the subsidiary, excluding noncontrolling interest" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income tax examination description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r112", "r126", "r127", "r149", "r255", "r263", "r264", "r408" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r72", "r253", "r254", "r257", "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r100" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Related party receivables and payables" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r100", "r355" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Contract liabilities" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r100" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r100" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Increase (Decrease) in Other Accounts Payable", "verboseLabel": "Other current payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r100" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r100" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r100" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid and other current receivables" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r183", "r187" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r183", "r187" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpenseRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense incurred on a debt or other obligation to related party.", "label": "Interest expense" } } }, "localname": "InterestExpenseRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r386" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest (expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOperating": { "auth_ref": [ "r82" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.", "label": "Interest income" } } }, "localname": "InterestIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r94", "r97", "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORY" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r17", "r58", "r344" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "verboseLabel": "Inventory's net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r86", "r88" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r324", "r327" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "SCHEDULE OF COMPONENTS OF LEASE COST" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease agreement, date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeFinanceLeaseRemainingLeaseTerm": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance leases remaining term" } } }, "localname": "LesseeFinanceLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Operating Leases, Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Operating Leases, 2027 and thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Operating Leases, 2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Operating Leases, 2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Operating Leases, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Operating Leases, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Operating Leases, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating leases remaining term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingSubleaseOptionToExtend": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend operating sublease.", "label": "Sublease term description" } } }, "localname": "LesseeOperatingSubleaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lease term" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r49", "r111", "r159", "r176", "r211", "r212", "r213", "r216", "r217", "r218", "r219", "r220", "r222", "r223", "r281", "r289", "r290", "r298", "r342", "r343" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r40", "r111", "r176", "r298", "r344", "r377", "r396" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r51", "r111", "r176", "r211", "r212", "r213", "r216", "r217", "r218", "r219", "r220", "r222", "r223", "r281", "r289", "r290", "r298", "r342", "r343", "r344" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "License [Member]" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate at the end of the reporting period.", "label": "Line of credit facility, annum interest rate" } } }, "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount awarded from other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded from Other Party" } } }, "localname": "LitigationSettlementAmountAwardedFromOtherParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.", "label": "Estimated fair value of long term loans payable" } } }, "localname": "LoansPayableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r57", "r111", "r176", "r211", "r216", "r217", "r218", "r222", "r223", "r298", "r376", "r395" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest", "periodEndLabel": "Non-Controlling Interests ending balance", "periodStartLabel": "Non-Controlling Interests beginning balance" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDisclosureTextBlock": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "NONCONTROLLING INTERESTS" } } }, "localname": "MinorityInterestDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/NoncontrollingInterests" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Noncontrolling Interest [Line Items]" } } }, "localname": "MinorityInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling ownership interest", "verboseLabel": "% of Non-Controlling Interests" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestTable": { "auth_ref": [ "r57", "r83", "r276", "r288" ], "lang": { "en-us": { "role": { "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest [Table]" } } }, "localname": "MinorityInterestTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r96", "r99", "r102" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r14", "r66", "r69", "r75", "r78", "r102", "r111", "r119", "r121", "r122", "r123", "r124", "r126", "r127", "r129", "r151", "r157", "r161", "r164", "r167", "r176", "r211", "r212", "r213", "r216", "r217", "r218", "r219", "r220", "r222", "r223", "r297", "r298", "r382", "r403" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss", "totalLabel": "Net Loss Attributable to Hartford Great Health Corp", "verboseLabel": "Net Loss Attributable to Hartford Great Health Corp" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails", "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r66", "r69", "r75", "r126", "r127", "r283", "r292" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less: net loss attributable to noncontrolling Interest", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements." } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r116", "r117", "r118", "r229", "r275" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r87" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Other income, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r47", "r113", "r336" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Related party loan and payables" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs and Expenses", "totalLabel": "Total Operating Cost and Expenses" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating cost and expenses" } } }, "localname": "OperatingCostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r151", "r157", "r161", "r164", "r167" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating loss", "totalLabel": "Operating Loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r320", "r327" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfComponentsOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of future lease payments", "verboseLabel": "Lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r312" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "HFUS_LeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current operating Lease liabilities", "terseLabel": "Including: current lease liabilities", "verboseLabel": "Current Operating Lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails", "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r312" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "HFUS_LeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liabilities, noncurrent", "verboseLabel": "Including: noncurrent lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfFutureMinimumLeasePaymentsForOperatingAndFinanceLeasesDetails", "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r316", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating cash flows paid for operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSupplementalCashFlowInformationForLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r311" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "HFUS_TotalLeaseRightOfUseAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "ROU assets-operating lease", "terseLabel": "ROU of lease liability", "verboseLabel": "ROU assets-Operating lease" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfLease-relatedAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r323", "r327" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted-average discount rate Operating Leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfWeighted-averageRemainingLeaseTermAndWeighted-averageDiscountRateForOperatingAndFinanceLeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r322", "r327" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted-average remaining lease term (years) Operating Leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfWeighted-averageRemainingLeaseTermAndWeighted-averageDiscountRateForOperatingAndFinanceLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r20", "r21", "r22", "r50" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherNotesPayableCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other payables" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "OTHER ASSETS" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/OtherAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMiscellaneous": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets.", "label": "Other miscellaneous assets" } } }, "localname": "OtherAssetsMiscellaneous", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets", "totalLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/ScheduleOfOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r277", "r278", "r285" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfNoncontrollingInterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r60" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r60", "r63", "r299", "r307" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r67", "r70", "r73", "r74", "r76", "r79", "r228", "r301", "r306", "r308", "r383", "r404" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r67", "r70", "r277", "r278", "r285" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Total Other Comprehensive Loss Attributable to Hartford Great Health Corp" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive income (loss), net of income tax" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r85", "r410" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other expenses" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r409" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income (Expense)" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNotesPayableCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Notes Payable, Current", "totalLabel": "Other Current Payables" } } }, "localname": "OtherNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "totalLabel": "Other income (expense), net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPaymentsToAcquireBusinesses": { "auth_ref": [ "r90" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.", "label": "Cash payments to acquire business" } } }, "localname": "OtherPaymentsToAcquireBusinesses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForPreviousAcquisition": { "auth_ref": [ "r92" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow representing an adjustment to the purchase price of a previous acquisition.", "label": "Payments for Previous Acquisition", "negatedLabel": "Cash used in Acquisitions" } } }, "localname": "PaymentsForPreviousAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r90", "r272" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Purchase price" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r91" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r34", "r226" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r34", "r226" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r34", "r344" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r18", "r41", "r42" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid and Other current receivables", "verboseLabel": "Prepaid and other current receivables" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/PrepaidAndOtherCurrentReceivablesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromPreviousAcquisition": { "auth_ref": [ "r89" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash inflow representing an adjustment to the purchase price of a previous acquisition.", "label": "Cash proceeds from Acquisitions" } } }, "localname": "ProceedsFromPreviousAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r93" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds of related party notes payable" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r202", "r204", "r205", "r206", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r14", "r66", "r69", "r75", "r95", "r111", "r119", "r126", "r127", "r151", "r157", "r161", "r164", "r167", "r176", "r211", "r212", "r213", "r216", "r217", "r218", "r219", "r220", "r222", "r223", "r277", "r282", "r284", "r292", "r293", "r297", "r298", "r387" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net (loss)", "totalLabel": "Net Loss", "verboseLabel": "Net loss including noncontrolling interests" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows", "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r45", "r193" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r196", "r422", "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r44", "r191" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r27", "r28", "r193", "r344", "r388", "r398" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r27", "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r27", "r191" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r243", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": { "auth_ref": [ "r33", "r309", "r326", "r330", "r331", "r333" ], "lang": { "en-us": { "role": { "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.", "label": "Related party receivables, description" } } }, "localname": "RelatedPartyTransactionDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDueFromToRelatedParty": { "auth_ref": [ "r113", "r214", "r216", "r217", "r221", "r222", "r223", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.", "label": "Due to/from related party" } } }, "localname": "RelatedPartyTransactionDueFromToRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.", "label": "Interest rate" } } }, "localname": "RelatedPartyTransactionRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r243", "r334", "r338", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r332", "r333", "r335", "r339", "r340" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for assets that are restricted in their use, generally by contractual agreements or regulatory requirements. This would include, but not limited to, a description of the restricted assets and the terms of the restriction.", "label": "RESTRICTED CASH" } } }, "localname": "RestrictedAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RestrictedCash" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r108", "r372", "r392" ], "calculation": { "http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash [Default Label]", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r16", "r23", "r108" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r38", "r229", "r252", "r344", "r394", "r418", "r420" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r116", "r117", "r118", "r120", "r125", "r127", "r177", "r249", "r250", "r251", "r261", "r262", "r296", "r415", "r417" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r142", "r143", "r156", "r162", "r163", "r169", "r170", "r172", "r238", "r239", "r356" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total revenue", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails", "http://hartfordhealthcare.org/role/StatementsOfOperations", "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r110", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r241" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "SCHEDULE OF ACCOUNTS AND OTHER PAYABLES" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/OtherCurrentPayablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidation-ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "SCHEDULE OF NET INFLOW (OUTFLOW) OF CASH AND CASH EQUIVALENTS OF DISPOSAL SUBSIDIARY" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION FOR LEASES" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "SCHEDULE OF OTHER ASSETS" } } }, "localname": "ScheduleOfOtherAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/OtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r45", "r193" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "SCHEDULE OF RECOGNIZED IDENTIFIED ASSETS ACQUIRED AND LIABILITIES ASSUMED" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r336", "r338" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r23", "r108", "r372", "r392" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "SCHEDULE OF RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RestrictedCashTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r151", "r154", "r160", "r181" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r151", "r154", "r160", "r181" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "SCHEDULE OF SEGMENT INFORMATION" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r139", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r156", "r157", "r158", "r159", "r161", "r162", "r163", "r164", "r165", "r167", "r172", "r197", "r198", "r411" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r139", "r140", "r141", "r151", "r155", "r161", "r165", "r166", "r167", "r168", "r169", "r171", "r172", "r173" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r84" ], "calculation": { "http://hartfordhealthcare.org/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r32", "r344", "r375", "r391" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short term borrowings" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r109", "r115" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r10", "r139", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r156", "r157", "r158", "r159", "r161", "r162", "r163", "r164", "r165", "r167", "r172", "r181", "r195", "r197", "r198", "r411" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/ScheduleOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r55", "r73", "r74", "r75", "r116", "r117", "r118", "r120", "r125", "r127", "r131", "r177", "r228", "r229", "r249", "r250", "r251", "r261", "r262", "r296", "r301", "r302", "r303", "r304", "r305", "r308", "r415", "r416", "r417", "r447" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails", "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r116", "r117", "r118", "r131", "r356" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/ScheduleOfNetAssetsLiabilitiesDisposedOfSubsidiaryDetails", "http://hartfordhealthcare.org/role/ScheduleOfNetInflowOutflowOfCashAndCashEquivalentsOfDisposalSubsidiaryDetails", "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit", "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r74", "r111", "r116", "r117", "r118", "r120", "r125", "r176", "r177", "r229", "r249", "r250", "r251", "r261", "r262", "r275", "r276", "r291", "r296", "r298", "r301", "r302", "r308", "r416", "r417", "r447" ], "calculation": { "http://hartfordhealthcare.org/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Total Stockholders\u2019 Deficit", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/BalanceSheets", "http://hartfordhealthcare.org/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r345", "r347" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/AcquisitionsJointVenturesAndDeconsolidationDetailsNarrative", "http://hartfordhealthcare.org/role/CommitmentsAndContingenciesDetailsNarrative", "http://hartfordhealthcare.org/role/LeasesDetailsNarrative", "http://hartfordhealthcare.org/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r132", "r133", "r134", "r135", "r136", "r137", "r138" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://hartfordhealthcare.org/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r115": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r15": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r178": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r201": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r241": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686" }, "r295": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918703-209980" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r328": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919784-209982" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r347": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)(1)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=117337116&loc=SL5958568-112826" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r428": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r429": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r431": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r432": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r433": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r434": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r435": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r436": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r437": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r438": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r439": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r441": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r442": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r443": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r444": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r445": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r446": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" } }, "version": "2.1" } ZIP 74 0001493152-21-031557-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-031557-xbrl.zip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end

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ÿ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�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